<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosbiol</journal-id>
<journal-title-group>
<journal-title>PLOS Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1544-9173</issn>
<issn pub-type="epub">1545-7885</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pbio.2005886</article-id>
<article-id pub-id-type="publisher-id">pbio.2005886</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Methods and Resources</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Muscle proteins</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal system</subject><subj-group><subject>Muscles</subject><subj-group><subject>Skeletal muscles</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal system</subject><subj-group><subject>Muscles</subject><subj-group><subject>Skeletal muscles</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject><subj-group><subject>Lipid metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Lipid metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Chemical synthesis</subject><subj-group><subject>Biosynthetic techniques</subject><subj-group><subject>Protein synthesis</subject><subj-group><subject>Muscle protein synthesis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Protein synthesis</subject><subj-group><subject>Muscle protein synthesis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Protein metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Circadian oscillators</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Chronobiology</subject><subj-group><subject>Circadian oscillators</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Amino acid metabolism</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Transcriptional programming of lipid and amino acid metabolism by the skeletal muscle circadian clock</article-title>
<alt-title alt-title-type="running-head">Muscle clock directs diurnal metabolism</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Dyar</surname>
<given-names>Kenneth Allen</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hubert</surname>
<given-names>Michaël Jean</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Mir</surname>
<given-names>Ashfaq Ali</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Ciciliot</surname>
<given-names>Stefano</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lutter</surname>
<given-names>Dominik</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Greulich</surname>
<given-names>Franziska</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Quagliarini</surname>
<given-names>Fabiana</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kleinert</surname>
<given-names>Maximilian</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Fischer</surname>
<given-names>Katrin</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Eichmann</surname>
<given-names>Thomas Oliver</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wright</surname>
<given-names>Lauren Emily</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Peña Paz</surname>
<given-names>Marcia Ivonne</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Casarin</surname>
<given-names>Alberto</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Pertegato</surname>
<given-names>Vanessa</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Romanello</surname>
<given-names>Vanina</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Albiero</surname>
<given-names>Mattia</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Mazzucco</surname>
<given-names>Sara</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Rizzuto</surname>
<given-names>Rosario</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Salviati</surname>
<given-names>Leonardo</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Biolo</surname>
<given-names>Gianni</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Blaauw</surname>
<given-names>Bert</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Schiaffino</surname>
<given-names>Stefano</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4220-4779</contrib-id>
<name name-style="western">
<surname>Uhlenhaut</surname>
<given-names>N. Henriette</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Helmholtz Diabetes Center (HMGU) and German Center for Diabetes Research (DZD), Institute for Diabetes and Obesity (IDO), Munich, Germany</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Venetian Institute of Molecular Medicine (VIMM), Padova, Italy</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Institute of Molecular Biosciences, University of Graz, Graz, Austria</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Biomedical Sciences, University of Padova, Padova, Italy</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Clinical Genetics Unit, Department of Woman and Child Health, University of Padova, and IRP Città della Speranza, Padova, Italy</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Clinica Medica, Department of Medical Sciences, University of Trieste, Trieste, Italy</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>Gene Center, Ludwig-Maximilians-Universitaet (LMU), Munich, Germany</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Locasale</surname>
<given-names>Jason</given-names>
</name>
<role>Academic Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Duke University, United States of America</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">kenneth.dyar@helmholtz-muenchen.de</email> (KAD); <email xlink:type="simple">henriette.uhlenhaut@helmholtz-muenchen.de</email> (NHU)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>8</month>
<year>2018</year>
</pub-date>
<volume>16</volume>
<issue>8</issue>
<elocation-id>e2005886</elocation-id>
<history>
<date date-type="received">
<day>5</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Dyar et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pbio.2005886"/>
<abstract>
<p>Circadian clocks are fundamental physiological regulators of energy homeostasis, but direct transcriptional targets of the muscle clock machinery are unknown. To understand how the muscle clock directs rhythmic metabolism, we determined genome-wide binding of the master clock regulators brain and muscle ARNT-like protein 1 (BMAL1) and REV-ERBα in murine muscles. Integrating occupancy with 24-hr gene expression and metabolomics after muscle-specific loss of BMAL1 and REV-ERBα, here we unravel novel molecular mechanisms connecting muscle clock function to daily cycles of lipid and protein metabolism. Validating BMAL1 and REV-ERBα targets using luciferase assays and in vivo rescue, we demonstrate how a major role of the muscle clock is to promote diurnal cycles of neutral lipid storage while coordinately inhibiting lipid and protein catabolism prior to awakening. This occurs by BMAL1-dependent activation of <italic>Dgat2</italic> and REV-ERBα-dependent repression of major targets involved in lipid metabolism and protein turnover (<italic>MuRF-1</italic>, <italic>Atrogin-1</italic>). Accordingly, muscle-specific loss of BMAL1 is associated with metabolic inefficiency, impaired muscle triglyceride biosynthesis, and accumulation of bioactive lipids and amino acids. Taken together, our data provide a comprehensive overview of how genomic binding of BMAL1 and REV-ERBα is related to temporal changes in gene expression and metabolite fluctuations.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author summary</title>
<p>Circadian clocks are known to regulate local and systemic homeostasis by anticipating rhythmic changes in behavior and nutritional state and by compartmentalizing incompatible metabolic pathways within precise temporal and spatial windows. Yet a precise mechanistic understanding of how the circadian clock in skeletal muscle controls homeostasis is just beginning to come to light. Here, we investigated how the muscle clock directs 24-hr metabolic rhythms. We compared genome-wide binding of clock transcription factors brain and muscle ARNT-like protein 1 (BMAL1) and REV-ERBα with 24-hr transcriptional and metabolic effects after their loss of function specifically in muscles. We found that the muscle clock plays a major role anticipating the transition from fasting to feeding. This occurs by direct activation of transcriptional programs promoting lipid storage, insulin sensitivity, and glucose metabolism, with coordinated repression of programs controlling lipid oxidation and protein catabolism. Importantly, these gene expression changes occur in the hours prior to systemic metabolic and hormonal cues that arise upon awakening. As such, we find that the muscle clock tips the scales in favor of glucose metabolism, whereas loss of function of the clock transcription factor BMAL1 is associated with persistent lipid metabolism, protein catabolism, and metabolic inefficiency.</p>
</abstract>
<funding-group>
<funding-statement>Emmy Noether grant (DFG) (grant number UH275/1-1). NHU. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. European Commission (Integrated Project MYOAGE) (grant number 223576). SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Telethon Italy Grant (grant number GGP13222). LS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Fondazione CARIPARO, Padova. LS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="10"/>
<table-count count="1"/>
<page-count count="47"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2018-08-22</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>ChIP-seq data are available at Gene Expression Omnibus, accession number GSE108650. Microarray data are available at Gene Expression Omnibus, accession number GSE43071. All other relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Circadian rhythms of metabolism are endogenously generated and maintained by tissue-specific gene networks under the transcriptional control of molecular clocks [<xref ref-type="bibr" rid="pbio.2005886.ref001">1</xref>]. While chronic misalignment/disruption of circadian clocks has consistently been linked to metabolic disorders and diseases [<xref ref-type="bibr" rid="pbio.2005886.ref002">2</xref>], precise pathogenic mechanisms and their relation to tissue-specific clock function remain largely undefined.</p>
<p>Global and tissue-specific conditional or inducible loss-of-function mouse models targeting clock genes have begun to unravel such relationships in skeletal muscle [<xref ref-type="bibr" rid="pbio.2005886.ref003">3</xref>], a multifaceted and highly dynamic tissue and a major player in whole-body energy homeostasis. Depending on fluctuations in energy supply and demand, skeletal muscle plays various essential metabolic roles in the uptake, storage, utilization, and release of oxidative substrates. Experimental efforts have established muscle as the main site for insulin-stimulated glucose disposal [<xref ref-type="bibr" rid="pbio.2005886.ref004">4</xref>] and a major consumer of lipoprotein-triacylglycerol-derived fatty acid and plasma free fatty acids (FFAs) [<xref ref-type="bibr" rid="pbio.2005886.ref005">5</xref>]. Importantly, muscle tissue serves a highly dynamic role as the main destination for circulating amino acids in the fed state and the main source of circulating amino acids during starvation and insulin deficiency [<xref ref-type="bibr" rid="pbio.2005886.ref006">6</xref>].</p>
<p>Using muscle-specific knockout (myocyte-specific loss of BMAL1 [mKO]) models of <italic>Bmal1</italic>, an essential and nonredundant core clock transcriptional activator, we previously demonstrated that a critical function of the muscle clock is to anticipate and promote diurnal changes in glucose uptake and oxidation prior to the sleep–wake transition [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>]. Accordingly, loss of brain and muscle ARNT-like protein 1 (BMAL1) is associated with reduced insulin sensitivity and glucose oxidation. However, no previous study has systematically addressed the muscle clock’s specific role in lipid and amino acid metabolism or the impact of muscle-specific <italic>Bmal1</italic> deletion on whole-body energy homeostasis. Furthermore, direct transcriptional targets of clock transcription factors in skeletal muscle remain mostly unknown.</p>
<p>BMAL1 forms a heterodimeric transcriptional activator together with circadian locomotor output cycles kaput (CLOCK) and constitutes an integral component of the core molecular oscillator [<xref ref-type="bibr" rid="pbio.2005886.ref008">8</xref>]. Global loss of BMAL1 results in loss of circadian physiology [<xref ref-type="bibr" rid="pbio.2005886.ref009">9</xref>], impaired entrainment of circadian behaviors to light/dark cycles [<xref ref-type="bibr" rid="pbio.2005886.ref010">10</xref>], and loss of rhythmic expression of canonical BMAL1 targets. These include <italic>Rev-erbα (Nr1d1)</italic> and <italic>Rev-erbβ (Nr1d2)</italic> [<xref ref-type="bibr" rid="pbio.2005886.ref011">11</xref>], each coding for dominant transcriptional repressors. REV-ERBα/β repress their targets by competitively binding DNA response elements recognized by other nuclear receptors, especially the RAR-related orphan receptor (ROR) constitutive activators, but also by recruiting the nuclear receptor corepressor 1–histone deacetylase 3 complex (NCoR1-HDAC3) [<xref ref-type="bibr" rid="pbio.2005886.ref012">12</xref>] and by indirectly binding to tissue-specific transcription factors [<xref ref-type="bibr" rid="pbio.2005886.ref013">13</xref>]. Circadian accumulation of REV-ERBα/β likewise causes rhythmic repression of target genes, including <italic>Bmal1</italic>. Together, BMAL1 and REV-ERBα thus form important positive and negative elements of the circadian clock.</p>
<p>To identify additional metabolic roles of the muscle clock, we created and integrated multiple in vivo high-throughput “omics” datasets. Here, we present a comprehensive in vivo map of BMAL1 and REV-ERBα genomic binding in adult mouse skeletal muscle and highlight specific transcriptional and metabolic consequences of muscle-specific loss of BMAL1 and REV-ERBα. We determine how BMAL1 binding can activate expression of <italic>Dgat2</italic>, thus promoting diurnal cycles of neutral lipid storage. We also show how REV-ERBα can coordinately inhibit a network of master regulators of lipid and protein metabolism, thus tempering diurnal rhythms of lipid oxidation and physiological protein turnover. Importantly, these changes occur prior to and independent of metabolic and hormonal cues that arise during the feeding phase, i.e., when glucose becomes the predominant fuel source. In addition, we show how loss of BMAL1 is associated with disruption of its target genes, including <italic>Rev-erbα</italic>, and leads to a state of metabolic inefficiency characterized by impaired neutral lipid storage, increased lipid catabolism and oxidation, increased muscle protein turnover, mild mitochondrial uncoupling, and increased energy expenditure (EE). Overall, our data bring to light previously uncharacterized molecular circuits underlying metabolic efficiency within skeletal muscle and illustrate mechanistically how circadian transcription factors can anticipate and confine the use of energy substrates to distinct temporal windows.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>Genome-wide binding of clock transcription factors BMAL1 and REV-ERBα in mouse skeletal muscle reveals tight coordination between factors</title>
<p>To understand how the muscle clock can transcriptionally direct rhythmic metabolism, we mapped in vivo genome-wide chromatin occupancy (cistromes) of the positive master clock regulator BMAL1 and the dominant repressor REV-ERBα in adult mouse gastrocnemius muscles. Accordingly, we performed chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) on tissues collected during maximum diurnal protein expression for BMAL1 and REV-ERBα at Zeitgeber time (ZT) 4 and 8, respectively (<xref ref-type="supplementary-material" rid="pbio.2005886.s004">S1A Fig</xref>).</p>
<p>We identified 2,787 BMAL1 and 1,263 REV-ERBα “high confidence” peaks (i.e., reproducible ChIP-seq peaks from 2 biological replicates), with 653 peaks showing “confident” occupancy by both factors (i.e., peaks shared by ≥3 of the 4 samples) (<xref ref-type="fig" rid="pbio.2005886.g001">Fig 1A</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s012">S1 Table</xref>). Extensive overlap between muscle BMAL1 and REV-ERBα targets is in agreement with previous reports for mouse liver [<xref ref-type="bibr" rid="pbio.2005886.ref014">14</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref015">15</xref>], suggesting that BMAL1 and REV-ERBα occupy many of the same <italic>cis</italic>-regulatory genomic sites and regulate many of the same targets, albeit at different times. Functional enrichment analysis [<xref ref-type="bibr" rid="pbio.2005886.ref016">16</xref>] of these shared genomic sites underscored their shared regulation of circadian processes, as well as their maintenance of myofiber form and function (<xref ref-type="fig" rid="pbio.2005886.g001">Fig 1B</xref>). For example, in addition to shared roles regulating the “Circadian Clock” and “Circadian rhythm” pathways, common muscle BMAL1 and REV-ERBα peaks were associated with genes regulating muscle mass and contractility, muscle cell differentiation, glucose and glucosamine metabolism, and the cellular response to hormones.</p>
<fig id="pbio.2005886.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.2005886.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Genome-wide binding of clock transcription factors BMAL1 and REV-ERBα in mouse skeletal muscle.</title>
<p>(A) Overlap of BMAL1 and REV-ERBα “high confidence” peaks identified in gastrocnemius muscle from WT mice. (B) Functional enrichment analysis (GREAT) of 653 shared muscle BMAL1 and REV-ERBα peaks. (C) Aligned genome browser tracks showing binding of BMAL1, REV-ERBα, and RNAP2 at selected clock-associated transcriptional regulators. The left axis indicates sequence-tag counts. Arrow indicates a REV-ERBα-specific peak in the <italic>Per1</italic> promoter. (D) Representative top-ranking motifs found in chromatin sites occupied by BMAL1 and REV-ERBα in vivo (selected from <xref ref-type="supplementary-material" rid="pbio.2005886.s013">S2 Table</xref>). Underlying data can be found in supporting files <xref ref-type="supplementary-material" rid="pbio.2005886.s012">S1</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s013">S2</xref> Tables, and at Gene Expression Omnibus (accession number GSE108650). ARE, androgen response element; bHLH, basic helix-loop-helix; BMAL1, brain and muscle ARNT-like protein 1; CLOCK, circadian locomotor output cycles kaput; DR1, direct repeat 1; DR2, direct repeat 2; FDR, false discovery rate; GO, Gene Ontology; GRE, glucocorticoid response element; GREAT, Genomic Regions Enrichment of Annotations Tool; IR3, inverted repeat 3; MEF2, myocyte enhancer binding factor 2; MGI, Mouse Genome Informatics; MSigDB, Molecular Signatures Database; MYF5, myogenic factor 5; MYOD, myoblast determination protein; MYOG, myogenin; NPAS2, neuronal PAS domain protein 2; PPARE, peroxisome proliferator–activated receptor response element; RNAP2, RNA polymerase II; RXR, retinoid X receptor; THRα, thyroid hormone receptor alpha; WT, wild type; ZT, Zeitgeber time.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.g001" xlink:type="simple"/>
</fig>
<p>Consistent with their integral role regulating core clock gene expression, we identified highly enriched common muscle BMAL1 and REV-ERBα peaks at promoters and enhancers of clock-associated transcriptional regulators like <italic>Per1</italic>, <italic>Per2</italic>, <italic>Cry1</italic>, <italic>Cry2</italic>, <italic>Rev-erbα</italic> (<italic>Nr1d1</italic>), <italic>Rev-erbβ</italic> (<italic>Nr1d2</italic>), <italic>Dbp</italic>, <italic>Tef</italic>, <italic>Dec1</italic> (<italic>Bhlhe40</italic>), <italic>Dec2</italic> (<italic>Bhlhe41</italic>), and <italic>Chrono</italic> (<italic>Ciart/Gm129</italic>) (<xref ref-type="fig" rid="pbio.2005886.g001">Fig 1C</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s004">S1C Fig</xref>). We also noted common BMAL1 and REV-ERBα peaks near several known [<xref ref-type="bibr" rid="pbio.2005886.ref017">17</xref>] muscle clock-dependent circadian genes, including <italic>Coq10b</italic>, <italic>Dgat2</italic>, <italic>Klf9</italic>, <italic>Mylk4</italic>, <italic>Tcap</italic>, and <italic>polybubiquitin-C</italic> (<italic>Ubc</italic>) (<xref ref-type="supplementary-material" rid="pbio.2005886.s004">S1D Fig</xref>).</p>
<p>Comparing our muscle cistromes to published mouse liver cistrome data for BMAL1 [<xref ref-type="bibr" rid="pbio.2005886.ref014">14</xref>] and REV-ERBα [<xref ref-type="bibr" rid="pbio.2005886.ref015">15</xref>], we found only 46 common BMAL1 peaks between tissues, associated with 42 common genes, and 264 common REV-ERBα peaks associated with 252 common genes (<xref ref-type="supplementary-material" rid="pbio.2005886.s004">S1B Fig</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s012">S1 Table</xref>). Common muscle and liver targets were mainly core circadian clock and known clock-dependent output genes. Interestingly, common muscle and liver REV-ERBα targets were additionally enriched for p53 signaling components, chromatin modifiers, as well as macroautophagy and mitophagy mediators. However, the vast majority of sites (98% of BMAL1 peaks and 80% of REV-ERBα peaks) were muscle specific. This implies highly tissue-specific roles for BMAL1 and REV-ERBα beyond their common regulation of core clock genes.</p>
<p>To verify specificity of our muscle cistrome data and uncover potentially novel muscle-specific transcriptional networks, we searched BMAL1 and REV-ERBα peaks for known transcription factor motifs. In agreement with their high degree of functional overlap, we found significant enrichment for E-boxes and the canonical REV-ERB direct repeat 2 (DR2) motif among the top-ranking motifs of each factor (<xref ref-type="fig" rid="pbio.2005886.g001">Fig 1D</xref>, <xref ref-type="supplementary-material" rid="pbio.2005886.s005">S2A–S2E Fig</xref>, <xref ref-type="supplementary-material" rid="pbio.2005886.s013">S2 Table</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s002">S2 Data</xref>). Both factors also showed a muscle-specific genomic signature, with enrichment for the basic helix-loop-helix (bHLH) myogenic regulatory factors myoblast determination protein (MYOD), myogenic factor 5 (MYF5), and myogenin (MYOG), in addition to multiple isoforms of their coregulator, the myocyte enhancer binding factor 2 (MEF2) [<xref ref-type="bibr" rid="pbio.2005886.ref018">18</xref>]. Highlighting potential loci for cross-talk between circadian clock components and hormones [<xref ref-type="bibr" rid="pbio.2005886.ref019">19</xref>], both BMAL1 and REV-ERBα peaks also showed motif enrichment for several different nuclear hormone receptors with relatively high diurnal expression levels in adult skeletal muscle (<xref ref-type="supplementary-material" rid="pbio.2005886.s006">S3A Fig</xref>), including androgen receptor (AR; androgen response element [“ARE”]), retinoid X receptor (“RXR”), peroxisome proliferator–activated receptor (PPAR; PPAR response element [“PPARE”]), glucocorticoid receptor (GR; glucocorticoid response element [“GRE”]), and thyroid hormone receptor (TR) alpha (“THRα”). In summary, our in vivo cistromes indicate that muscle BMAL1 and REV-ERBα sequentially bind and regulate many of the same target genes, yet in a decisively muscle-specific manner.</p>
</sec>
<sec id="sec004">
<title>Transcriptional reprogramming of metabolism after muscle-specific loss of BMAL1</title>
<p>To provide a functional context for associations between BMAL1 and REV-ERBα binding sites and target gene regulation, we focused on transcriptional changes of key targets and coordinately regulated gene networks after mKO and loss of REV-ERBα [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref017">17</xref>]. REACTOME pathway enrichment analysis [<xref ref-type="bibr" rid="pbio.2005886.ref020">20</xref>] performed on 931 differentially expressed genes in muscles from mKO mice [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>] uncovered changes in canonical clock-related pathways and general perturbations in fatty acid, triglyceride (TG), and phospholipid metabolism (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2A</xref>).</p>
<fig id="pbio.2005886.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.2005886.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Transcriptional reprogramming of metabolic pathways in mKO muscles.</title>
<p>(A) REACTOME pathway enrichment analysis of 931 differentially expressed genes from mKO TA muscles. (B) Diurnal expression profiles of selected BMAL1-dependent circadian genes in TA determined by microarray and plotted as absolute expression levels (<italic>n</italic> = 3 × timepoint; mean ± SEM *<italic>p</italic> = 0.05, **<italic>p</italic> = 0.01, ***<italic>p</italic> = 0.001, 2-way ANOVA with Bonferroni correction). (C) Diurnal REV-ERBα and REV-ERBβ protein levels determined by western blot in vastus lateralis; GAPDH used as loading control. (D-F) Diurnal expression profiles in TA muscle of selected (D) REV-ERBα and HDAC3 target genes, (E) PPARα/δ-regulated mediators of lipid catabolism and oxidation, (F) GR-regulated mediators of protein turnover (<italic>n</italic> = 3 × timepoint; mean ± SEM *<italic>p</italic> = 0.05, **<italic>p</italic> = 0.01, ***<italic>p</italic> = 0.001, 2-way ANOVA with Bonferroni correction). (G) Venn diagram showing relative overlap and pathway enrichment of differentially regulated mKO genes with BMAL1 and REV-ERBα ChIP-seq peaks. Underlying data can be found in supporting files <xref ref-type="supplementary-material" rid="pbio.2005886.s001">S1 Data</xref>, <xref ref-type="supplementary-material" rid="pbio.2005886.s012">S1 Table</xref>, and at Gene Expression Omnibus (accession number GSE43071). BMAL1, brain and muscle ARNT-like protein 1; ChIP-seq, chromatin immunoprecipitation followed by next-generation sequencing; CLOCK, circadian locomotor output cycles kaput; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GR, glucocorticoid receptor; HDAC3, histone deacetylase 3; MAPK, mitogen-activated protein kinase; MEF2, myocyte enhancer binding factor 2; mKO, myocyte-specific loss of BMAL1; NFκB, nuclear factor kappa B; NPAS2, neuronal PAS domain protein 2; PPARα/δ, peroxisome proliferator–activated receptor alpha/delta; RORα, RAR-related orphan receptor alpha; TA, tibialis anterior; TGFβ, transforming growth factor beta; WT, wild type; ZT, Zeitgeber time.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.g002" xlink:type="simple"/>
</fig>
<p>Accordingly, the top-ranking pathways affected by loss of <italic>Bmal1</italic> included genes regulated by “BMAL1:CLOCK” and “Circadian Clock.” Moreover, we noted that most muscle clock-dependent circadian genes [<xref ref-type="bibr" rid="pbio.2005886.ref017">17</xref>] displayed transcriptional changes one might expect from direct muscle BMAL1 targets and suggested very specific yet disparate metabolic consequences. For example, <italic>Slc7a2</italic> and <italic>Coq10b</italic> were both highly oscillatory genes in wild-type (WT) muscles, and both completely lost 24-hr oscillation in mKO muscles (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2B</xref>). <italic>Slc7a2</italic> codes for a cationic amino acid transporter, whereas <italic>Coq10b</italic> is thought to code for a scaffold/chaperone protein regulating coenzyme Q localization within the inner mitochondrial membrane [<xref ref-type="bibr" rid="pbio.2005886.ref021">21</xref>]. According to our cistrome data, both genes may be direct functional targets of BMAL1, and their altered expression profiles in mKO muscles suggest that impaired cationic amino acid transport [<xref ref-type="bibr" rid="pbio.2005886.ref022">22</xref>] and coenzyme Q deficiency might be consequences of muscle clock perturbation/misalignment.</p>
<p>Likewise, REV-ERBα and REV-ERBβ displayed drastically disrupted diurnal expression [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>] and transcriptional activity in mKO muscles (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2A</xref>). While <italic>Rev-erbα</italic> and <italic>Rev-erbβ</italic> are among the highest expressed nuclear receptors in fast glycolytic and slow oxidative muscles (<xref ref-type="supplementary-material" rid="pbio.2005886.s006">S3A Fig</xref>), REV-ERBα and REV-ERBβ protein levels are restricted to an 8-hr temporal window at the end of the light phase, around ZT8–ZT12 (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2C</xref>). Loss of REV-ERBα/β in mKO muscles was especially apparent at the protein level, with normal accumulation of REV-ERBα and REV-ERBβ completely abolished in mutant muscles. This underscores the fact that muscle-specific <italic>Bmal1</italic> knockout (KO) mice are also, in essence, muscle-specific <italic>Rev-erbα</italic> and <italic>Rev-erbβ</italic> double-KO mice, in agreement with enrichment analysis (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2A</xref>). Accordingly, we noted derepression (i.e., increased expression) of canonical REV-ERB target genes (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2D</xref>)—like <italic>p21</italic> (<italic>Cdkn1a</italic>) [<xref ref-type="bibr" rid="pbio.2005886.ref023">23</xref>] and <italic>Clock</italic> [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref024">24</xref>]—and previously identified skeletal muscle HDAC3 targets [<xref ref-type="bibr" rid="pbio.2005886.ref025">25</xref>] including <italic>Ppp1r3c</italic>, a master regulator of glycogen synthesis; <italic>Mybph</italic>, coding for a protein thought to be involved in autophagosome maturation [<xref ref-type="bibr" rid="pbio.2005886.ref026">26</xref>]; <italic>Ampd1</italic>, the predominant skeletal muscle adenosine monophosphate (AMP) deaminase; and <italic>Thra</italic> coding for THRα.</p>
<p>REV-ERBα/β are known to regulate lipid metabolism in peripheral tissues [<xref ref-type="bibr" rid="pbio.2005886.ref012">12</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref015">15</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref027">27</xref>], including skeletal muscle [<xref ref-type="bibr" rid="pbio.2005886.ref028">28</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref029">29</xref>], but a comprehensive understanding of their direct muscle targets, their cross-talk with other nuclear hormone receptors, and the effects of muscle-specific loss of function remain largely unknown. REV-ERBα is known to directly compete with and inhibit TR/RXR binding at target sites during muscle differentiation [<xref ref-type="bibr" rid="pbio.2005886.ref030">30</xref>], and REV-ERBα and PPAR signaling pathways are likewise known to converge [<xref ref-type="bibr" rid="pbio.2005886.ref031">31</xref>]. PPARs are nuclear hormone receptors that mediate adaptive metabolic responses, including increased lipid oxidation and amino acid catabolism in muscle [<xref ref-type="bibr" rid="pbio.2005886.ref032">32</xref>] following their activation by endogenous or dietary lipids or lipid derivatives [<xref ref-type="bibr" rid="pbio.2005886.ref033">33</xref>]. REV-ERBα/β is known to repress transactivation of some PPAR targets by competitively binding to nearby genomic sites in a concentration-dependent manner [<xref ref-type="bibr" rid="pbio.2005886.ref034">34</xref>].</p>
<p>Consistent with motif enrichment of BMAL1 and REV-ERBα peaks (<xref ref-type="fig" rid="pbio.2005886.g001">Fig 1D</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s005">S2E Fig</xref>), PPAR signaling was also among the top-ranking pathways impacted by mKO (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2A</xref>). Furthermore, mKO muscles showed an altered gene expression profile reminiscent of acute pharmacological activation using the PPARδ receptor agonist GW501516 [<xref ref-type="bibr" rid="pbio.2005886.ref035">35</xref>]. In particular, we noticed significantly increased expression of major regulatory genes involved in mobilizing intracellular lipid stores (<italic>Atgl</italic>/<italic>Pnpla2</italic>) and channeling fatty acids from lipid droplets to the mitochondria for oxidation (<italic>Plin5</italic>) (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2E</xref>). Additionally, mKO muscles showed significantly increased expression of genes involved in fatty acid transport (<italic>Fatp-1/Slc27a1</italic>), activation of fatty acids to corresponding acyl-CoAs (<italic>Acsl1</italic>), and finally breakdown (<italic>Acadm</italic>) and oxidation (<italic>Hadha</italic>) of fatty acids. However, we observed no major changes in diurnal expression of PPARs in fast or slow muscles (<xref ref-type="supplementary-material" rid="pbio.2005886.s006">S3B Fig</xref>), suggesting that increased PPAR target expression in mKO muscles results from increased presence of endogenous ligands and/or PPAR activation. Highlighting potential sites for cross-talk/competition between REV-ERBα and PPARs, we noted REV-ERBα peaks near known PPAR regulatory elements (PPREs) in promoters of <italic>Plin5</italic> and <italic>Acsl1</italic> [<xref ref-type="bibr" rid="pbio.2005886.ref036">36</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref037">37</xref>].</p>
<p>To gain more mechanistic insight into how BMAL1 and REV-ERBα regulate muscle targets, and their functional roles, we further stratified our cistrome data according to direction of expression changes in mKO muscles (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2G</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s012">S1 Table</xref>). Hundreds of BMAL1 and REV-ERBα targets showed differential regulation, suggesting a direct link between loss of BMAL1 and REV-ERBα and gene expression changes in mKO muscles. According to pathway enrichment analysis [<xref ref-type="bibr" rid="pbio.2005886.ref020">20</xref>], down-regulated BMAL1 and REV-ERBα targets reflected common regulation of circadian clock genes and transforming growth factor beta (TGFβ) signaling components. Down-regulated BMAL1 targets were further associated with mitogen-activated protein kinase (MAPK) and other stress response pathways, whereas down-regulated REV-ERBα targets were associated with nuclear factor kappa B (NFκB) activation. Interestingly, up-regulated target genes showed less cooperation between BMAL1 and REV-ERBα and suggested more specific regulation of calcium and Wnt signaling by BMAL1, while REV-ERBα showed specificity for the GR signaling pathway and heme biosynthesis (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2G</xref>). We further corroborated REV-ERBα-specific association with GR targets by visually inspecting prominent REV-ERBα peaks with high enrichment scores near selected GR-regulated genes (<xref ref-type="supplementary-material" rid="pbio.2005886.s005">S2F Fig</xref>), including transcriptional regulators like <italic>Fos</italic> and <italic>Trp53</italic> [<xref ref-type="bibr" rid="pbio.2005886.ref038">38</xref>].</p>
<p>When glucose availability is low, skeletal muscle adapts to preferentially increase the uptake and oxidation of lipids [<xref ref-type="bibr" rid="pbio.2005886.ref039">39</xref>] while coordinately increasing protein degradation for production and release of amino acids destined for gluconeogenesis [<xref ref-type="bibr" rid="pbio.2005886.ref040">40</xref>]. This transcriptionally regulated proteolytic process is under tight hormonal control [<xref ref-type="bibr" rid="pbio.2005886.ref041">41</xref>] and is largely mediated by synergism between ligand-bound GR and activated members of the forkhead box O (FOXO) family of transcription factors [<xref ref-type="bibr" rid="pbio.2005886.ref042">42</xref>]. REV-ERBα is also speculated to cross-talk with GR in adult muscle [<xref ref-type="bibr" rid="pbio.2005886.ref043">43</xref>]. Accordingly, several putative REV-ERBα/GR target genes uncovered by our muscle cistrome showed transiently increased expression in mutant muscles, particularly during the hours around the light–dark transition (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2F</xref>, <xref ref-type="supplementary-material" rid="pbio.2005886.s005">S2F</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s006">S3C</xref> Figs), coinciding with peak levels of endogenous glucocorticoids [<xref ref-type="bibr" rid="pbio.2005886.ref044">44</xref>] and loss of REV-ERBα protein in mKO muscle (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2C</xref>). These included major mediators of muscle protein turnover, like <italic>MuRF-1</italic> (<italic>Trim63</italic>) and <italic>Atrogin-1/MAFbx</italic> (<italic>Fbxo32</italic>)—two E3 ubiquitin ligases involved in targeting myofibrillar proteins for degradation—and polyubiquitin-C (<italic>Ubc</italic>), a major determinant of the intracellular ubiquitin pool. In addition, we found increased expression of several genes coding for proteasome subunits (<italic>Psmb3</italic>, <italic>Psmb6</italic>, <italic>Psmc4</italic>, <italic>Psmd14</italic>), as well as master regulators of autophagy (<italic>Trp53</italic>, <italic>Atg12</italic>, and <italic>Ulk1</italic>), and finally <italic>Snat2</italic> (<italic>Slc38a2</italic>), the highly energized System A amino acid transporter increased by cortisol [<xref ref-type="bibr" rid="pbio.2005886.ref045">45</xref>] and amino acid starvation [<xref ref-type="bibr" rid="pbio.2005886.ref046">46</xref>].</p>
<p>Collectively, our data suggest that one role of the muscle clock is to anticipate the feeding phase by direct REV-ERB-mediated repression of important targets involved in the mobilization and metabolism of lipids and amino acids. Furthermore, muscle-specific loss of BMAL1, and thus REV-ERBα, is associated with increased expression of direct REV-ERBα targets and coordinated gene networks known to regulate lipid and amino acid metabolism, muscle protein turnover, and autophagy.</p>
</sec>
<sec id="sec005">
<title>Muscle-specific loss of BMAL1 alters 24-hr lipid and amino acid metabolism</title>
<p>To understand how local diurnal rhythms of muscle metabolism are impacted by differential expression of gene programs described above, we performed global 24-hr metabolite profiling of tibialis anterior (TA) muscles from mKO mice and their WT littermates (<xref ref-type="fig" rid="pbio.2005886.g003">Fig 3A</xref>). Tissues were collected every 4 hr across the light/dark cycle, and metabolites were profiled by mass spectrometry (liquid chromatography/mass spectrometry [LC/MS] and gas chromatography/MS [GC/MS], see <xref ref-type="sec" rid="sec013">Materials and methods</xref>). Importantly, we used the contralateral muscles from the same cohort of mice used for 24-hr transcriptomics [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>], allowing us to directly correlate diurnal muscle metabolite alterations with diurnal changes in muscle gene expression.</p>
<fig id="pbio.2005886.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.2005886.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Global metabolite alterations associated with muscle-specific clock disruption.</title>
<p>(A) Experimental design showing integration of 24-hr metabolomics data with transcriptomics data from contralateral muscles. (B) Global 24-hr metabolomics of TA muscles from WT and mKO mice. Heatmap shows mean scaled abundance (<italic>n</italic> = 5 × timepoint × group) of detected metabolites across the light/dark cycle (white/black bar). Metabolites are sorted by phase according to WT muscle and aligned between groups to show effect in mKO. (C) Class distribution of metabolites significantly impacted by muscle-specific <italic>Bmal1</italic> KO (genotype effect <italic>p</italic> &lt; 0.05, mixed effects model). (D) Integrated pathway enrichment analysis combining metabolomics and transcriptomics data. (E) Class distribution of metabolites oscillating with a 24-hr period (<italic>p</italic> &lt; 0.05, JTK_CYCLE; red = significantly increased in mKO muscles; green = significantly reduced). (F) Integrated pathway enrichment and topology analysis of 24-hr cycling metabolites. Underlying data can be found in supporting file <xref ref-type="supplementary-material" rid="pbio.2005886.s001">S1 Data</xref>. KO, knockout; mKO, myocyte-specific loss of BMAL1; TA, tibialis anterior; WT, wild type; ZT, Zeitgeber hour.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.g003" xlink:type="simple"/>
</fig>
<p>A large proportion of metabolites showed clear alterations in diurnal oscillation and abundance in mKO muscles (<xref ref-type="fig" rid="pbio.2005886.g003">Fig 3B</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s014">S3 Table</xref>). Lipids and amino acids showed the greatest impact from clock disruption (<xref ref-type="fig" rid="pbio.2005886.g003">Fig 3C</xref>), comprising 42% and 40%, respectively, of all significantly altered metabolites (genotype effect <italic>p</italic> &lt; 0.05, mixed effects model). Integrated pathway enrichment analysis [<xref ref-type="bibr" rid="pbio.2005886.ref047">47</xref>] likewise revealed substantial alterations in amino acid and lipid metabolism pathways (<xref ref-type="fig" rid="pbio.2005886.g003">Fig 3D</xref>). In particular, we noted that several anabolic pathways directly linked to glycolysis were affected, including alanine, glycine, serine, and glycerolipid metabolism.</p>
<p>Identification of 24-hr period oscillating metabolites (JTK_Cycle <italic>p</italic> &lt; 0.05) revealed a completely unexpected &gt;2-fold increase in circadian metabolites in mKO muscles (<xref ref-type="fig" rid="pbio.2005886.g003">Fig 3E</xref>). De novo oscillating metabolites identified by this analysis were predominantly amino acids—including alanine, glutamate, leucine, and valine—but also included pentoses (ribose and ribulose), tricarboxylic acid (TCA) cycle intermediates (malate and fumarate), and essential lipids (docosapentaenoate 22:5n3). Relatively few metabolites lost 24-hr oscillation after clock disruption, yet these were again mainly lipid-related metabolites like carnitine, essential lipids (linoleate 18:2n6 and linolenate 18:3n3 or 6), and amino acids (arginine and ornithine). Our integrated pathway enrichment and topology analysis [<xref ref-type="bibr" rid="pbio.2005886.ref047">47</xref>] of these 24-hr oscillating metabolites reflected a gain of oscillation in pathways related to alanine, glutamate, and branched-chain amino acid (BCAA) metabolism; pantothenate and CoA biosynthesis; and glyoxylate and dicarboxylate metabolism (<xref ref-type="fig" rid="pbio.2005886.g003">Fig 3F</xref>). Conversely, oscillation of pathways involved in the biosynthesis of unsaturated fatty acids, arginine and ornithine metabolism, and linoleic and linolenic acid metabolism all showed impaired 24-hr oscillation after loss of BMAL1. Finally, pathways involved in carbohydrate metabolism (starch and sucrose, fructose and mannose, and galactose metabolism), amino and nucleotide sugar metabolism, and aminoacyl-tRNA biosynthesis all retained 24-hr oscillation in mKO muscles.</p>
<p>In summary, our integrated metabolic analyses identified lipids and amino acids as the metabolite classes showing the greatest impact from loss of BMAL1, with generally increased abundance and increased 24-hr oscillation patterns in mKO muscles. In extension of previously reported impairments to glucose metabolism [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref048">48</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref049">49</xref>], our data demonstrate an important role for BMAL1 in the regulation of lipid and amino acid metabolism.</p>
</sec>
<sec id="sec006">
<title>Impaired neutral lipid storage and accumulation of bioactive lipids in mKO muscles</title>
<p>Skeletal muscle TGs are an important and readily available local fuel reserve [<xref ref-type="bibr" rid="pbio.2005886.ref050">50</xref>], especially after long periods of activity, when muscle glycogen stores are depleted [<xref ref-type="bibr" rid="pbio.2005886.ref051">51</xref>]. In humans, replenishment of muscle TG stores can occur within hours [<xref ref-type="bibr" rid="pbio.2005886.ref051">51</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref052">52</xref>], and content is increased when carbohydrate availability is low and circulating lipids are elevated, like during fasting or high-fat diet [<xref ref-type="bibr" rid="pbio.2005886.ref053">53</xref>]. To gain a general perspective on diurnal rhythms of muscle neutral lipid storage, we profiled TGs at 2 physiologically relevant time points in WT and mKO muscles.</p>
<p>Quantitative lipidomics performed at “lights on” (ZT0) and “lights off” (ZT12, 12 hr later) revealed a 2-fold accumulation of total TG in WT muscles at ZT12 (<xref ref-type="fig" rid="pbio.2005886.g004">Fig 4A</xref>), the end of the physiological fasting phase. This accumulation was completely abolished in mKO muscles, with total TG content remaining static at basal levels. We noticed that mKO mice showed a normal daily rhythm of food intake, with completely normal distribution of feeding time and amount (<xref ref-type="supplementary-material" rid="pbio.2005886.s007">S4A Fig</xref>). Similarly, plasma non-esterified fatty acids (NEFAs), lactate, and ketone bodies (β-hydroxybutyrate [β-OH-B] and acetoacetate [AcAc]) were all comparable to WT levels in sedentary mice independently of whether they had been fasted (4 hr, collected at ZT11) or fed (collected at ZT14), as well as in endurance-trained mice after 1 hr of treadmill running (<xref ref-type="supplementary-material" rid="pbio.2005886.s007">S4B Fig</xref>). Reduced TG accumulation in mKO muscles therefore seems to reflect local alterations in muscle lipid metabolism rather than differences in feeding behavior or interorgan lipid fluxes.</p>
<fig id="pbio.2005886.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.2005886.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Impaired storage of neutral lipids and accumulation of bioactive lipids in mKO muscles.</title>
<p>(A) Muscle triglyceride extracted from gastrocnemius muscles, quantified by HPLC, and normalized to cell protein (mean ± SEM; <italic>n</italic> = 5 × group × timepoint; **<italic>p</italic> &lt; 0.01, *<italic>p</italic> &lt; 0.05, Student’s <italic>t</italic> test). (B) Diurnal variations of selected lysoglycerophospholipids in WT and mKO TA muscles (mean ± SEM; <italic>n</italic> = 5 × group × timepoint; *<italic>p</italic> &lt; 0.05, repeated measures ANOVA). (C) Temporal distribution of significantly increased lysoglycerophospholipids comparing WT and mKO TA (+<italic>p</italic> &lt; 0.05, Ŧ<italic>p</italic> &lt; 0.1, repeated measures ANOVA). (D) Diurnal variations of selected long-chain PUFAs, essential FAs, and related metabolites in WT and mKO TA muscles (mean ± SEM; <italic>n</italic> = 5 × group × timepoint; *<italic>p</italic> &lt; 0.05, repeated measures ANOVA). Underlying data can be found in supporting files <xref ref-type="supplementary-material" rid="pbio.2005886.s001">S1 Data</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s014">S3 Table</xref>. FA, fatty acid; HPLC, high-performance liquid chromatography; HODE, hydroxyoctadecadienoate; lysoPC, lysoglycerophosphocholine; lysoPE, lysoglycerophosphoethanolamine; lysoPI, lysoglycerophosphoinositol; mKO, myocyte-specific loss of BMAL1; PUFA, polyunsaturated fatty acid; TA, tibialis anterior; WT, wild type; ZT, Zeitgeber time.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.g004" xlink:type="simple"/>
</fig>
<p>Profiling individual TG species revealed a general reduction of TG accumulation in mKO muscles at ZT12 rather than specific changes in esterified fatty acid composition. All TG species were increased around 2-fold at ZT12 compared to ZT0 in WT muscles, and all were drastically reduced at ZT12 in mKO muscles (<xref ref-type="supplementary-material" rid="pbio.2005886.s007">S4C Fig</xref>). At the same time, the total distribution of TG species was completely normal in mKO muscles (<xref ref-type="supplementary-material" rid="pbio.2005886.s007">S4D Fig</xref>), with over 92% of all TG species containing 48, 50, 52, or 54 carbons and multiple unsaturated fatty acids, regardless of time point or genotype.</p>
<p>While neutral lipid storage was impaired in mKO muscles, we noted a striking general increase of various bioactive lipids involved in signaling and inflammation. These included several lysoglycerophospholipids (lysoPLs) comprising a wide spectrum in terms of hydrophilic and hydrophobic moieties (<xref ref-type="fig" rid="pbio.2005886.g004">Fig 4B and 4C</xref>; <xref ref-type="supplementary-material" rid="pbio.2005886.s014">S3 Table</xref>). While many lysoPLs were significantly increased in mKO muscles, ZT12 emerged as a particularly important time point, with 85% significantly increased in mKO muscles during the light–dark transition, including the lysophosphatidylcholine LPC (16:0), thought to be an endogenous PPAR ligand [<xref ref-type="bibr" rid="pbio.2005886.ref054">54</xref>].</p>
<p>Circadian metabolomics also revealed a transient increase in mKO muscles of many long-chain polyunsaturated fatty acids (PUFAs; docosapentaenoate 22:5n3 and docosahexaenoate 22:6n3), essential fatty acids (linoleate 18:2n6 and linolenate 18:3n3 or n6), and oxidation- and inflammation-associated metabolites (13-hydroxyoctadecadienoate + 9- hydroxyoctadecadienoate, dihomo-linolenate 20:3n3 or n6, and arachidonate 20:4n6) (<xref ref-type="fig" rid="pbio.2005886.g004">Fig 4D</xref>; <xref ref-type="supplementary-material" rid="pbio.2005886.s014">S3 Table</xref>). Importantly, most of these lipid species are also thought to be endogenous PPAR ligands [<xref ref-type="bibr" rid="pbio.2005886.ref055">55</xref>] and so may contribute to increased expression of PPAR targets in mKO muscle. Taken together, mKO muscles showed reduced neutral lipid storage (TG) and a significant accumulation of bioactive lipids, particularly during the hours around the light–dark transition.</p>
</sec>
<sec id="sec007">
<title>Increased glucogenic amino acids in mKO muscles linked to TCA cycle anaplerosis</title>
<p>Amino acids were the other major metabolite class significantly impacted by muscle-specific loss of BMAL1. In particular, we noted a significant increase of glucogenic amino acids in mKO muscles (<xref ref-type="fig" rid="pbio.2005886.g005">Fig 5A</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s008">S5A Fig</xref>). Alanine, glutamine, glutamate, glycine, serine, threonine, methionine, proline, and aspartate were all significantly increased between 20% and 300% at multiple time points throughout the light/dark cycle in mKO muscles. At ZT16, the BCAAs leucine, isoleucine, and valine, in addition to cysteine, were all significantly increased 25%–35% in mKO muscles relative to WT. In contrast, the cationic amino acids arginine and lysine were significantly reduced 30%–60%, with 24-hr oscillation severely blunted in mKO muscles (<xref ref-type="fig" rid="pbio.2005886.g005">Fig 5B</xref>), concordant with reduced <italic>Slc7a2</italic> at the end of the dark phase (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2B</xref>). Finally, aromatic amino acids phenylalanine, tyrosine, and tryptophan remained unchanged (<xref ref-type="supplementary-material" rid="pbio.2005886.s008">S5A Fig</xref>). We also noted increased levels of several metabolites linked to intermediary amino acid metabolism, including 5’-inosine monophosphate (5’-IMP) and 5’-guanosine monophosphate (5’-GMP) (<xref ref-type="supplementary-material" rid="pbio.2005886.s008">S5B Fig</xref>), both regulators of the purine nucleotide cycle [<xref ref-type="bibr" rid="pbio.2005886.ref056">56</xref>], as well as the TCA cycle intermediates citrate, fumarate, and malate (<xref ref-type="fig" rid="pbio.2005886.g005">Fig 5C</xref>).</p>
<fig id="pbio.2005886.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.2005886.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Increased amino acids in mKO muscles linked to TCA cycle anaplerosis.</title>
<p>(A-C) Diurnal levels of selected amino acids (A), cationic amino acids (B), and TCA cycle intermediates (C) in WT and mKO TA muscles (mean ± SEM; <italic>n</italic> = 5 × group × time point; *<italic>p</italic> &lt; 0.05, repeated measures ANOVA). (D) Serum alanine (genotype effect <italic>p</italic> &lt; 0.05) and glycine (genotype effect <italic>p</italic> &lt; 0.01) from ad libitum fed mice (mean ± SEM; <italic>n</italic> = 3–4; 2-way ANOVA with Bonferroni correction). (E) Serum amino acids at ZT8 after a 6-hr fast. (mean ± SEM; <italic>n</italic> = 3–4; *<italic>p</italic> &lt; 0.05 Student’s <italic>t</italic> test). (F) Simplified scheme showing interrelationships between increased amino acids, purine nucleotides, and TCA cycle intermediates in mKO muscle (indicated by red text). Increased glycolytic flux in the context of impaired PDH activity [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>] may divert glycolytic intermediates to alternative biosynthetic pathways, including serine, glycine, and alanine formation. Circadian metabolomics data also suggest mKO muscles undergo increased rates of protein turnover, increased formation and release of alanine and glycine, and increased anaplerotic flow of carbon into an expanded TCA cycle via citrate, fumarate, and malate. Underlying data can be found in supporting file <xref ref-type="supplementary-material" rid="pbio.2005886.s001">S1 Data</xref>. 3PG, 3-phosphoglycerate; α-KG, alpha-ketoglutarate; AMP, adenosine monophosphate; GDP, guanosine diphosphate; GTP, guanosine triphosphate; mKO, myocyte-specific loss of BMAL1; PDH, pyruvate dehydrogenase; TA, tibialis anterior; TCA, tricarboxylic acid; WT, wild type; ZT, Zeitgeber time.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.g005" xlink:type="simple"/>
</fig>
<p>To investigate whether the increase in free amino acid levels observed in mKO muscles are directly correlated with differences in circulating amino acids, we quantified serum amino acids in ad libitum–fed WT and mKO mice across the light/dark cycle. Importantly, mKO mice showed persistently increased serum alanine and glycine levels throughout the dark phase (<xref ref-type="fig" rid="pbio.2005886.g005">Fig 5D</xref>), despite normal feeding behavior and blood lipid profiles (<xref ref-type="supplementary-material" rid="pbio.2005886.s007">S4A Fig</xref>). These reflect the largest differences we observed in mKO muscles (<xref ref-type="fig" rid="pbio.2005886.g005">Fig 5A</xref>) and are in agreement with transiently increased expression of REV-ERBα targets (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2F</xref>) linked to the temporally restricted production and release of these major [<xref ref-type="bibr" rid="pbio.2005886.ref041">41</xref>] glucogenic precursors. To validate these findings under a more controlled nutritional state, we also examined serum amino acids after a 6-hr fast at ZT8, during the normal physiological fasting+rest phase when diurnal insulin levels are lowest [<xref ref-type="bibr" rid="pbio.2005886.ref057">57</xref>]. While serum amino acids were generally increased in mKO mice, only alanine and glycine reached significance (<xref ref-type="fig" rid="pbio.2005886.g005">Fig 5E</xref>).</p>
<p>Contextualizing our results from a temporal perspective, we conclude that increased amino acids, purine nucleotides, and TCA cycle intermediates in mKO muscles are all closely related (<xref ref-type="fig" rid="pbio.2005886.g005">Fig 5F</xref>). We noticed diurnal alanine levels increased substantially in mKO muscles as glutamate levels decreased, starting around ZT8–ZT12 and coinciding with inhibition of pyruvate dehydrogenase (PDH) in mKO muscles [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>]. Increased alanine in mKO muscles thus likely reflects increased mass-action conversion of pyruvate and glutamate into alanine and α-ketoglutarate, a freely reversible and near-equilibrium reaction catalyzed by alanine aminotransferase [<xref ref-type="bibr" rid="pbio.2005886.ref058">58</xref>]. Quantitatively, this is the most important anaplerotic reaction contributing to expansion of the TCA intermediate pool at the start of exercise [<xref ref-type="bibr" rid="pbio.2005886.ref059">59</xref>]. In support of this interpretation, peak alanine levels in mKO muscle increased 83% compared to control levels at ZT16 and coincided with peak TCA intermediates citrate, fumarate, and malate, which increased respectively 251%, 62%, and 52% at ZT16.</p>
<p>Alanine is a particularly important precursor for hepatic gluconeogenesis [<xref ref-type="bibr" rid="pbio.2005886.ref041">41</xref>], and its production and export reflect nutritional state more closely than that of glutamine, the other major amino acid produced and released by skeletal muscle [<xref ref-type="bibr" rid="pbio.2005886.ref060">60</xref>]. Alanine increases the most during the earliest phases of starvation [<xref ref-type="bibr" rid="pbio.2005886.ref061">61</xref>] and correlates with increased muscle protein degradation [<xref ref-type="bibr" rid="pbio.2005886.ref041">41</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref058">58</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref062">62</xref>]. The carbon required for alanine formation is derived mostly from circulating glucose and muscle glycogen, while the nitrogen comes from the catabolism of other amino acids, mainly BCAA, as well as others [<xref ref-type="bibr" rid="pbio.2005886.ref063">63</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref064">64</xref>]. The particularly large increase of alanine in mKO muscles thus indicates an energy deficit and related increase in proteolysis in mKO muscles during this time [<xref ref-type="bibr" rid="pbio.2005886.ref065">65</xref>]. However, feeding is normal in mKO mice (<xref ref-type="supplementary-material" rid="pbio.2005886.s007">S4A Fig</xref>), and muscles from mKO mice show normal or even slightly increased content of muscle glycolytic intermediates, AKT phosphorylation, and glycemia [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>]. Therefore, fasting, or some other systemic starvation signal (i.e., alterations in circulating glucose or insulin), cannot explain increased alanine and other amino acids in mKO muscles. Instead, their accumulation must reflect a local defect in energy sensing or metabolism related to loss of BMAL1.</p>
</sec>
<sec id="sec008">
<title>Increased lipid and amino acid oxidation in mKO muscles linked to oxidative stress, altered mitochondrial function, and metabolic inefficiency</title>
<p>Accumulation of bioactive lipids and amino acids can be symptomatic of mitochondrial dysfunction or may simply reflect an imbalance between oxidative substrate supply and energy demand [<xref ref-type="bibr" rid="pbio.2005886.ref066">66</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref067">67</xref>]. We uncovered several complementary lines of evidence that suggest mKO muscles have increased lipid and amino acid oxidative capacity and altered mitochondrial function. According to our 24-hr metabolome, long-chain acylcarnitines showed distinct diurnal fluctuations in WT muscles, with a peak during the rest+fasting phase and reduced levels during the activity+feeding phase (<xref ref-type="fig" rid="pbio.2005886.g006">Fig 6A</xref>). These diurnal oscillations were similar in mKO muscles, except for slightly reduced peak oscillation for some species, like oleoylcarnitine and palmitoylcarnitine, and a modest increase at ZT12, which was statistically significant only for myristoylcarnitine.</p>
<fig id="pbio.2005886.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.2005886.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Increased lipid oxidative capacity yet reduced mitochondrial efficiency in mKO muscles.</title>
<p>(A) Diurnal levels of selected acylcarnitines in TA muscles (mean ± SEM; <italic>n</italic> = 5 × group × time point; *<italic>p</italic> &lt; 0.05, repeated measures ANOVA). (B) Palmitate oxidation in gastrocnemius homogenates (mean ± SEM; <italic>n</italic> = 12–13; **<italic>p</italic> &lt; 0.01, Student’s <italic>t</italic> test). (C) CS activity in vastus lateralis muscle extracts (mean ± SEM; <italic>n</italic> = 18). (D) Maximum catalytic activity of Respiratory Chain Complex I (NADH:ubiquinone oxidoreductase; <italic>n</italic> = 6), Complex II (succinate dehydrogenase; <italic>n</italic> = 18), Complex III (decylubiquinol cytochrome <italic>c</italic> oxidoreductase; <italic>n</italic> = 18), Complex II+III (succinate cytochrome <italic>c</italic> reductase; <italic>n</italic> = 18), and Complex IV (cytochrome <italic>c</italic> oxidase; <italic>n</italic> = 18) in vastus lateralis muscle extracts (mean% relative to WT ± SEM; ***<italic>p</italic> &lt; 0.001, Student’s <italic>t</italic> test). (E) Real-time fluorescence of isolated flexor digitorum brevis muscle fibers loaded with TMRM and imaged every 60 s; data expressed relative to initial fluorescence; 5 μM Olm and 4 μM FCCP were added where indicated (mean ± SEM; <italic>n</italic> = 21–24 fibers isolated from 5 animals per group). (F) Diurnal levels of GSSG and GSH in mKO and WT TA muscles (mean ± SEM; <italic>n</italic> = 5 × group × time point; *<italic>p</italic> &lt; 0.05, repeated measures ANOVA). (G) Diurnal expression in TA and SOL muscles determined by microarray and plotted as absolute expression levels (<italic>n</italic> = 3 × time point; mean ± SEM *<italic>p</italic> = 0.05, **<italic>p</italic> = 0.01, 2-way ANOVA with Bonferroni correction). Underlying data can be found in supporting files <xref ref-type="supplementary-material" rid="pbio.2005886.s001">S1 Data</xref> and at Gene Expression Omnibus (accession number GSE43071). CS, citrate synthase; FCCP, carbonylcyanide-p-trifluoromethoxyphenyl hydrazone; GSH, reduced glutathione; GSSG, oxidized glutathione; mKO, myocyte-specific loss of BMAL1; Olm, oligomycin; SOL, soleus; TA, tibialis anterior; TMRM, tetramethylrhodamine methyl ester; WT, wild type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.g006" xlink:type="simple"/>
</fig>
<p>In contrast, all medium- and short-chain acylcarnitines were significantly reduced at various timepoints. This was particularly striking for acetylcarnitine (<xref ref-type="fig" rid="pbio.2005886.g006">Fig 6A</xref>) but also branched-chain acylcarnitines derived from BCAA catabolism, including isobutyrylcarnitine, 2-methylbutyroylcarnitine, isovalerylcarnitine, propionylcarnitine, and succinylcarnitine (<xref ref-type="supplementary-material" rid="pbio.2005886.s014">S3 Table</xref>). Reduced levels of short- and medium-chain acylcarnitines relative to essentially normal long-chain acylcarnitines and increased BCAA (only at ZT16) may reflect increased lipid and BCAA catabolism, with faster transit of carbon chains through the pathways. Increased lipid and amino acid catabolism could also supply increased acetyl CoA or succinyl CoA, in agreement with TCA cycle anaplerosis (<xref ref-type="fig" rid="pbio.2005886.g005">Fig 5C</xref>). To measure lipid catabolism rates, we quantified [1-<sup>14</sup>C]palmitate oxidation to [1-<sup>14</sup>C]CO<sub>2</sub> in whole gastrocnemius muscle homogenates collected at ZT12. Compared to control muscles, mKO muscles showed a clear and significant 22% increase in palmitate oxidation rate (<xref ref-type="fig" rid="pbio.2005886.g006">Fig 6B</xref>), in agreement with transcriptional changes of lipid metabolism genes (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2F</xref>), and suggesting increased β-oxidation capacity.</p>
<p>Increased oxidative capacity in mKO muscles can result from a combination of factors, including increased mitochondrial content, increased activity of respiratory chain complexes, or increased proton conductance related to mitochondrial membrane potential (Δ<italic>ψ</italic><sub>m</sub>) [<xref ref-type="bibr" rid="pbio.2005886.ref068">68</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref069">69</xref>]. To quantify mitochondrial content in control and mKO muscles, we measured citrate synthase (CS) activity in muscle homogenates and found no differences (<xref ref-type="fig" rid="pbio.2005886.g006">Fig 6C</xref>). We next assayed enzymatic activities of respiratory chain complexes I–IV and found maximum catalytic activity of complexes I, II, and III were likewise unchanged in mKO muscles (<xref ref-type="fig" rid="pbio.2005886.g006">Fig 6D</xref>). However, we detected a highly significant 20% reduction in complex II+III activity in mKO muscles, suggesting a mild coenzyme Q deficiency, consistent with reduced <italic>Coq10b</italic> (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2B</xref>), whereas complex IV activity was significantly reduced around 30%.</p>
<p>To investigate alterations in Δ<italic>ψ</italic><sub>m</sub>, we performed real-time fluorescence imaging of Δ<italic>ψ</italic><sub>m</sub> in isolated muscle fibers loaded with the potentiometric fluorescent dye tetramethylrhodamine methyl ester in the presence of oligomycin A, an inhibitor of the mitochondrial F<sub>1</sub>F<sub>O</sub>-ATP synthase. In this system, maintenance of Δ<italic>ψ</italic><sub>m</sub> relies on the reverse activity of ATP synthase. Oligomycin addition caused no change in Δ<italic>ψ</italic><sub>m</sub> in control muscle fibers (<xref ref-type="fig" rid="pbio.2005886.g006">Fig 6E</xref>), whereas marked depolarization was induced by the protonophore carbonylcyanide-p-trifluoromethoxyphenyl hydrazone (FCCP). While WT mitochondria were polarized and metabolically efficient, progressive mitochondrial depolarization was apparent in mKO myofibers. Addition of FCCP had little impact on these already depolarized cells, suggesting mKO muscle mitochondria have reduced Δ<italic>ψ</italic><sub>m</sub> and a general loss of coupling efficiency.</p>
<p>Mild uncoupling of skeletal muscle mitochondria is thought to mitigate potentially damaging oxidative stress [<xref ref-type="bibr" rid="pbio.2005886.ref068">68</xref>]. Examining various markers of oxidative stress, we noted that oxidized glutathione (GSSG) oscillated around 30% over 24 hr in control muscles. GSSG was normally highest during the rest+fasting phase and remained lowest during the activity+feeding phase (<xref ref-type="fig" rid="pbio.2005886.g006">Fig 6F</xref>). However, in mKO muscles, GSSG remained constitutively increased across the light/dark cycle, suggesting increased buffering demand. On the other hand, reduced glutathione was only slightly increased in mKO muscles, and the difference was significant only at ZT4. Another biomarker of oxidative stress resulting from peroxidation of PUFAs, 4-hydroxy-2-nonenal, also showed only a slight trend for increased abundance during the fasting+rest phase and otherwise remained within a normal diurnal physiological range (<xref ref-type="supplementary-material" rid="pbio.2005886.s009">S6A Fig</xref>). Overall, while chronic loss of BMAL1 appears to be associated with a mild and transient increase in oxidative stress, this appears to be sufficiently buffered through a combination of mild uncoupling and various endogenous antioxidant systems.</p>
<p>Mild oxidative stress is known to increase protein degradation in muscle cells by increasing expression and activity of the ubiquitin-proteasome system [<xref ref-type="bibr" rid="pbio.2005886.ref070">70</xref>] and so may also be causally linked to increased amino acids (<xref ref-type="fig" rid="pbio.2005886.g005">Fig 5A</xref>). Mild uncoupling was previously shown to increase 2-fold by starvation in rat skeletal muscle mitochondria and is mediated by uncoupling proteins in the presence of fatty acids and in response to coenzyme Q–generated superoxide [<xref ref-type="bibr" rid="pbio.2005886.ref071">71</xref>]. We noted <italic>Ucp3</italic> expression was significantly increased at ZT8 in mKO TA muscles compared to WT, while <italic>Ucp2</italic> expression was massively induced at all time points in mKO soleus, peaking around ZT8 (<xref ref-type="fig" rid="pbio.2005886.g006">Fig 6G</xref>).</p>
<p>Our results indicate that reduced energy efficiency and increased supply of oxidative substrates are linked to a mild increase in oxidative stress and a transcriptionally regulated mild uncoupling in mKO muscles. However, evidence suggests these changes should be considered in terms of altered function rather than dysfunction. Increased oxidative capacity with increased uncoupling from ATP production is observed in muscles of endurance-trained athletes [<xref ref-type="bibr" rid="pbio.2005886.ref072">72</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref073">73</xref>] and in rodents fed a high-fat diet [<xref ref-type="bibr" rid="pbio.2005886.ref074">74</xref>], with enhanced sensitivity of mitochondrial uncoupling to fatty acids seen in both cases. As such, one might interpret reduced coupling efficiency of mKO muscle mitochondria similarly as a consequence of increased lipid metabolism. In any case, we saw no differences in endurance capacity after a graded exercise tolerance test to exhaustion (<xref ref-type="supplementary-material" rid="pbio.2005886.s009">S6B Fig</xref>). Using glycemia &lt;76 mg/dl to establish fatigue [<xref ref-type="bibr" rid="pbio.2005886.ref075">75</xref>], mKO mice showed neither deficit nor advantage in terms of exercise endurance capacity, running more than 2 km in around 2 hr, just as their WT littermates. Normal exercise endurance in mKO mice likely reflects normal 24-hr glycogen stores in muscle and liver (<xref ref-type="supplementary-material" rid="pbio.2005886.s009">S6C Fig</xref>), since liver glycogen stores are known to be the main determinant of exercise endurance capacity in mice [<xref ref-type="bibr" rid="pbio.2005886.ref076">76</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref077">77</xref>].</p>
</sec>
<sec id="sec009">
<title>Muscle-specific loss of BMAL1 causes fat-to-lean body mass partitioning, increased rates of muscle protein synthesis, and increased EE</title>
<p>We previously showed that mKO mice have increased muscle mass yet normal bodyweight compared to their WT littermates [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>]. Closer examination confirmed [<xref ref-type="bibr" rid="pbio.2005886.ref048">48</xref>] significant differences in body composition in mKO mice (both fat and lean tissue mass). While bodyweight of adult mice was normal, mKO mice showed increased lean mass and reduced fat mass according to EchoMRI, ultimately translating into an increased lean-to-fat body mass ratio (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7A</xref>). We found this was due to a combination of about 30% reduction in total body fat mass (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7B</xref>) and a 10%–20% increase in muscle mass (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7C</xref>).</p>
<fig id="pbio.2005886.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.2005886.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Muscle-specific loss of BMAL1 associated with fat-to-lean mass partitioning, increased rates of muscle protein synthesis, and increased EE.</title>
<p>(A-B) <italic>n</italic> = 11–12 mice; 5-mo-old male littermates; mean ± SEM; **<italic>p</italic> &lt; 0.01, Student’s <italic>t</italic> test. (A) Normal bodyweight, increased percent lean mass, reduced percent fat mass, and increased lean-to-fat mass ratio in mKO mice. (B) About 30% reduced total body fat. (C) Increased muscle mass relative to bodyweight (TA; <italic>n</italic> = 44 five-mo-old male littermates; dashed line indicates mean trend line). (D-E) In vivo protein synthesis rates of TA measured by IV-SUnSET. (D) Representative image of western blot analysis for puromycin-labeled peptides followed by ponceau staining to verify equal protein loading. TA from a transgenic mouse with c.a.AKT was used as positive control. (E) Quantification of puromycin-labeled peptides expressed as a percentage of the values obtained in WT ZT4 (mean ± SEM; <italic>n</italic> = 10, ZT4; <italic>n</italic> = 5, ZT16; *<italic>p</italic> &lt; 0.05, Student’s <italic>t</italic> test). (F-I) Effects of muscle-specific <italic>Bmal1</italic> mKO on (F) food intake, (G) locomotor activity (X + Y axis counts and running wheel rotations), (H) RER (VCO2/VO2), and (I) EE all measured at thermoneutrality (30 °C). <italic>n</italic> = 10 four-mo-old male littermates; mean ± SEM; *<italic>p</italic> &lt; 0.05, Student’s <italic>t</italic> test; ANCOVA genotype effect <italic>p</italic> = 0.046 (total EE) and <italic>p</italic> = 0.023 (dark phase EE) when considering body weight, lean mass, and fat mass as covariates. (J) Relationship between EE and lean mass at ZT16 (<italic>n</italic> = 10; dashed line indicates mean trend line). Underlying data can be found in supporting file <xref ref-type="supplementary-material" rid="pbio.2005886.s001">S1 Data</xref>. BMAL1, brain and muscle ARNT-like protein 1; c.a.AKT, constitutively active AKT; EE, energy expenditure; IV-SUnSET, in vivo surface sensing of translation; mKO, myocyte-specific loss of BMAL1; n.s., not significant; RER, respiratory exchange ratio; TA, tibialis anterior; VCO2, volume carbon dioxide produced; VO2, volume oxygen consumed; WT, wild type; ZT, Zeitgeber time.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.g007" xlink:type="simple"/>
</fig>
<p>Reduced peripheral fat mass in mKO mice is in agreement with increased lipid oxidation and reduced lipid storage in muscles of mKO mice. On the other hand, increased alanine synthesis and release and persisting peak expression of genes involved in protein degradation suggest that mKO muscle mass should be reduced rather than increased. We thus hypothesized that increased mKO muscle mass must reflect increased rates of daily protein turnover, with net balance favoring muscle protein synthesis. To accurately quantify muscle protein synthesis rates in mKO mice and WT littermates, we used the nonradioactive in vivo surface sensing of translation (IV-SUnSET) technique [<xref ref-type="bibr" rid="pbio.2005886.ref078">78</xref>]. We performed experiments at ZT4 and ZT16, in the middle of the physiological fasting and feeding phases, respectively. Muscles from mKO mice showed clearly increased puromycin incorporation into muscle peptides compared to their WT littermates (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7D</xref>). Impressively, protein synthesis rates of some mKO mice even approached the extremely high protein synthesis rates observed in a muscle-specific transgenic model with constitutively active AKT (c.a.AKT) [<xref ref-type="bibr" rid="pbio.2005886.ref079">79</xref>]. Quantification revealed that WT mice had lower muscle protein synthesis rates at ZT4, the middle of the physiological fasting phase, and approximately 2-fold increased synthesis rates at ZT16, during the middle of the feeding phase (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7E</xref>). This is in agreement with previous results obtained in skeletal muscles of fasted and fed WT mice [<xref ref-type="bibr" rid="pbio.2005886.ref080">80</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref081">81</xref>]. However, muscle protein synthesis rates remained significantly elevated at ZT4 in mKO mice compared to WT littermates.</p>
<p>Increased rates of muscle protein synthesis and increased muscle mass in mKO mice are consistent with functional roles we identified for BMAL1 and REV-ERBα target genes in the regulation of myofiber size and muscle mass (<xref ref-type="fig" rid="pbio.2005886.g001">Fig 1B</xref>). It is thus probable that these changes in mKO mice arise from local changes in transcription and metabolism inherently linked to loss of BMAL1 rather than changes in feeding behavior or activity. In fact, we could not detect any significant changes in daily feeding pattern or in daily caloric intake, whether measured under standard housing conditions at 22 °C (<xref ref-type="supplementary-material" rid="pbio.2005886.s007">S4A Fig</xref>) or under thermoneutral conditions [<xref ref-type="bibr" rid="pbio.2005886.ref082">82</xref>] at 30 °C (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7F</xref>). Locomotor activity across the light/dark cycle and total activity levels, measured under thermoneutral conditions (30 °C) by beam breaks (X + Y counts) and running wheel (rotations), were similarly unaltered (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7G</xref>).</p>
<p>Differences in body composition are known to impact 24-hr fuel selection and EE [<xref ref-type="bibr" rid="pbio.2005886.ref083">83</xref>]. Accordingly, respiratory exchange ratio (RER) measured at 30 °C was significantly lower during the light phase in mKO mice compared to WT littermates, but not during the dark phase (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7H</xref>). This is consistent with a shift in nutrient partitioning to promote more fat utilization in mKO animals. Likewise, mKO mice showed significantly increased EE throughout the dark phase at 30 °C (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7I</xref>). However, resting metabolic rate (RMR) measured at thermoneutrality throughout the rest+fasting phase [<xref ref-type="bibr" rid="pbio.2005886.ref084">84</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref085">85</xref>] was not significantly increased in mKO mice, suggesting the approximately 15% increased EE observed during the dark phase reflects a genotype effect rather than differences in body composition. Indeed, even after accounting for differences in lean mass [<xref ref-type="bibr" rid="pbio.2005886.ref085">85</xref>], we noted a persisting general trend for increased EE in mKO mice during the dark phase (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7J</xref>). A significant genotype effect on total EE (<italic>p</italic> = 0.046) and EE specifically during the dark phase (<italic>p</italic> = 0.023) was confirmed by ANCOVA using body weight, lean mass, and fat mass as covariates, as previously suggested [<xref ref-type="bibr" rid="pbio.2005886.ref084">84</xref>].</p>
<p>Overall, these results significantly expand upon our previous observations and indicate that muscle-specific loss of BMAL1 can significantly impact systemic energy homeostasis, alter interorgan metabolite fluxes, and the storage, release, and use of energy substrates in other tissues. Importantly, our cistrome, metabolome, transcriptome, and metabolic phenotyping data all point to fundamental roles of BMAL1 and REV-ERBα in the regulation of energy balance and in systemic lipid and amino acid homeostasis.</p>
</sec>
<sec id="sec010">
<title>BMAL1 promotes diurnal muscle TG synthesis by direct transcriptional activation of <italic>Dgat2</italic></title>
<p>In addition to its known role driving circadian expression of clock genes like <italic>Rev-erbα/β</italic>, we identified a crucial role for BMAL1 in the regulation of diurnal TG levels. To explain the mechanism behind reduced TG content and increased lysoPLs in mKO muscles, we examined expression profiles of genes involved in glycerophospholipid and TG metabolism. Mutant muscles showed significant differences in expression of 4 crucial enzymes (<xref ref-type="fig" rid="pbio.2005886.g008">Fig 8A</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s010">S7A Fig</xref>). We first noted up-regulation of <italic>Agpat3</italic>, a lysophosphatidic acid acyltransferase abundantly expressed in human skeletal muscle [<xref ref-type="bibr" rid="pbio.2005886.ref086">86</xref>] and known PPARα-regulated gene [<xref ref-type="bibr" rid="pbio.2005886.ref087">87</xref>]. Likewise, oscillation of <italic>Adpn</italic> (<italic>Pnpla3</italic>), an acyl-CoA-dependent acyltransferase involved in the conversion of lysophosphatidic acid into phosphatidic acid, remained constitutively increased. Phosphatidic acid is a precursor of both TGs and glycerophospholipids, and overexpression of <italic>Adpn</italic> induces both TG and glycerophospholipid synthesis in mammalian cells [<xref ref-type="bibr" rid="pbio.2005886.ref088">88</xref>].</p>
<fig id="pbio.2005886.g008" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.2005886.g008</object-id>
<label>Fig 8</label>
<caption>
<title>BMAL1 promotes diurnal muscle triglyceride synthesis by direct transcriptional activation of <italic>Dgat2</italic>.</title>
<p>(A) Diurnal expression profiles in TA muscles of selected key regulators of glycerophospholipid and triglyceride metabolism (<italic>n</italic> = 3 × time point; mean ± SEM *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, 2-way ANOVA with Bonferroni correction; see also <xref ref-type="supplementary-material" rid="pbio.2005886.s010">S7A Fig</xref>). (B) Scheme showing alterations identified in mKO muscles related to reduced TG content and increased lysoPLs. Increased glycolytic flux in the context of impaired PDH activity [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>] channels glycolytic intermediates to lysoPL biosynthesis. Red = increased gene expression or metabolite abundance in mKO relative to WT; green = reduced gene expression or abundance. (C) Validation of BMAL1 transcriptional targets by cotransfecting HEK-293T cells with LUC reporter constructs containing muscle BMAL1 binding sites from known and putative target promoters linked to LUC, along with expression plasmids for BMAL1 and CLOCK or empty control vector (pcDNA3). Data is expressed as mean fold-change normalized to the empty vector (<italic>n</italic> = 3; ±SEM). (D) In vivo BMAL1 occupancy at target sites in WT and mKO gastrocnemius at ZT4 and ZT16 (mean fold-enrichment over IgG ± SEM; <italic>n</italic> = 2 pooled biological replicates for each of 2 independent ChIP-qPCR experiments). Underlying data can be found in supporting file <xref ref-type="supplementary-material" rid="pbio.2005886.s001">S1 Data</xref> and at Gene Expression Omnibus (accession number GSE43071). BMAL1, brain and muscle ARNT-like protein 1; ChIP-qPCR, chromatin immunoprecipitation–quantitative real-time PCR; CLOCK, circadian locomotor output cycles kaput; HEK-293T, human embryonic kidney 293T; IgG, immunoglobulin G; LUC, luciferase; lysoPL, lysoglycerophospholipid; mKO, myocyte-specific loss of BMAL1; PDH, pyruvate dehydrogenase; TA, tibialis anterior; WT, wild type; ZT, Zeitgeber time.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.g008" xlink:type="simple"/>
</fig>
<p>Particularly relevant for the reduced TG content in mKO muscles was the marked down-regulation of <italic>Dgat2</italic>, the major enzyme that converts diacylglycerols to TGs in mouse skeletal muscle [<xref ref-type="bibr" rid="pbio.2005886.ref089">89</xref>]. According to our muscle cistrome data, <italic>Dgat2</italic> is a direct BMAL1 and REV-ERBα target gene and oscillates with a 24-hr period in both fast and slow muscles [<xref ref-type="bibr" rid="pbio.2005886.ref017">17</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref090">90</xref>]. In mKO muscles, <italic>Dgat2</italic> oscillation was severely blunted, and expression markedly reduced.</p>
<p>In mammalian cells, glycerophospholipids can be converted to lysoPLs by the activity of specific phospholipases, including phospholipase A2 group 7 (<italic>Pla2g7</italic>), another PPARα-regulated gene that showed markedly increased expression in mKO muscles. Pharmacological activation of PPARα was shown to increase expression of <italic>Pla2g7</italic> and abundance of the LPC(16:0) in serum, liver, and muscle [<xref ref-type="bibr" rid="pbio.2005886.ref054">54</xref>]. LPC(16:0) is also an endogenous PPAR ligand that further activates PPARα targets in a feed-forward mechanism. This effect is blocked by <italic>Pla2g7</italic> small interfering RNA (siRNA), and PPARα antagonism also inhibits <italic>Pla2g7</italic> expression.</p>
<p>Modeled together with known perturbations in PDH [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>] and diversion of glycolytic intermediates (<xref ref-type="fig" rid="pbio.2005886.g008">Fig 8B</xref>), our transcript data suggest impaired biosynthesis of TGs yet increased production of bioactive lysoPLs in mKO muscles, in agreement with metabolomics data (<xref ref-type="fig" rid="pbio.2005886.g004">Fig 4A–4C</xref>). Increased PUFAs in mKO muscles (<xref ref-type="fig" rid="pbio.2005886.g004">Fig 4D</xref>) is also consistent with increased phospholipase A2 activity, since phospholipase A2 acts specifically at the <italic>sn</italic>-2 position of phospholipids where PUFAs are preferentially located.</p>
<p>To verify whether BMAL1 can transcriptionally activate putative targets identified by our muscle cistromes and transcriptomes, we cotransfected human embryonic kidney 293T (HEK-293T) cells with reporter constructs containing muscle BMAL1 binding sites linked to luciferase, along with empty control vectors or expression plasmids for BMAL1 and CLOCK (<xref ref-type="fig" rid="pbio.2005886.g008">Fig 8C</xref>). As expected, cotransfection of BMAL1 and CLOCK with reporters of classical known BMAL1 target sites in the promoters of <italic>Rev-erbα</italic>, <italic>Rev-erbβ</italic>, and <italic>Per2</italic> led to a potent induction of transcription (3–70-fold) over basal control levels (empty vector). Likewise, BMAL1 and CLOCK cotransfection with <italic>Coq10b</italic> and <italic>Dgat2</italic> reporters led to a 2-fold transcriptional induction, in agreement with in vivo binding data for BMAL1, and 24-hr <italic>Coq10b</italic> and <italic>Dgat2</italic> expression in WT and <italic>Bmal1</italic> mKO muscles.</p>
<p>To investigate a direct link between loss of genomic BMAL1 binding in mKO muscles and reduced expression and oscillation of putative and established BMAL1 targets, we used directed chromatin immunoprecipitation–quantitative real-time PCR (ChIP-qPCR). We collected mutant and WT muscles at 2 time points, ZT4 and ZT16, i.e., during relatively high and low diurnal genomic Bmal1 binding [<xref ref-type="bibr" rid="pbio.2005886.ref011">11</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref014">14</xref>]. In WT muscles, we detected specific BMAL1 binding at a positive control locus near <italic>Per1</italic> at ZT4 (<xref ref-type="fig" rid="pbio.2005886.g008">Fig 8D</xref>) and relatively low binding at ZT16. Importantly, BMAL1 binding was severely attenuated in mKO muscles at both time points. In agreement with muscle-specific loss of <italic>Rev-erbα</italic> expression, BMAL1 binding at a known regulatory locus near <italic>Rev-erbα</italic> was also severely attenuated in mutant muscles. Supporting a direct role in the transcriptional activation of <italic>Dgat2</italic> by BMAL1, we saw similar BMAL1 binding at its target site in the <italic>Dgat2</italic> promoter. Binding was higher at ZT4 in WT muscles yet attenuated in mKO muscles. Furthermore, we detected no BMAL1 binding at a negative intronic <italic>Dgat2</italic> site.</p>
<p>Finally, closer inspection of the <italic>Dgat2</italic> promoter genomic sequence revealed 2 likely tandem E-boxes separated by 15 bp in the very middle of our BMAL1 <italic>Dgat2</italic> peak summit (<xref ref-type="supplementary-material" rid="pbio.2005886.s010">S7B Fig</xref>). Taken together, our data demonstrate that transient binding of muscle BMAL1 to the <italic>Dgat2</italic> promoter is linked to transcriptional activation and a 2–3-fold increase in diurnal <italic>Dgat2</italic> expression. Muscle-specific loss of BMAL1 is associated with 2–3-fold reduced <italic>Dgat2</italic> expression, 2-fold reduced muscle TG content at ZT12, and accumulation of several bioactive lipid species. Muscle-specific overexpression of <italic>Dgat2</italic> was shown to cause a 1.8-fold increase in muscle TG content [<xref ref-type="bibr" rid="pbio.2005886.ref091">91</xref>]; thus, modulating local <italic>Dgat2</italic> expression levels is sufficient to increase muscle TG synthesis and storage. Our data highlight mechanistically how BMAL1 promotes diurnal rhythms of neutral lipid storage in preparation for the feeding+activity phase, when bioactive lipids could potentially impair insulin signaling and glucose metabolism. We also show how loss of BMAL1 leads to reduced TG storage and accumulation of bioactive lysoPLs.</p>
</sec>
<sec id="sec011">
<title>REV-ERBα inhibits lipid and protein catabolism by direct repression of key lipid and protein metabolism target genes</title>
<p>To monitor in vivo properties of REV-ERB-dependent transcriptional repression in muscles from WT and mKO mice, we used a REV-ERB luciferase reporter (<italic>mBmal1</italic>::<italic>luc</italic>) [<xref ref-type="bibr" rid="pbio.2005886.ref092">92</xref>] containing 2 ROR response elements spaced by 26 bp derived from the proximal promoter region of mouse <italic>Bmal1</italic> [<xref ref-type="bibr" rid="pbio.2005886.ref093">93</xref>]. Cotransfecting HEK-293T cells with this REV-ERB sensor, along with an expression plasmid for mouse REV-ERBα, led to a 5-fold reduction of transcriptional activity compared to an empty control vector, thus demonstrating its sensitivity to REV-ERBα-mediated repression (<xref ref-type="fig" rid="pbio.2005886.g009">Fig 9A</xref>). To show that lack of REV-ERBα in mKO muscles is associated with transcriptional derepression of REV-ERBα targets, we used in vivo bioluminescence imaging of TA muscles from WT and mKO mice cotransfected with the REV-ERB sensor and either REV-ERBα or an empty control vector (<xref ref-type="fig" rid="pbio.2005886.g009">Fig 9B</xref>). Mice were imaged at ZT10, during peak endogenous REV-ERBα and REV-ERBβ protein levels in WT muscles. Accordingly, WT muscles transfected with exogenous REV-ERBα showed only a minor reduction of luciferase activity compared to contralateral muscles transfected with the empty control vector (<xref ref-type="fig" rid="pbio.2005886.g009">Fig 9C</xref>). Importantly, muscles from mKO mice transfected with the empty vector showed the highest sensor activity, while the introduction (“rescue”) of REV-ERBα in contralateral mKO muscles led to a significant 2-fold repression of luciferase activity. Overall, our data show that lack of REV-ERBα in mKO muscles is associated with increased transcriptional activity (i.e., derepression) of REV-ERBα targets.</p>
<fig id="pbio.2005886.g009" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.2005886.g009</object-id>
<label>Fig 9</label>
<caption>
<title>REV-ERBα controls muscle lipid and protein metabolism by directly repressing key regulators.</title>
<p>(A) Cotransfection of HEK-293T cells with empty control vector or mouse REV-ERBα expression plasmid, along with REV-ERB sensor (<italic>mBmal1</italic>::<italic>luc</italic>), containing 2 ROREs from the proximal promoter of <italic>Bmal1</italic> linked to LUC. Data from 2 independent experiments are expressed as mean fold-change normalized to the empty vector (<italic>n</italic> = 6; ±SEM). (B) In vivo imaging of LUC activity in WT and mKO mouse TA muscles following electric pulse–mediated gene transfer of <italic>mBmal1</italic>::<italic>luc</italic> cotransfected either with empty vector or REV-ERBα expression plasmid. Imaging analysis was performed 3 d after gene transfer at ZT10 as described in Materials and methods. Pseudocolors overlaid on the image indicate the luminescence intensity from <italic>mBmal1</italic>::<italic>luc</italic> reporter gene activity as indicated by the scale bar radiance (photons/second/cm<sup>2</sup>/steradian). (C) Quantification of LUC activity in TA muscles normalized to mKate2, an exogenous spike-in control plasmid (mean ± SEM; <italic>n</italic> = 3 mice; *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, Student’s <italic>t</italic> test). (D) Cotransfection of HEK-293T cells with empty control vector, mouse REV-ERBα expression plasmid, mouse GR expression plasmid, or c.a.FOXO3A expression plasmid, along with GR:FOXO sensor containing −5 kb or −1 kb promoter sequence from mouse <italic>MuRF-1</italic> linked to LUC. Data are expressed as mean fold-change normalized to the empty vector (<italic>n</italic> = 2–3; ±SEM). (E) In vivo REV-ERBα, NCoR1, and HDAC3 occupancy at target sites in control and mKO gastrocnemius at ZT8 (mean fold-enrichment over IgG ± SEM; <italic>n</italic> = 4 independent biological replicates from 4 independent ChIP-qPCR experiments; <italic>Foxl2</italic> promoter used as negative control). (F) Gene expression (RT-qPCR) of mKO TA muscles at ZT10 following electric pulse-mediated gene transfer of REV-ERBα expression plasmids or empty vector. Data normalized to <italic>36B4</italic> expression and expressed as fold-change relative to contralateral muscle containing empty vector (mean ± SEM, <italic>n</italic> = 4 mice, *<italic>p</italic> &lt; 0.05, Student’s <italic>t</italic> test). Underlying data can be found in supporting file <xref ref-type="supplementary-material" rid="pbio.2005886.s001">S1 Data</xref>. BMAL1, brain and muscle ARTN-like protein 1; c.a.FOXO3A, constitutively active forkhead box O3; ChIP-qPCR, chromatin immunoprecipitation–quantitative real-time PCR; CLOCK, circadian locomotor output cycles kaput; GR, glucocorticoid receptor; HDAC3, histone deacetylase 3; HEK-293T, human embryonic kidney 293T; IgG, immunoglobulin G; LUC, luciferase; mKO, myocyte-specific loss of BMAL1; NCor1, nuclear receptor corepressor 1; PDH, pyruvate dehydrogenase; ROR, RAR-related orphan receptor; RORE, ROR response element; RT-qPCR, quantitative reverse transcription PCR; TA, tibialis anterior; ZT, Zeitgeber time.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.g009" xlink:type="simple"/>
</fig>
<p>Our cistrome data revealed that muscle REV-ERBα peaks are highly enriched with GRE motifs, suggesting binding sites for both factors are within close proximity. Mouse, rat, and human <italic>MuRF-1</italic> all contain a consensus GRE around 200 bp upstream of the transcription start site (TSS) [<xref ref-type="bibr" rid="pbio.2005886.ref094">94</xref>], which is directly under the summit of the <italic>MuRF-1</italic> REV-ERBα peak we uncovered. In fact, we noted 2 putative (A/G)GGTCA monomer sites approximately 200 bp and approximately 450 bp downstream of the GRE in the first exon of <italic>MuRF-1</italic> (<xref ref-type="supplementary-material" rid="pbio.2005886.s011">S8A Fig</xref>). A consensus FOXO binding site is also directly adjacent to the GRE, and FOXO and GR were previously shown to synergistically activate <italic>MuRF-1</italic> expression from this same promoter site [<xref ref-type="bibr" rid="pbio.2005886.ref094">94</xref>]. To determine the functional relevance of REV-ERBα binding to the <italic>MuRF-1</italic> promoter, we cotransfected luciferase reporter constructs containing either −5 kb or −1 kb fragments of the mouse <italic>MuRF-1</italic> promoter along with expression constructs for mouse REV-ERBα, GR, and a constitutively active form of FOXO3 (c.a.FOXO3A) [<xref ref-type="bibr" rid="pbio.2005886.ref095">95</xref>]. GR and c.a.FOXO3A each induced both <italic>MuRF-1</italic> promoter constructs, and they together increased each reporter activity &gt;3-fold (<xref ref-type="fig" rid="pbio.2005886.g009">Fig 9D</xref>). Addition of REV-ERBα alone or with either GR or c.a.FOXO3A had only a limited repressive effect on either <italic>MuRF-1</italic> reporter; however, REV-ERBα completely blocked the synergistic activation by GR and c.a.FOXO3A when combined together. While several additional interesting muscle REV-ERBα targets suggested by our cistrome and transcriptome data remain to be rigorously validated as functional targets on a case-by-case basis, our results already highlight the role of REV-ERBα repression at major established sites known to be coactivated by GR and FOXO in muscle cells.</p>
<p>To demonstrate that increased expression of putative functional REV-ERBα targets is associated with loss of REV-ERBα genomic binding in mKO muscles, we performed directed ChIP-qPCR of REV-ERBα and corepressors NCoR1 and HDAC3. We focused on selected loci at ZT8, when REV-ERBα is abundant in control muscles (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2C</xref>). We detected REV-ERBα binding at positive control loci like <italic>Bmal1</italic> and <italic>Clock</italic> promoters, in addition to binding at novel muscle REV-ERBα loci we uncovered near <italic>Plin5</italic>, <italic>Acsl1</italic>, <italic>Ucp3</italic>, <italic>MuRF-1</italic>, <italic>Atrogin-1</italic>, and <italic>polyubiquitin-C</italic> (<xref ref-type="fig" rid="pbio.2005886.g009">Fig 9E</xref>). Importantly, binding was severely abrogated in mKO muscles, establishing these as direct REV-ERBα targets. Binding of corepressors NCoR1 and HDAC3 at most sites was likewise reduced in mutant muscles, consistent with loss of REV-ERBα occupancy and increased expression (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2D–2F</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s006">S3C Fig</xref>).</p>
<p>Finally, to investigate whether REV-ERBα can modulate expression of these genes in vivo, we performed a REV-ERBα “rescue” in mKO muscles via electric pulse–mediated gene transfer. Importantly, the introduction of REV-ERBα into mKO muscles (<xref ref-type="supplementary-material" rid="pbio.2005886.s011">S8B Fig</xref>) led to 20%–50% reduced expression of <italic>Clock</italic>, <italic>Plin5</italic>, <italic>Acsl1</italic>, <italic>Ucp3</italic>, <italic>MuRF-1</italic>, <italic>Atrogin-1</italic>, and <italic>polyubiquitin-C</italic> at ZT10 relative to contralateral muscles transfected with the empty control vector (<xref ref-type="fig" rid="pbio.2005886.g009">Fig 9F</xref>).</p>
<p>Moving beyond skeletal muscle, we found further evidence for a common network of REV-ERBα-regulated lipid and amino acid metabolism genes in diurnal expression data from liver-specific overexpression of <italic>Rev-erbα</italic> [<xref ref-type="bibr" rid="pbio.2005886.ref009">9</xref>]. Since <italic>Bmal1</italic> is a direct target of REV-ERBα, transgenic activation of REV-ERBα constitutively represses <italic>Bmal1</italic> across the light/dark cycle, analogous to our muscle-specific <italic>Bmal1</italic> KO. Likewise, <italic>Rev-erbα</italic> overexpression was linked to reduced expression and blunted diurnal oscillation of <italic>Clock</italic>, <italic>p21</italic> (<italic>Cdkn1a</italic>), <italic>Plin5</italic> (<italic>2310076L09Rik</italic>), and <italic>Snat2</italic> (<italic>Slc38a2</italic>) (<xref ref-type="supplementary-material" rid="pbio.2005886.s011">S8C Fig</xref>).</p>
<p>Altogether, our data highlight a coordinated network of REV-ERBα target genes controlling both lipid and amino acid metabolism in skeletal muscle and perhaps in other tissues. We show how normal diurnal rhythms of muscle REV-ERBα might serve to repress these genes in anticipation of the feeding+activity phase, when glucose returns as the predominant fuel source. Furthermore, muscle-specific loss of BMAL1 also leads to loss of REV-ERBα-dependent repression and persistently increased expression of these targets, likely causing increased lipid metabolism and increased protein turnover.</p>
</sec>
</sec>
<sec id="sec012" sec-type="conclusions">
<title>Discussion</title>
<p>Here, we present a comprehensive map of in vivo genomic binding for the clock transcription factors BMAL1 and REV-ERBα in adult mouse skeletal muscle and the transcriptional and metabolic consequences of muscle-specific loss of BMAL1 and REV-ERBα. We have sought to shed some light on the complex and highly dynamic regulation of skeletal muscle metabolism from a 24-hr perspective and have attempted to contextualize our results and add functional relevance by linking genomic binding to 24-hr patterns of putative target gene expression and metabolite fluctuations. We hope these rich genomics and metabolomics data profiles will provide a useful resource to others for further hypothesis generation and validation. We have tried to maximize the potential for correlations between different assays by using predominantly fast glycolytic muscles from the same cohort of animals when possible (for example, contralateral TA muscles were used for metabolomics and transcriptomics, gastrocnemius muscles were used for quantitative lipidomics and ChIP-qPCR, vastus lateralis muscles were used for western blotting and mitochondrial respiratory chain activity assays). Details can be found in <xref ref-type="supplementary-material" rid="pbio.2005886.s015">S4 Table</xref>.</p>
<p>To preserve glucose during periods of fasting, peripheral tissue metabolism shifts to prioritize the use of lipids, ketone bodies, and amino acids as energy substrates [<xref ref-type="bibr" rid="pbio.2005886.ref096">96</xref>]. This occurs concomitantly with increased peripheral glucose production derived mostly from amino acids supplied from skeletal muscle protein breakdown. Accordingly, low blood glucose and the resulting low circulating insulin levels are catalysts for increased peripheral lipolysis, muscle protein degradation, and amino acid release. These homeostatic adaptations are readily apparent during starvation, high-fat diet, and endurance exercise. Our data suggest that the same mechanisms are at play and relevant during normal 24-hr fasting/feeding and rest/activity cycles. Indeed, the normal circadian rise in blood glucose concentrations at awakening is exquisitely controlled at multiple levels and by multiple tissues to ensure coordinated maintenance of glycemia and peripheral insulin sensitivity [<xref ref-type="bibr" rid="pbio.2005886.ref097">97</xref>]. Our study highlights several examples of how the muscle clock plays an important role in these processes by directly modulating and coordinating local transcriptional programs in anticipation of diurnal oscillations of hormones and metabolites (summarized in <xref ref-type="fig" rid="pbio.2005886.g010">Fig 10</xref>).</p>
<fig id="pbio.2005886.g010" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.2005886.g010</object-id>
<label>Fig 10</label>
<caption>
<title>BMAL1- and REV-ERB-dependent programming of muscle metabolism.</title>
<p>Our integration of multiple “–omics” datasets indicates that the muscle clock may modulate diurnal fuel selection in anticipation of the feeding phase by direct BMAL1-dependent activation of genes promoting neutral lipid storage (<italic>Dgat2</italic>) and metabolic efficiency (<italic>Coq10b</italic>) while coordinating REV-ERB-mediated repression of a network of genes involved in lipid metabolism (<italic>Plin5</italic>, <italic>Acsl1</italic>, <italic>Ucp3</italic>, <italic>Pdk4</italic>) and muscle protein turnover (<italic>MuRF-1</italic>, <italic>Atrogin-1</italic>, <italic>polyubiquitin-C</italic>, <italic>Snat2</italic>). Muscle clock disruption causes loss of BMAL1-dependent activation and REV-ERB-dependent repression of target genes, resulting in a state of metabolic inefficiency characterized by increased lipid mobilization and oxidation and in increased protein turnover. BMAL1, brain and muscle ARNT-like protein 1; HDAC3, histone deacetylase 3; NCoR1, nuclear receptor corepressor 1; RORE, ROR response element.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.g010" xlink:type="simple"/>
</fig>
<p>Tissue-specific circadian clocks are thought to function as metabolic rheostats [<xref ref-type="bibr" rid="pbio.2005886.ref098">98</xref>]. This occurs both by synchronizing cells within each tissue and by fine-tuning local tissue metabolism in anticipation of rhythmic systemic changes in behavior or nutritional state. Our data indicate that the muscle clock is particularly tuned to regulate muscle metabolism, as genomic binding sites for BMAL1 and REV-ERBα were mostly muscle-specific (<xref ref-type="supplementary-material" rid="pbio.2005886.s004">S1B Fig</xref>). This reflects known tissue specificity of circadian clock transcription factor binding [<xref ref-type="bibr" rid="pbio.2005886.ref013">13</xref>] and is likely a consequence of differences in tissue-specific chromatin accessibility. Our interpretation is supported by the fact that both factors also shared a muscle-specific enhancer genomic signature, with muscle binding sites for BMAL1 and REV-ERBα also showing high enrichment of motifs for myogenic regulatory factors—like MYOD, MYF5, and MYOG—and coregulators like MEF2.</p>
<p>While common muscle BMAL1 and REV-ERBα target genes largely reflect their involvement in the regulation of glucose metabolism and muscle mass, our REV-ERBα-specific cistrome also highlights a specialized metabolic role in regulating muscle lipid and protein metabolism. This was not previously observed in genome-wide studies mapping REV-ERBα binding in proliferating and differentiating myoblasts in culture [<xref ref-type="bibr" rid="pbio.2005886.ref099">99</xref>] and so may be a particular facet of REV-ERBα’s physiological role in differentiated muscle cells within an in vivo context.</p>
<p>Our results suggest that REV-ERBα may regulate lipid and protein metabolism target genes via cross-talk/competition with other relevant nuclear hormone receptors, especially PPARs and GR, but also others, including AR and thyroid hormone receptor (TR). Such promiscuity among nuclear hormone receptors at target sites is well known [<xref ref-type="bibr" rid="pbio.2005886.ref100">100</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref101">101</xref>] and is thought to permit more subtle or complicated regulatory mechanisms [<xref ref-type="bibr" rid="pbio.2005886.ref037">37</xref>]. Highlighting potential sites for cross-talk/competition between REV-ERBα and PPARs, we found REV-ERBα peaks near established [<xref ref-type="bibr" rid="pbio.2005886.ref036">36</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref037">37</xref>] PPREs of <italic>Plin5</italic> and <italic>Acsl1</italic>. Importantly, overexpression of <italic>Plin5</italic> alone is sufficient to drive expression of a cluster of PPARα target genes involved in lipid catabolism and mitochondrial oxidation in rat TA muscles [<xref ref-type="bibr" rid="pbio.2005886.ref102">102</xref>]. This is thought to occur by a feed-forward mechanism whereby increased perilipin-5 (PLIN5) promotes increased production of endogenous PPAR ligands. Increased activation of PPAR targets in mKO muscles may thus likewise result from a loss of REV-ERB-dependent repression of critical targets, including <italic>Plin5</italic>, in conjunction with increased production of endogenous PPAR ligands.</p>
<p>Another potentially important link between rhythmic PPAR activity and the circadian clock is through the PAR-domain basic leucine zipper (PAR bZip) proteins D-site-binding protein (DBP), thyrotroph embryonic factor (TEF), and hepatic leukemia factor (HLF). Like REV-ERBα/β, these transcription factors are direct BMAL1 targets and oscillate with high amplitude over 24 hr at the level of mRNA and protein in most peripheral tissues [<xref ref-type="bibr" rid="pbio.2005886.ref103">103</xref>]. They are thought to regulate diurnal liver PPAR signaling indirectly by their transcriptional control of acyl-CoA thioesterase (ACOT) proteins, which in turn liberate fatty acids from acyl-CoA esters that can then serve as endogenous PPARα ligands [<xref ref-type="bibr" rid="pbio.2005886.ref104">104</xref>]. Interestingly, <italic>Acot</italic> genes (<italic>Acot1-13</italic>) were generally unchanged or showed slightly increased expression in mKO muscles—despite loss of BMAL1 and despite massively reduced 24-hr oscillation of <italic>Dbp</italic>, <italic>Tef</italic>, and <italic>Hlf</italic>—and increased expression of the PAR bZip repressor <italic>Nfil3</italic> [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>], another potential REV-ERBα target gene [<xref ref-type="bibr" rid="pbio.2005886.ref105">105</xref>]. Accordingly, it remains to be determined whether there are similar links between PPAR signaling and PAR bZIP factors in muscle.</p>
<p>What is clear from our data is that time of day is a particularly crucial component for physiological REV-ERB action in adult skeletal muscle, as every 12 hr, muscle cells alternate between endogenous REV-ERBα/β gain and loss of function (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2C</xref>). These considerations have obvious chronotherapeutic implications for successful pharmacological targeting of muscle REV-ERBα/β. When considering the timing and the relative abundance of REV-ERBα/β protein expression in relation to other nuclear hormone receptors and their known and potential cross-talk, it is very tempting to think of physiological REV-ERB action in terms of a temporal genomic “reset.” In this way, REV-ERBα/β may block and thus resensitize common yet context-dependent regulatory regions of important metabolic target genes, preparing them to respond to the next day’s particular challenges. Future studies are certainly warranted to comprehensively explore and better define these potential relationships.</p>
<p>Our data illuminate how BMAL1, REV-ERBα, and their target genes work together to establish a transcriptional logic that defines 24-hr energy state and a coherent fuel selection within the muscle cell, thus maximizing metabolic efficiency. For example, we show how BMAL1-dependent activation of <italic>Dgat2</italic> could promote synthesis and storage of neutral lipids, while REV-ERB-dependent repression of lipid metabolism genes could coordinately dial down mobilization and oxidation of lipids. This occurs in conjunction with transcriptional activation of gene programs promoting muscle insulin sensitivity and glucose metabolism in anticipation of the feeding+activity phase [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>]. In the absence of BMAL1, muscle cells appear to become untethered from (and thus unable to anticipate) rhythmic systemic nutritional signals and persist in a fasting state, resulting in accumulation and de novo diurnal oscillation of lipids and amino acids. Loss of BMAL1 appears to uncouple glycolysis from oxidation, and divert glycolytic intermediates to alternative sugar, nucleotide, lipid, and amino acid biosynthetic pathways (Figs <xref ref-type="fig" rid="pbio.2005886.g005">5F</xref> and <xref ref-type="fig" rid="pbio.2005886.g008">8B</xref>, and [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>]).</p>
<p>Likewise, REV-ERB-dependent inhibition of the ubiquitin-proteasome system (<italic>MuRF-1</italic>, <italic>Atrogin-1</italic>, <italic>polyubiquitin-C</italic>, and proteasome subunits) and the autophagy-lysosome pathway (<italic>Trp53</italic>, <italic>Atg12</italic>, <italic>Mybph</italic>, and others) might provide an anticipatory brake on these metabolically expensive and potentially devastating processes. Our results suggest that BMAL1 thus tempers physiological rhythms of muscle protein breakdown in anticipation of feeding. However, BMAL1’s role in regulating protein turnover appears to be somewhat limited in scope, as it does not play a major role in pathological protein degradation associated with the massively catabolic state of denervation atrophy [<xref ref-type="bibr" rid="pbio.2005886.ref106">106</xref>] or in age-associated sarcopenia [<xref ref-type="bibr" rid="pbio.2005886.ref003">3</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>]. It will be important to establish whether this is also the case in other forms of muscle atrophy, such as glucocorticoid therapy, sepsis, diabetes, or cancer cachexia. Indeed, one possibility that remains to be tested is whether mKO muscles, or other models of circadian misalignment, exhibit increased sensitivity to endogenous glucocorticoids due to the loss of REV-ERBα-dependent repression. This could lead to the transiently increased expression of GR targets like <italic>MuRF-1</italic>, <italic>Atrogin-1</italic>, <italic>polyubiquitin-C</italic>, and others that we observe.</p>
<p>Reduced peripheral fat mass in mKO mice is in agreement with increased lipid oxidation and reduced lipid storage. On the other hand, increased alanine synthesis and release and persisting peak expression of genes involved in protein degradation suggest that increased mKO muscle mass reflects overall increased protein turnover, with net balance favoring muscle protein synthesis. Indeed, mKO mice showed significantly increased rates of protein synthesis at ZT4 (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7D and 7E</xref>). Increased rates of protein synthesis often go hand in hand with increased rates of protein degradation. For example, the paradoxical up-regulation of protein synthesis and mammalian target of rapamycin complex 1 (mTORC1) activation during denervation atrophy occurs via a proteasome-mediated increase in intramuscular amino acids [<xref ref-type="bibr" rid="pbio.2005886.ref107">107</xref>]. Likewise, protein degradation is often a necessary correlate of muscle growth/remodeling [<xref ref-type="bibr" rid="pbio.2005886.ref108">108</xref>].</p>
<p>One of many interesting REV-ERBα target genes we uncovered was <italic>Snat2</italic> (<italic>Slc38a2</italic>). Sodium-dependent neutral amino acid transporter 2 (SNAT2) is a major determinant of cell size [<xref ref-type="bibr" rid="pbio.2005886.ref046">46</xref>] and anabolic amino acid concentration in muscle cells [<xref ref-type="bibr" rid="pbio.2005886.ref109">109</xref>] because of its dual role as an amino acid transporter–receptor [<xref ref-type="bibr" rid="pbio.2005886.ref110">110</xref>]. SNAT2 couples System A transport with System L activity, thus increasing uptake of BCAA, including the potently anabolic essential amino acid leucine, and activation of mTORC1. Loss of REV-ERB-mediated repression of <italic>Snat2</italic> (<xref ref-type="fig" rid="pbio.2005886.g002">Fig 2F</xref> and <xref ref-type="supplementary-material" rid="pbio.2005886.s011">S8C Fig</xref>) may thus contribute to the increased BCAA observed at ZT16 in mKO muscles (<xref ref-type="fig" rid="pbio.2005886.g005">Fig 5A</xref>) and might also contribute to increased rates of muscle protein synthesis. Even a mildly increased futile cycle of protein breakdown and resynthesis in mKO muscles would add a substantial contribution to metabolic rate [<xref ref-type="bibr" rid="pbio.2005886.ref111">111</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref112">112</xref>] and negatively impact overall metabolic efficiency. Indeed, we also noted significantly increased EE in mKO mice (<xref ref-type="fig" rid="pbio.2005886.g007">Fig 7I</xref>).</p>
<p>Our finding of increased protein synthesis in mKO muscles appears to contrast with the reported cytosolic role of BMAL1 as a translation factor that promotes rhythmic protein synthesis as a substrate of the mTOR-effector p70S6K1 (S6K1) [<xref ref-type="bibr" rid="pbio.2005886.ref113">113</xref>]. Lipton and colleagues found approximately 10% reduced in vivo protein synthesis rates in livers from WT mice between ZT0 and ZT12, the beginning and the end of the fasting phase, respectively. On the other hand, livers from global BMAL1 KO mice showed approximately 30% reduced protein synthesis rates at ZT0 and ZT12 compared to WT mice. Examining different timepoints, in a different tissue, and using a different in vivo model of BMAL1 ablation, we found approximately 2-fold-increased protein synthesis rates in WT muscles at ZT16, the middle of the feeding+activity phase, compared to WT muscles at ZT4, the middle of the fasting+rest phase. While seemingly at odds, our results and those of Lipton and colleagues in WT mice are both in agreement with published results obtained from livers and muscles of fasted and fed WT mice [<xref ref-type="bibr" rid="pbio.2005886.ref080">80</xref>]. However, we found that protein synthesis rates remained elevated rather than reduced in mKO muscles at ZT4. Some important considerations may explain possible discrepancies. For example, liver protein synthesis rates are much higher than skeletal muscle under fed/fasted states and over 24 hr [<xref ref-type="bibr" rid="pbio.2005886.ref114">114</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref115">115</xref>]. Furthermore, muscle and liver show important tissue-specific differences in their regulation of protein synthesis [<xref ref-type="bibr" rid="pbio.2005886.ref116">116</xref>]. For example, rapamycin-induced inhibition of mTORC1 completely blocks the stimulation of protein synthesis in liver upon feeding yet only partially inhibits muscle protein synthesis [<xref ref-type="bibr" rid="pbio.2005886.ref117">117</xref>]. In addition, leucine increases protein synthesis in skeletal muscle but not in liver [<xref ref-type="bibr" rid="pbio.2005886.ref118">118</xref>–<xref ref-type="bibr" rid="pbio.2005886.ref121">121</xref>]. Finally, mice lacking S6K1 have normal global translational activity in muscle [<xref ref-type="bibr" rid="pbio.2005886.ref115">115</xref>] and continue to show increased muscle protein synthesis and hypertrophy in response to AKT activation [<xref ref-type="bibr" rid="pbio.2005886.ref122">122</xref>].</p>
<p>The uptake of oxidative substrates and their rate of flux through catabolic pathways are ultimately determined by the efficiency of electron transport and proton conductance (the sum of ATP synthesis and proton leak) [<xref ref-type="bibr" rid="pbio.2005886.ref069">69</xref>]. Increased oxidative capacity in conjunction with increased uncoupling from ATP production is seen in endurance-trained athletes [<xref ref-type="bibr" rid="pbio.2005886.ref072">72</xref>] and in rodents fed a high-fat diet [<xref ref-type="bibr" rid="pbio.2005886.ref074">74</xref>]. The resulting loss of metabolic efficiency (i.e., uncoupling substrate oxidation from ATP production) is thought to protect against an excessive buildup of Δ<italic>ψ</italic><sub>m</sub> and uncontrolled formation of reactive oxygen species (ROS) [<xref ref-type="bibr" rid="pbio.2005886.ref068">68</xref>]. Diurnal mitochondrial coupling efficiency is thus likely lowest from ZT8 to ZT12, at the end of the resting phase, characterized by low respiration rates, low levels of intracellular ADP (<xref ref-type="supplementary-material" rid="pbio.2005886.s008">S5B Fig</xref>), and around peak diurnal expression of <italic>Ucp3</italic> and <italic>Ucp2</italic> (<xref ref-type="fig" rid="pbio.2005886.g006">Fig 6G</xref>). In this state, total oxygen consumption would be dominated by basal uncoupling mechanisms [<xref ref-type="bibr" rid="pbio.2005886.ref072">72</xref>], and decreased efficiency of energy production would cause a concomitant rise in basal TCA cycle flux. In WT muscles, ZT8–ZT12 coincides with the peak of diurnal citrate levels, which oscillate around 2–3-fold over 24 hr. Increased TCA flux at this time may be beneficial in that it could provide a more rapid response in anticipation of increased energy demand upon awakening, analogous to its advantageous role proposed in endurance athletes compared to sedentary controls [<xref ref-type="bibr" rid="pbio.2005886.ref072">72</xref>]. However, despite increased muscle TCA intermediates, there is no clear advantage gained in terms of exercise endurance in mKO mice (<xref ref-type="supplementary-material" rid="pbio.2005886.s009">S6B Fig</xref>), and so increased TCA cycle anaplerosis may simply reflect a mismatch between pyruvate formation and oxidation, as suggested by Gibala and colleagues [<xref ref-type="bibr" rid="pbio.2005886.ref059">59</xref>].</p>
<p>It is important to stress that the mild mitochondrial alterations we observe in mKO muscles should not be considered in terms of dysfunction. Interestingly, our results are in stark contrast to the severe exercise intolerance and mitochondrial dysfunction reported for <italic>Clock</italic> mutant mice [<xref ref-type="bibr" rid="pbio.2005886.ref123">123</xref>] and global <italic>Rev-erbα</italic> KO mice [<xref ref-type="bibr" rid="pbio.2005886.ref029">29</xref>]. However, interpretation of these particular global models and their relation to the muscle clock is complicated by the fact that all tissues are affected, including the central pacemaker. Further studies using conditional muscle-specific and inducible <italic>Clock</italic> and <italic>Rev-erbα/β</italic> KO models, also keeping in mind REV-ERBα’s indirect DNA binding roles [<xref ref-type="bibr" rid="pbio.2005886.ref013">13</xref>], would certainly help to clarify the particular relationships. Rather, our data suggest the mitochondrial alterations we observe in mKO muscles are likely operating within a normal physiological range, albeit at one extreme analogous to the fasted state. While loss of BMAL1 leads to a mild state of metabolic inefficiency under chow diet and standard housing conditions, endogenous muscle antioxidant systems appear to sufficiently buffer any associated increase in oxidative stress.</p>
<p>Our data thus support the idea that specifically inhibiting muscle REV-ERBα/β [<xref ref-type="bibr" rid="pbio.2005886.ref124">124</xref>] in certain situations may provide a relatively safe means to temporarily modulate metabolic efficiency and EE in skeletal muscle, a major oxidative tissue and relevant pharmacological target in humans [<xref ref-type="bibr" rid="pbio.2005886.ref125">125</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref126">126</xref>]. Indeed, pioneering groups have already begun to wade into these therapeutic waters and, importantly, have already shown in mice that selective REV-ERB antagonism accelerates muscle regeneration in response to acute muscle injury [<xref ref-type="bibr" rid="pbio.2005886.ref099">99</xref>] and promotes muscle differentiation and maintenance of muscle mass in a model of Duchenne muscular dystrophy (DMD) [<xref ref-type="bibr" rid="pbio.2005886.ref127">127</xref>]. Intriguingly, Welch and colleagues showed REV-ERB antagonism enhances Wnt and Notch signaling, leading to satellite cell self-renewal. Selective inhibition of REV-ERBα/β in muscle would also promote increased <italic>Bmal1</italic> expression, which is proposed to have positive effects on sleep [<xref ref-type="bibr" rid="pbio.2005886.ref128">128</xref>] and longevity [<xref ref-type="bibr" rid="pbio.2005886.ref129">129</xref>], and would further promote neutral lipid storage (Figs <xref ref-type="fig" rid="pbio.2005886.g004">4A</xref> and <xref ref-type="fig" rid="pbio.2005886.g008">8</xref>), muscle insulin sensitivity, and glucose metabolism [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>].</p>
<p>In conclusion, we present a comprehensive in vivo view of BMAL1 and REV-ERBα genomic binding in adult mouse skeletal muscle and show how this can be related to common and specific transcriptional programs and metabolite oscillations in the presence or absence of muscle BMAL1 and REV-ERBα/β. Our integration and presentation of multiple in vivo high-throughput “–omics” datasets provides an entry point to explore how BMAL1 and REV-ERBα can direct various physiological processes, including the regulation of muscle energy homeostasis. Our data suggest that the muscle clock, via BMAL1 and REV-ERBα, plays an important role regulating metabolic efficiency by (1) confining substrate use to appropriate temporal windows, (2) modulating rates of energetically expensive protein turnover, (3) promoting storage of neutral lipids, and (4) controlling oxidation of lipid substrates. We also show how the muscle clock may specifically inhibit a network of genes involved in lipid mobilization and oxidation, protein degradation, and amino acid transport via direct REV-ERB-mediated repression in anticipation of the feeding phase, all while coordinately activating genes promoting neutral lipid storage, insulin sensitivity, and glucose oxidation [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>]. The translational relevance of our findings is already evident based on a series of very elegant recent studies performed by Hansen [<xref ref-type="bibr" rid="pbio.2005886.ref130">130</xref>], Loizides-Mangold [<xref ref-type="bibr" rid="pbio.2005886.ref131">131</xref>], Perrin [<xref ref-type="bibr" rid="pbio.2005886.ref132">132</xref>,<xref ref-type="bibr" rid="pbio.2005886.ref133">133</xref>], van Moorsel [<xref ref-type="bibr" rid="pbio.2005886.ref134">134</xref>], and colleagues using human biopsies and human muscle cells in culture. While we have focused only on 2 circadian clock transcription factors and a small subset of potential target genes, additional mediators and physiological roles of the muscle clock remain to be explored. We hope the comprehensive nature of our resource will serve as an important basis from which to continue the exploration of muscle circadian rhythms in health and disease.</p>
</sec>
<sec id="sec013" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec014">
<title>Contact for reagent and resource sharing</title>
<p>Further information and requests for resources and reagents should be directed to and will be fulfilled by Kenneth Dyar (<email xlink:type="simple">kenneth.dyar@helmholtz-muenchen.de</email>).</p>
</sec>
<sec id="sec015">
<title>Ethics statement</title>
<p>All experimental procedures were performed according to European Commission guidelines and were reviewed and approved by the local Veterinary Central Service, University of Padova, and the relevant Italian authority (Ministero della Salute, Ufficio VI), in compliance with Italian Animal Welfare Law (Law n 116/1992 and subsequent modifications) and Directive 2010/63/EU of the European Parliament. Accordingly, experiments performed before 2012 were sent to the Italian Ministry of Health (Project# 27/09). Experiments performed after 2012 were approved by the Italian Ministry of Health (Decree# 164/2012-B of 09.08.12).</p>
</sec>
<sec id="sec016">
<title>Animals</title>
<p>Animals were housed in a temperature-controlled room (22 °C) under a 12-hr light/dark regimen, with lights on at ZT0 (6 AM) and lights off at ZT12 (6 PM), with standard chow diet (Mucedola, Settimo Milanese, Italy) and water provided ad libitum. Muscle-specific inactivation of <italic>Bmal1</italic> (mKO) was obtained as described [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>] by crossing a floxed <italic>Bmal1</italic> C57BL/6 mouse line with a C57BL/6 mouse line carrying a Cre recombinase transgene under control of the <italic>Mlc1f</italic> promoter (<italic>Mlc1f-Cre</italic>). In the resulting mKO mice, the region coding for the BMAL1 bHLH DNA binding domain is excised. Cre-negative littermates were used as controls. All mice used in this study were 3–5-mo-old male littermates, unless specified otherwise. Littermates were randomly assigned to experimental groups. Tissues were collected immediately after cervical dislocation at ZT0, 4, 8, 12, 16, and 20, snap frozen in liquid nitrogen, and stored at −80 °C until subsequent use. <xref ref-type="supplementary-material" rid="pbio.2005886.s015">S4 Table</xref> details the various muscles and tissues used for this paper.</p>
</sec>
<sec id="sec017">
<title>Metabolic phenotyping</title>
<p>Total body fat and lean tissue mass were quantified by nuclear magnetic resonance (EchoMRI). EE, RER (VCO2/VO2), locomotor activity, and feeding behavior were monitored on a TSE system (Bad Homburg, Germany).</p>
</sec>
<sec id="sec018">
<title>Exercise and endurance training experiments</title>
<p>To measure exercise endurance, forced running on a motorized treadmill was used (Harvard Apparatus PANLAB, LE 8710 M). The protocol was based on [<xref ref-type="bibr" rid="pbio.2005886.ref135">135</xref>], with some minor modifications. Briefly, mice were first acclimated to low-speed running (22 cm/s and 10% incline) for 10 min each day for 2 d prior to the test. Acclimation was always performed under dim red light around ZT12 (lights off), the normal start of the circadian activity phase. On the day of the endurance test, food was removed 3 hr before starting at ZT12 to ensure consistent baseline blood glucose levels. For the test, mice began running at 22 cm/s and 10% incline under dim red light. Speed was gradually increased by 5 cm/s every 30 min up to 45 cm/s. Mice were encouraged to run by humanely stimulating their tail with a soft brush. The operator was blind to genotype of the mice, and exhaustion was defined by mice refusing to run for 10 sec and confirmed by blood glucose &lt;76 g/dl [<xref ref-type="bibr" rid="pbio.2005886.ref075">75</xref>]. Time and running distance were recorded for each mouse. For endurance training, mice trotted on a motorized treadmill 25 cm/s and 0% incline 1 hr daily for 4 wk, starting around ZT12. After humanely encouraging mice to run with a soft brush on their tail during the first few acclimation sessions, mice ran without much need for further encouragement.</p>
</sec>
<sec id="sec019">
<title>Clinical blood chemistry</title>
<p>Sedentary mice were either fed ad libitum, and blood was collected at ZT14 (“fed ZT14”), or fasted for 4 hr late in the afternoon (ZT7–ZT11), and blood was collected at ZT11 (“fasted ZT11”). A separate cohort of endurance-trained WT and mKO littermates was measured after 4 wk training on a motorized treadmill 25 cm/s and 0% incline 1 hr daily, starting around ZT12. Blood was collected after running 25 cm/s and 0% incline for 1 hr. Blood was collected from the orbital sinus in heparin-coated Pasteur pipettes and centrifuged immediately after collection. Plasma samples were kept at −20 °C until dosing. FFAs, β-OH-B, and AcAc were dosed using an automated spectrophotometer, Cobas Fara II (Roche), according to the manufacturer’s instructions. Blood glucose and lactate levels were measured with a YSI 2300 STAT Plus glucose and lactate analyzer (YSI Life Sciences, Yellow Springs, OH) according to the manufacturer’s instructions.</p>
</sec>
<sec id="sec020">
<title>Quantification of serum amino acids</title>
<p>Mice were fasted 6 hr (8 AM–2 PM), and blood was collected at ZT8 (2 PM). Blood was collected from the orbital sinus in Pasteur pipettes, allowed to clot at room temperature (RT) for 30 min, centrifuged, and kept at −20 °C until use. Amino acid concentrations were assessed by GC/MS (HP 5890; Agilent Technologies, Santa Clara, CA), using the internal standard technique, as previously reported [<xref ref-type="bibr" rid="pbio.2005886.ref136">136</xref>]. Briefly, known amounts of internal standards (L-[<sup>15</sup>N]glycine, L-[<sup>15</sup>N]glutamate, L-[<sup>15</sup>N]glutamine, L-[1-<sup>13</sup>C, methyl-<sup>2</sup>H<sub>3</sub>]methionine, L-[3,3-<sup>2</sup>H<sub>2</sub>]cysteine, L-[<sup>15</sup>N]alanine, L-[1-<sup>13</sup>C]leucine, L-[1-<sup>13</sup>C]phenylalanine, L-[3,3-<sup>2</sup>H<sub>2</sub>]tyrosine, L-[<sup>15</sup>N]threonine, L-[<sup>15</sup>N]serine, and L-[<sup>15</sup>N]proline [Cambridge Isotope Laboratories]) were added to plasma samples. Amino acid concentrations were determined considering the following mass-to-charge ratios (m/z): 218/219 for glycine, 432/433 for glutamate, 431/432 for glutamine, 320/324 for methionine, 406/408 for cysteine, 158/159 for alanine, 302/303 for leucine, 336/337 for phenylalanine, 466/468 for tyrosine, 404/405 for threonine, 362/363 for serine, and 184/185 for proline.</p>
</sec>
<sec id="sec021">
<title>In vivo ChIP assays</title>
<p>In vivo skeletal muscle ChIP was performed with sonicated nuclear extract prepared from formaldehyde-cross-linked gastrocnemius muscle according to [<xref ref-type="bibr" rid="pbio.2005886.ref137">137</xref>]. For immunoprecipitation, we used anti-BMAL1 (ab93806, Abcam), anti-REV-ERBα (generous gift from Ron Evans), anti-RNA Polymerase II (#MMS-126R; clone 8WG1, Biolegends), anti-NCOR1 (#20018-1-AP, Protein Tech), anti-HDAC3 (ab7030, Abcam), or rabbit IgG (2027x, Santa Cruz). DNA was column purified and used for sequencing or real-time qPCR (enrichment expressed as fold-change relative to IgG; primer sequences used are listed in <xref ref-type="supplementary-material" rid="pbio.2005886.s015">S4 Table</xref>).</p>
</sec>
<sec id="sec022">
<title>ChIP-seq library prep</title>
<p>Libraries from ChIP and input DNA were prepared with the KAPA Hyperprep Kit (Kapa Biosystems, KK8504); Illumina-compatible adapters were synthesized by Integrated DNA Technologies (IDT) and used at a final concentration of 68 nM. Adapter-ligated libraries were size selected (360–610 bp) in a Pippin Gel station (Sage Science) using 2% dye free gels (Sage Science, CDF2010). Library concentration was estimated by real-time PCR with the KAPA Library Quantification Kit (Kapa Biosystems, KK4873). Library quality was evaluated with the Agilent High Sensitivity DNA Kit on a 2100 Bioanalyzer (Agilent). Libraries were run on a HighSeq2500/HighSeq4000 sequencers (Illumina) at the NGS Core Facility at HMGU.</p>
</sec>
<sec id="sec023">
<title>Bioinformatics pipeline for ChIP-Seq data analysis</title>
<sec id="sec024">
<title>Pre-processing</title>
<p>ChIP-Seq FASTQ files were mapped against the mouse mm10 genome with BWA version 7.12 using MEM algorithm [<xref ref-type="bibr" rid="pbio.2005886.ref138">138</xref>]. Duplicate reads were removed using samtools version 0.1.19 [<xref ref-type="bibr" rid="pbio.2005886.ref139">139</xref>]. Multi-mapping reads were removed with bamtools version 2.4.0 [<xref ref-type="bibr" rid="pbio.2005886.ref140">140</xref>] using read threshold of MAPQ ≥ 24.</p>
</sec>
<sec id="sec025">
<title>Adjusting sequencing depth</title>
<p>Sequencing read depth was adjusted by down sampling replicate BAM files to the replicate with lowest read count, resulting in about 13 million unique reads for RNAP2 and about 20 million unique reads each for BMAL1 and REV-ERBα replicates (see <xref ref-type="table" rid="pbio.2005886.t001">Table 1</xref> below for further details).</p>
<table-wrap id="pbio.2005886.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.2005886.t001</object-id>
<label>Table 1</label> <caption><title>Counts of samples at different stages of bioinformatics analysis.</title></caption>
<alternatives>
<graphic id="pbio.2005886.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">sample description</th>
<th align="center">map percent</th>
<th align="center">read #</th>
<th align="center">rmdup read #</th>
<th align="center">unique reads #<break/>(MAPQ &gt; 24)</th>
<th align="center">downsampled unique reads #</th>
<th align="center"># peaks <italic>p</italic> &lt; 0.05</th>
<th align="center">high confidence peaks</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" style="background-color:#EAF1DD">Muscle_RNAP2_ZT4_rep1</td>
<td align="char" char="." style="background-color:#EAF1DD">96.75</td>
<td align="center" style="background-color:#EAF1DD">18,912,373</td>
<td align="center" style="background-color:#EAF1DD">16,083,495</td>
<td align="center" style="background-color:#EAF1DD">12,951,866</td>
<td align="center" style="background-color:#EAF1DD">12,951,866</td>
<td align="center" style="background-color:#EAF1DD">87,115</td>
<td align="left" rowspan="2" style="background-color:#EAF1DD">} 10764</td>
</tr>
<tr>
<td align="left" style="background-color:#EAF1DD">Muscle_RNAP2_ZT4_rep2</td>
<td align="char" char="." style="background-color:#EAF1DD">99.33</td>
<td align="center" style="background-color:#EAF1DD">26,923,018</td>
<td align="center" style="background-color:#EAF1DD">23,744,982</td>
<td align="center" style="background-color:#EAF1DD">21,078,107</td>
<td align="center" style="background-color:#EAF1DD">13,000,000</td>
<td align="center" style="background-color:#EAF1DD">168,711</td>
</tr>
<tr>
<td align="left" style="background-color:#DBE5F1">Muscle_Bmal1_ZT4_rep1</td>
<td align="char" char="." style="background-color:#DBE5F1">99.15</td>
<td align="center" style="background-color:#DBE5F1">27,754,186</td>
<td align="center" style="background-color:#DBE5F1">21,676,362</td>
<td align="center" style="background-color:#DBE5F1">19,181,165</td>
<td align="center" style="background-color:#DBE5F1">19,181,165</td>
<td align="center" style="background-color:#DBE5F1">34,730</td>
<td align="left" rowspan="2" style="background-color:#DBE5F1">} 2787</td>
</tr>
<tr>
<td align="left" style="background-color:#DBE5F1">Muscle_Bmal1_ZT4_rep2</td>
<td align="char" char="." style="background-color:#DBE5F1">97.85</td>
<td align="center" style="background-color:#DBE5F1">44,673,573</td>
<td align="center" style="background-color:#DBE5F1">32,176,505</td>
<td align="center" style="background-color:#DBE5F1">28,279,965</td>
<td align="center" style="background-color:#DBE5F1">20,000,000</td>
<td align="center" style="background-color:#DBE5F1">177,586</td>
</tr>
<tr>
<td align="left" style="background-color:#F2DBDB">Muscle_Rev-erbα_ZT8_rep1</td>
<td align="char" char="." style="background-color:#F2DBDB">99.68</td>
<td align="center" style="background-color:#F2DBDB">36,031,011</td>
<td align="center" style="background-color:#F2DBDB">28,439,234</td>
<td align="center" style="background-color:#F2DBDB">25,292,094</td>
<td align="center" style="background-color:#F2DBDB">20,000,000</td>
<td align="center" style="background-color:#F2DBDB">28,832</td>
<td align="left" rowspan="2" style="background-color:#F2DBDB"><bold>} 1263</bold></td>
</tr>
<tr>
<td align="left" style="background-color:#F2DBDB">Muscle_Rev-erbα_ZT8_rep2</td>
<td align="char" char="." style="background-color:#F2DBDB">99.43</td>
<td align="center" style="background-color:#F2DBDB">28,909,625</td>
<td align="center" style="background-color:#F2DBDB">22,233,385</td>
<td align="center" style="background-color:#F2DBDB">19,698,054</td>
<td align="center" style="background-color:#F2DBDB">19,698,054</td>
<td align="center" style="background-color:#F2DBDB">29,883</td>
</tr>
<tr>
<td align="left">Muscle_Input_rep1</td>
<td align="char" char=".">99.11</td>
<td align="center">28,600,958</td>
<td align="center">26,311,286</td>
<td align="center">23,540,615</td>
<td align="left"/>
<td align="left"/>
<td align="left" rowspan="2"/>
</tr>
<tr>
<td align="left">Muscle_Input_rep2</td>
<td align="char" char=".">99.58</td>
<td align="center">29,104,973</td>
<td align="center">24,849,024</td>
<td align="center">21,920,901</td>
<td align="left"/>
<td align="left"/>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>Abbreviation: MAPQ, mapping quality.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec026">
<title>Peak calling</title>
<p>Macs2 version 2.1.1 [<xref ref-type="bibr" rid="pbio.2005886.ref141">141</xref>] peak caller was used to perform peak calling on the replicates using input DNA. Peak calling cutoff was set to <italic>p</italic>-value 0.05. In addition to narrow peak files, read density distribution (Bedgraphs) was used to visualize ChIP-seq tracks using Integrated Genome Browser [<xref ref-type="bibr" rid="pbio.2005886.ref142">142</xref>].</p>
</sec>
<sec id="sec027">
<title>Peak universe, “high confidence” and “confident” peak tables, and overlapping peaks</title>
<p>A peak table was created for each sample. Replicate sample tables were then combined into a unified peak universe for each factor with unique ranges across the genome and containing overlapping peaks information including the tag counts (enrichment score). “High confidence” peaks were identified as reproducible peaks common between replicate samples. “Confident” peaks were reproducible peaks common between BMAL1 and REV-ERBα and present in ≥3 of the 4 samples.</p>
<p>To assess overlapping peaks between liver and muscle, liver peak location coordinates for BMAL1 [<xref ref-type="bibr" rid="pbio.2005886.ref014">14</xref>] and REV-ERBα [<xref ref-type="bibr" rid="pbio.2005886.ref015">15</xref>] were first converted from mm9 to mm10 using UCSC liftOver.</p>
</sec>
<sec id="sec028">
<title>Heatmaps</title>
<p>Bedgraphs were used to plot the read density map near the universe peak centers using deepTools version 2.2.4 [<xref ref-type="bibr" rid="pbio.2005886.ref143">143</xref>]. Replicates for each factor were merged using UCSC tools bedGraphToBigWig and bigWigMerge (<ext-link ext-link-type="uri" xlink:href="http://hgdownload.cse.ucsc.edu/admin/exe/macOSX.x86_64/" xlink:type="simple">http://hgdownload.cse.ucsc.edu/admin/exe/macOSX.x86_64/</ext-link>).</p>
<p>Then, deepTools computeMatrix tool was used followed by plotHeatmap tool [<xref ref-type="bibr" rid="pbio.2005886.ref143">143</xref>].</p>
</sec>
<sec id="sec029">
<title>Peak annotation</title>
<p>Peak annotation was performed with HOMER version v4.8 [<xref ref-type="bibr" rid="pbio.2005886.ref144">144</xref>]. GENCODE database for mm10 [<xref ref-type="bibr" rid="pbio.2005886.ref145">145</xref>] was used as a reference for assigning feature level annotation.</p>
</sec>
<sec id="sec030">
<title>Motif discovery</title>
<p>To minimize bias, a combination of two different methods was used for motif discovery:</p>
<list list-type="order">
<list-item><p>HOMER version v4.8 [<xref ref-type="bibr" rid="pbio.2005886.ref144">144</xref>]. For BMAL1 we searched for motifs of 8-, 10-, 12-, 14-, 15-, and 16-mers. For REV-ERBα, we searched for motifs of 8-, 10-, and 12-mers.</p></list-item>
<list-item><p>Clover version published on Jan 14, 2016 [<xref ref-type="bibr" rid="pbio.2005886.ref146">146</xref>], was used with default settings.</p></list-item>
</list>
</sec>
<sec id="sec031">
<title>Functional enrichment analysis of peaks</title>
<p>Genomic Regions Enrichment of Annotations Tool (GREAT) [<xref ref-type="bibr" rid="pbio.2005886.ref016">16</xref>] was used to analyze functional significance of BMAL1 and REV-ERBα peaks using mouse NCBI build 38 genome assembly (mm10), whole genome as background, and associating genomic regions with genes using “basal plus extension” and the following parameters: proximal 20 kb upstream, 2 kb downstream, plus distal up to 500 kb.</p>
</sec>
</sec>
<sec id="sec032">
<title>Global metabolite profiling</title>
<p>Metabolite profiling, peak identification, and curation were performed by Metabolon using described methods [<xref ref-type="bibr" rid="pbio.2005886.ref147">147</xref>]. Briefly, the nontargeted metabolic profiling platform used by Metabolon combines 3 independent platforms: UHPLC/MS/MS optimized for basic species, UHPLC/MS/MS optimized for acidic species, and GC/MS. We analyzed a total of 60 TA muscles from 60 male muscle-specific <italic>Bmal1</italic> KO and control littermates (5 × group × time point).</p>
</sec>
<sec id="sec033">
<title>Metabolomics data processing and analysis</title>
<p>Metabolomics data (“origscale”) can be found in supporting file <xref ref-type="supplementary-material" rid="pbio.2005886.s003">S3 Data</xref>. The data were first normalized according to raw area counts and processed according to [<xref ref-type="bibr" rid="pbio.2005886.ref148">148</xref>]. Run day correction was performed for each metabolite by setting the run day medians equal to 1. We removed metabolites with more than 50% missing values and transformed data to log10. Data points outside 4 times the standard deviation for each metabolite were considered as outliers and removed. Missing data were imputed by k-nearest-neighbor algorithm. To identify metabolites that show significant change over time and/or genotype, we fit data to a linear mixed effects model. Significant changes were estimated by performing F-test statistics to each fixed effect term (ANOVA) Genotype, Time, Genotype × Time. Calculations were done using MATLAB R2015b, Statistics Toolbox. Heatmaps were generated using the mean of 5 replicates. Hierarchical clustering was performed with squared euclidean distance and Ward’s minimum variance algorithm. Data were sorted by phase according to WT muscle and aligned between groups to show effect in mKO. Metabolites were categorized according to Metabolon superpathways: Amino Acids, Carbohydrates, Cofactors and Vitamins, Energy, Lipids, Nucleotides, Peptides, and Xenobiotics. To identify significantly enriched KEGG pathways in our data, we performed a hypergeometric distribution test on metabolites showing a Genotype effect <italic>p</italic> &lt; 0.05. To identify 24-hr cycling metabolites, we used the nonparametric test JTK_CYCLE as described in [<xref ref-type="bibr" rid="pbio.2005886.ref147">147</xref>], using an adjusted <italic>p</italic> &lt; 0.05.</p>
</sec>
<sec id="sec034">
<title>Extraction of total lipids</title>
<p>Muscles were weighed and homogenized in 800 μl dH2O. Lipids were extracted twice according to Folch and colleagues [<xref ref-type="bibr" rid="pbio.2005886.ref149">149</xref>] using chloroform/methanol/water (2/1/0.6, v/v/v) containing 500 pmol butylated hydroxytoluene, 1% acetic acid, and 100 pmol of internal standards (ISTD, 17:0–17:0 PC, 17:0 LPC, 17:0–17:0–17:0 TG, Avanti Polar Lipids) per sample. Extraction was performed under constant shaking for 90 min at RT. After centrifugation at 1,000 x <italic>g</italic> for 15 min at RT, the lower organic phase was collected. Then, 2.5 ml chloroform was added to the remaining aqueous phase, and the second extraction was performed as described above. Combined organic phases of the double extraction were dried under a stream of nitrogen and resolved in 900 μl 2-propanol/chloroform/methanol (7/2/1, v/v/v).</p>
</sec>
<sec id="sec035">
<title>Quantitative analysis of TG by HPLC with light scattering detection</title>
<p>For HPLC-ELSD, 20 μl of the resolved extract was evaporated and dissolved in 100 μl chloroform/methanol (2/1, v,v). The chromatographic setup for lipid separation consisted of an Agilent 1100 combining pump, injector, precooled sample manager (4 °C), and column oven (40 °C) (Agilent, Santa Clara, CA). For detection of lipids, a Sedex 85 evaporative light scattering detector (Sedere, Alfortville, France) was used. Data acquisition was performed by the Chemstation software (B 04.01, Agilent, Santa Clara, CA). A ternary gradient with a Betasil Diol column (100 × 4.6 mm, particle size 5 μm, Thermo Fisher Scientific, Waltham, MA) was used for chromatographic separation. The solvent system consisted of eluent A (isooctane/ethylacetate, 99.8/0.2, v/v), eluent B (acetone/ethylacetate, 2/1, v/v, containing 0.02% [v/v] acetic acid), and eluent C (isopropanol/water, 85/15, v/v, containing 0.05% [v/v] acetic acid and 0.3% [v/v] ammonium acetate). For external calibration, TG 54:3 (Larodan, Solna, Sweden) was prepared in chloroform:methanol (2:1, v/v), and the final concentration ranged from 1 μM to 2.5 μM. Injection volume for all samples including external calibration was 10 μl.</p>
</sec>
<sec id="sec036">
<title>Qualitative analysis of lipids by ultra-performance liquid chromatography (UPLC) with qTOF detection</title>
<p>For UPLC-qTOF, 120 μl of the resolved extract was transferred to an autosampler vial for analysis. Chromatographic separation was performed using an AQUITY UPLC system (Waters), equipped with a BEH-C18-column (2.1 × 150 mm, 1.7 μm; Waters) as previously described [<xref ref-type="bibr" rid="pbio.2005886.ref150">150</xref>]. A SYNAPTG1 qTOF HD mass spectrometer (Waters) equipped with an ESI source was used for detection. For positive and negative ionization mode, 5 μl and 10 μl were injected, respectively. Data acquisition was done by the MassLynx 4.1 software (Waters Corporation). Lipid classes were analyzed with the “Lipid Data Analyzer 1.6.2” software [<xref ref-type="bibr" rid="pbio.2005886.ref151">151</xref>]. Extraction efficacy and lipid recovery were normalized using ISTD, and lipid classes were expressed as percent composition.</p>
</sec>
<sec id="sec037">
<title>Separation of neutral lipids by thin-layer chromatography</title>
<p>Extracted lipids were spotted on a silica gel 60 (Merck, Darmstadt, Germany). For comparison, a standard solution containing TG 54:3 was used. The silica gel was developed using n-hexane/diethylether/acetic acid (80/20/2, v/v/v) as solvent system, and lipids were visualized by charring using concentrated sulfuric acid.</p>
</sec>
<sec id="sec038">
<title>Palmitate oxidation</title>
<p>Gastrocnemius muscles were immediately removed after cervical dislocation. Tissues were quickly weighed, and placed in ice-cold homogenization buffer (250 mM Sucrose, 10 mM Tris-HCL, 1 mM EDTA, pH = 7.4). Muscles were then thoroughly minced with scissors and transferred to a 10 ml glass homogenization mortar on ice, and ice-cold homogenization buffer was added up to a 20-fold dilution (w/v) suspension. Samples were then homogenized with 10 strokes of a motor-driven, tightly fitting glass mortar/Teflon pestle Potter Elvehjem homogenizer operated at 1,600 rpm. Reactions were initiated by adding 50 μl of muscle homogenates to 450 μl of prewarmed oxidation medium (30 °C; 111 mM sucrose, 11.1 mM Tris-HCl, 5.56 mM KH<sub>2</sub>PO<sub>4</sub>, 1.11 mM MgCl<sub>2</sub>, 88.9 mM KCl, 0.222 mM EDTA, 1.11 mM DTT, 2.22 mM ATP, 0.33% fatty acid–free BSA, 2.22 mM Carnitine, 0.056 mM CoA, 0.111 mM Malate, 222 uM cold Palmitate, + 0.5 uCi [1-<sup>14</sup>C]-palmitic acid; prepared fresh daily; pH 7.4). After incubation for 90 min in a shaking water bath (100 rpm; 30 °C), reactions were terminated by addition of 100 μl 1 M perchloric acid, and the CO2 produced during the incubation was trapped in 100 μl NaOH that had been added to a small tube inside the reaction vial. Palmitate oxidation rates were determined by measuring incorporation into <sup>14</sup>CO<sub>2</sub> and <sup>14</sup>C-acid-soluble metabolites (ASM) by liquid scintillation counting.</p>
</sec>
<sec id="sec039">
<title>Analysis of mitochondrial function</title>
<p>Spectrophotometric activity of mitochondrial respiratory chain complexes CI, CII, CIII, CII+III, CIV, as well as CS, was measured according to [<xref ref-type="bibr" rid="pbio.2005886.ref152">152</xref>] using muscle homogenates from frozen vastus lateralis muscles from the same cohort of mice used for gene expression and metabolomics analyses. Mitochondrial membrane potential was measured by epifluorescence microscopy based on the accumulation of TMRM fluorescence in isolated muscle fibers from flexor digitorum brevis (FDB) muscles as previously described [<xref ref-type="bibr" rid="pbio.2005886.ref153">153</xref>], with minor modifications. Briefly, fresh FDB muscles from adult mice were digested in type I collagenase at 37 °C for 2 hr and dissociated into single fibers by gentle pipetting. Isolated FDB myofibers were then placed in 1 ml Tyrode’s buffer (Sigma) and loaded with 2.5 nM TMRM (Molecular Probes) supplemented with 1 μM cyclosporine H (a P-glycoprotein inhibitor) for 30 min at 37 °C. At the times indicated by arrows, oligomycin (Olm, 5 μM; Sigma) or the protonophore FCCP (4 μM; Sigma) was added to the culture medium.</p>
</sec>
<sec id="sec040">
<title>Assessment of muscle protein synthesis</title>
<p>Quantification of muscle protein synthesis rates was performed using the nonradioactive IV-SUnSET technique as described in [<xref ref-type="bibr" rid="pbio.2005886.ref078">78</xref>].</p>
</sec>
<sec id="sec041">
<title>Gene expression profiling and analyses</title>
<p>Microarray sample processing, quality control, and data analysis are reported in [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>].</p>
</sec>
<sec id="sec042">
<title>SDS-PAGE and western blotting</title>
<p>Muscle lysates were prepared in RIPA buffer (Sigma) supplemented with Halt protease and phosphatase inhibitor cocktail (#78446, Thermo Scientific), protein concentration determined using the bicinchoninic acid assay (Pierce, Rockford, IL, USA), and SDS-PAGE performed using NuPAGE 4%–12% gels (Invitrogen). Proteins were transferred onto a PVDF membrane and incubated with rabbit anti-REV-ERBα (kind gift from Ron Evans), mouse anti-REV-ERBβ (D-8; sc-398252, Santa Cruz), or mouse anti-GAPDH (ab8245, Abcam). Membranes were then incubated with HRP-conjugated donkey anti-rabbit (sc-2317, Santa Cruz) or goat anti-mouse (170–6516, Biorad) secondary antibodies. HRP activity was measured by chemiluminescence (Immobilon Western, Millipore), and bands visualized on CP-BU Medical X-Ray Film (Agfa HealthCare NV, Gevaert, Belgium).</p>
</sec>
<sec id="sec043">
<title>Plasmids</title>
<p>Mouse promoter regions of <italic>Rev-erbα</italic> (forward, 5′-CCCCTAGTCACCACTAACCTC-3′; reverse, 5′-AGAGACGTGTGCCCTGCTA-3′), <italic>Rev-erbβ</italic> (forward, 5′-ATGTAGGAGGGAGGCTCGG-3′; reverse, 5′-GCCTCGCGCAGACTATGG-3′), <italic>Dgat2</italic> (forward, 5′-AGCTGCTAGGATTGTAGGATTACAG-3′; reverse, 5′-AGAGCTGAGGTAGGTAGCCG-3′), and <italic>Coq10b</italic> (forward, 5′-GCTAACCAAATGCAGCAGGC-3′; reverse, 5′-TGTGAAGCCGGTAGCCAAC-3′) were amplified using High Fidelity Platinum Taq DNA polymerase (Invitrogen), cloned into pGL3-Basic (Promega), and verified by sequencing. pRL-CMV renilla expression construct was from Promega. pCMV-AC-mKate (mKate2) was from OriGene. Both <italic>mPer2</italic>::<italic>luc</italic> (423-bp <italic>mPer2</italic> promoter fragment) and <italic>mBmal1</italic>::<italic>luc</italic> (530-bp <italic>mBmal1</italic> promoter fragment) reporter plasmids were generous gifts from Kazuhiro Yagita and described in [<xref ref-type="bibr" rid="pbio.2005886.ref154">154</xref>]. Mouse full-length <italic>Bmal1</italic> and <italic>Clock</italic> pcDNA3-HA constructs were generous gifts from Marina Antoch (Roswell Park Cancer Institute) and described in [<xref ref-type="bibr" rid="pbio.2005886.ref155">155</xref>]. Mouse full-length <italic>Rev-erbα</italic> ORF (forward, 5′-ATGACGACCCTGGACTCCAA-3′; reverse, 5′-TCACTGGGCGTCCACCCGGA-3′) was amplified using AccuPrime GC-Rich DNA Polymerase (Invitrogen) and shuttled into Gateway pDONR-221 (Invitrogen) with Gateway BP Clonase Enzyme (Invitrogen). Mouse <italic>Rev-erbα</italic> ORF was then shuttled into Gateway pcDNA-Dest47 expression vector with Gateway LR Clonase Enzyme (Invitrogen). The −1 kb and −5 kb <italic>MuRF-1</italic> promoter luciferase reporters and c.a.FOXO3A plasmids were generous gifts from Marco Sandri. The mouse GR construct was generated by PCR amplifying a Kpn1/BamH1 PCR fragment from full-length mouse GR ORF (BioScience IMAGE40111802) using forward 5′-GGGGTACCATGGACTCCAAAGAATC-3′ and reverse 5′- CGGGATCCTCATTTCTGATGAAAC-3′ primers and cloning into Kpn1/BamH1-digested pcDNA3.</p>
</sec>
<sec id="sec044">
<title>In vitro transfection and luciferase assays</title>
<p>HEK-293T cells were cultured in DMEM with 10% FBS and penicillin-streptomycin. Cells were seeded in 96-well plates at 100,000 cell/mL for transfection and luciferase measurements. For BMAL1 target validation, cells were cotransfected with 25 ng promoter reporter construct, 25 ng pRL-CMV, and either 25 ng BMAL1-HA + 25 ng CLOCK-HA or 50 ng empty pcDNA3. For REV-ERBα sensor validation, cells were cotransfected with 25 ng <italic>mBmal1</italic>::<italic>luc</italic>, 25 ng pRL-CMV, and either 200 ng REV-ERBα or 200 ng empty pcDNA-Dest47. For MuRF-1 reporter experiments, cells were cotransfected with 25 ng <italic>MuRF-1</italic> reporter, 25 ng pRL-CMV, and 25 ng each of GR, c.a.FOXO3A, and REV-ERBα. To maintain consistent DNA transfection concentrations across experiments, 50 ng or 25 ng empty pcDNA-Dest47 was supplemented, respectively, when transfecting only one or two transcription factors. Transfection was performed with FuGene HD (Promega) and transfection medium replaced with Phenol Red free DMEM. The next day, cells were lysed, and firefly and renilla luciferase were sequentially measured using Dual-Glo Luciferase assay system (Promega). Firefly raw values were normalized to Renilla raw values for each replicate. Data from 2 independent experiments are expressed as mean fold-change of the test condition normalized to the empty vector ± SEM.</p>
</sec>
<sec id="sec045">
<title>In vivo transfection of adult skeletal muscle</title>
<p>Six-mo-old adult male <italic>Bmal1</italic> mKO mice and WT littermates were anesthetized by i.p. injection of a mixture of Zoletil 100 (a combination of Zolazapam and Tiletamine, 1:1, 10 mg/kg, Laboratoire Virbac) and Rompun (Xilazine 2%, 0.06 ml/kg, Bayer). Gene transfer of TA muscles was induced by intramuscular injection of plasmid DNA (40 μg, consisting of 15 μg <italic>mBmal1</italic>::<italic>luc</italic> reporter plasmid, 5 μg mKate2 exogenous spike-in control, and 20 μg either REV-ERBα or empty pcDNA-Dest47) followed by electroporation using stainless steel electrodes connected to a ECM830 BTX porator (Genetronics, San Diego, CA).</p>
</sec>
<sec id="sec046">
<title>Optical bioluminescence imaging</title>
<p>In vivo bioluminescence images were acquired with the IVIS 100 system (Perkin-Elmer) under general anesthesia by i.p. injection of a mixture of Zoletil 100 (a combination of Zolazapam and Tiletamine, 1:1, 10 mg/kg, Laboratoire Virbac) and Rompun (Xilazine 2%, 0.06 ml/kg, Bayer) and analysis performed according to [<xref ref-type="bibr" rid="pbio.2005886.ref156">156</xref>] with the following parameters: field of view 25 cm, binning factor 8, exposure time 1 min. Living Image software (version 4.3) was used for image capture and analysis.</p>
</sec>
<sec id="sec047">
<title>RNA isolation and qPCR</title>
<p>Total RNA was isolated, purified, and reverse transcribed to cDNA, and RT-qPCR was performed as described in [<xref ref-type="bibr" rid="pbio.2005886.ref007">7</xref>]. Analysis was performed using the standard curve method, and all data were normalized relative to <italic>36B4</italic> expression.</p>
</sec>
<sec id="sec048">
<title>Quantification and statistical analysis</title>
<p>All data are expressed as means ± SEM unless otherwise stated. Statistical analysis was performed using unpaired Student’s <italic>t</italic> test or 2-way ANOVA. When ANOVA revealed significant genotype differences, further analysis was performed using Bonferroni’s multiple comparison test. Differences between groups were considered statistically significant for <italic>p</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="sec049">
<title>Supporting information</title>
<supplementary-material id="pbio.2005886.s001" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s001" xlink:type="simple">
<label>S1 Data</label>
<caption>
<title>Numerical data behind figures.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s002" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s002" xlink:type="simple">
<label>S2 Data</label>
<caption>
<title>Motif location and frequency data.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s003" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s003" xlink:type="simple">
<label>S3 Data</label>
<caption>
<title>Raw 24-hr metabolomics data.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s004" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Supporting information for <xref ref-type="fig" rid="pbio.2005886.g001">Fig 1</xref>.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s005" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s005" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Supporting information for <xref ref-type="fig" rid="pbio.2005886.g001">Fig 1</xref>.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s006" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s006" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Supporting information for <xref ref-type="fig" rid="pbio.2005886.g002">Fig 2</xref>.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s007" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s007" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>Supporting information for <xref ref-type="fig" rid="pbio.2005886.g004">Fig 4</xref>.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s008" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s008" xlink:type="simple">
<label>S5 Fig</label>
<caption>
<title>Supporting information for <xref ref-type="fig" rid="pbio.2005886.g005">Fig 5</xref>.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s009" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s009" xlink:type="simple">
<label>S6 Fig</label>
<caption>
<title>Supporting information for <xref ref-type="fig" rid="pbio.2005886.g006">Fig 6</xref>.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s010" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s010" xlink:type="simple">
<label>S7 Fig</label>
<caption>
<title>Supporting information for <xref ref-type="fig" rid="pbio.2005886.g008">Fig 8</xref>.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s011" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s011" xlink:type="simple">
<label>S8 Fig</label>
<caption>
<title>Supporting information for <xref ref-type="fig" rid="pbio.2005886.g009">Fig 9</xref>.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s012" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s012" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Cistrome supporting data.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s013" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s013" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Motif enrichment analysis.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s014" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s014" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>ANOVA analysis of metabolomics data.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.2005886.s015" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pbio.2005886.s015" xlink:type="simple">
<label>S4 Table</label>
<caption>
<title>Reagents and resource descriptions.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank X. Zhao and R. Evans for generously providing REV-ERBα antibodies. The crucial sequencing help of T. Strom, E. Graf, S. Lösecke, and T. Schwarzmayr of the NGS Core Facility at HMGU is also acknowledged. We are very grateful to R. Biensø and H. Pilegaard for help with glycogen assays, and we thank P. Kotzbeck, R. Zechner, P. Pfluger, S. Keipert, C. Jouffe, T. Müller, B. Staels, H. Duez, and T. Schwarz-Romond for useful discussions and suggestions. The technical support of S. Schön, C. Sportelli, K.Beresowski, and T. Horn is greatly appreciated.</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item><term>3PG</term>
<def><p>3-phosphoglycerate</p></def>
</def-item>
<def-item><term>5’-GMP</term>
<def><p>5’-guanosine monophosphate</p></def>
</def-item>
<def-item><term>5’-IMP</term>
<def><p>5’-inosine monophosphate</p></def>
</def-item>
<def-item><term>AcAc</term>
<def><p>acetoacetate</p></def>
</def-item>
<def-item><term>ACOT</term>
<def><p>acyl-CoA thioesterase</p></def>
</def-item>
<def-item><term>AMP</term>
<def><p>adenosine monophosphate</p></def>
</def-item>
<def-item><term>AR</term>
<def><p>androgen receptor</p></def>
</def-item>
<def-item><term>ARE</term>
<def><p>androgen response element</p></def>
</def-item>
<def-item><term>ASM</term>
<def><p><sup>14</sup>C-acid-soluble metabolites</p></def>
</def-item>
<def-item><term>β-OH-B</term>
<def><p>β-hydroxybutyrate</p></def>
</def-item>
<def-item><term>BCAA</term>
<def><p>branched-chain amino acid</p></def>
</def-item>
<def-item><term>bHLH</term>
<def><p>basic helix-loop-helix</p></def>
</def-item>
<def-item><term>BMAL1</term>
<def><p>brain and muscle ARNT-like protein 1</p></def>
</def-item>
<def-item><term>c.a.AKT</term>
<def><p>constitutively active AKT</p></def>
</def-item>
<def-item><term>c.a.FOXO3A</term>
<def><p>constitutively active forkhead box O3</p></def>
</def-item>
<def-item><term>ChIP-qPCR</term>
<def><p>chromatin immunoprecipitation–quantitative real-time PCR</p></def>
</def-item>
<def-item><term>ChIP-seq</term>
<def><p>chromatin immunoprecipitation followed by next-generation sequencing</p></def>
</def-item>
<def-item><term>CLOCK</term>
<def><p>circadian locomotor output cycles kaput</p></def>
</def-item>
<def-item><term>CS</term>
<def><p>citrate synthase</p></def>
</def-item>
<def-item><term>DBP</term>
<def><p>D-site-binding protein</p></def>
</def-item>
<def-item><term>DMD</term>
<def><p>Duchenne muscular dystrophy</p></def>
</def-item>
<def-item><term>DR1</term>
<def><p>direct repeat 1</p></def>
</def-item>
<def-item><term>DR2</term>
<def><p>direct repeat 2</p></def>
</def-item>
<def-item><term>EE</term>
<def><p>energy expenditure</p></def>
</def-item>
<def-item><term>FCCP</term>
<def><p>carbonylcyanide-p-trifluoromethoxyphenyl hydrazone</p></def>
</def-item>
<def-item><term>FDB</term>
<def><p>flexor digitorum brevis</p></def>
</def-item>
<def-item><term>FDR</term>
<def><p>false discovery rate</p></def>
</def-item>
<def-item><term>FFA</term>
<def><p>free fatty acid</p></def>
</def-item>
<def-item><term>FOXO</term>
<def><p>forkhead box O</p></def>
</def-item>
<def-item><term>GC/MS</term>
<def><p>gas chromatography/mass spectrometry</p></def>
</def-item>
<def-item><term>GDP</term>
<def><p>guanosine diphosphate</p></def>
</def-item>
<def-item><term>GO</term>
<def><p>Gene Ontology</p></def>
</def-item>
<def-item><term>GR</term>
<def><p>glucocorticoid receptor</p></def>
</def-item>
<def-item><term>GRE</term>
<def><p>glucocorticoid response element</p></def>
</def-item>
<def-item><term>GREAT</term>
<def><p>Genomic Regions Enrichment of Annotations Tool</p></def>
</def-item>
<def-item><term>GSSG</term>
<def><p>oxidized glutathione</p></def>
</def-item>
<def-item><term>GTP</term>
<def><p>guanosine triphosphate</p></def>
</def-item>
<def-item><term>HDAC3</term>
<def><p>histone deacetylase 3</p></def>
</def-item>
<def-item><term>HEK-293T</term>
<def><p>human embryonic kidney 293T</p></def>
</def-item>
<def-item><term>HLF</term>
<def><p>hepatic leukemia factor</p></def>
</def-item>
<def-item><term>IDT</term>
<def><p>Integrated DNA Technologies</p></def>
</def-item>
<def-item><term>IR3</term>
<def><p>inverted repeat 3</p></def>
</def-item>
<def-item><term>IV-SUnSET</term>
<def><p>in vivo surface sensing of translation</p></def>
</def-item>
<def-item><term>KO</term>
<def><p>knockout</p></def>
</def-item>
<def-item><term>LC/MS</term>
<def><p>liquid chromatography/mass spectrometry</p></def>
</def-item>
<def-item><term>LPC</term>
<def><p>lysophosphatidylcholine</p></def>
</def-item>
<def-item><term>lysoPC</term>
<def><p>lysoglycerophosphocholine</p></def>
</def-item>
<def-item><term>lysoPE</term>
<def><p>lysoglycerophosphoethanolamine</p></def>
</def-item>
<def-item><term>lysoPI</term>
<def><p>lysoglycerophosphoinositol</p></def>
</def-item>
<def-item><term>lysoPL</term>
<def><p>lysoglycerophospholipid</p></def>
</def-item>
<def-item><term>MAPK</term>
<def><p>mitogen-activated protein kinase</p></def>
</def-item>
<def-item><term>MEF2</term>
<def><p>myocyte enhancer binding factor 2</p></def>
</def-item>
<def-item><term>MGI</term>
<def><p>Mouse Genome Informatics</p></def>
</def-item>
<def-item><term>mKO</term>
<def><p>myocyte-specific loss of BMAL1</p></def>
</def-item>
<def-item><term>MSigDB</term>
<def><p>Molecular Signatures Database</p></def>
</def-item>
<def-item><term>mTORC1</term>
<def><p>mammalian target of rapamycin complex 1</p></def>
</def-item>
<def-item><term>MYF5</term>
<def><p>myogenic factor 5</p></def>
</def-item>
<def-item><term>MYOD</term>
<def><p>myoblast determination protein</p></def>
</def-item>
<def-item><term>MYOG</term>
<def><p>myogenin</p></def>
</def-item>
<def-item><term>n.s.</term>
<def><p>not significant</p></def>
</def-item>
<def-item><term>NCoR1</term>
<def><p>nuclear receptor corepressor</p></def>
</def-item>
<def-item><term>NEFA</term>
<def><p>non-esterified fatty acid</p></def>
</def-item>
<def-item><term>NFκB</term>
<def><p>nuclear factor kappa B</p></def>
</def-item>
<def-item><term>NPAS2</term>
<def><p>neuronal PAS domain protein 2</p></def>
</def-item>
<def-item><term>PAR bZip</term>
<def><p>PAR-domain basic leucine zipper</p></def>
</def-item>
<def-item><term>PDH</term>
<def><p>pyruvate dehydrogenase</p></def>
</def-item>
<def-item><term><italic>Pla2g7</italic></term>
<def><p>phospholipase A2 group 7</p></def>
</def-item>
<def-item><term>PLIN5</term>
<def><p>perilipin-5</p></def>
</def-item>
<def-item><term>PPAR</term>
<def><p>peroxisome proliferator–activated receptor</p></def>
</def-item>
<def-item><term>PPRE</term>
<def><p>PPAR regulatory element</p></def>
</def-item>
<def-item><term>PUFA</term>
<def><p>polyunsaturated fatty acid</p></def>
</def-item>
<def-item><term>RER</term>
<def><p>respiratory exchange ratio</p></def>
</def-item>
<def-item><term>RMR</term>
<def><p>resting metabolic rate</p></def>
</def-item>
<def-item><term>ROR</term>
<def><p>RAR-related orphan receptor</p></def>
</def-item>
<def-item><term>RORE</term>
<def><p>ROR response element</p></def>
</def-item>
<def-item><term>ROS</term>
<def><p>reactive oxygen species</p></def>
</def-item>
<def-item><term>RT</term>
<def><p>room temperature</p></def>
</def-item>
<def-item><term>RXR</term>
<def><p>retinoid X receptor</p></def>
</def-item>
<def-item><term>S6K1</term>
<def><p>p70S6K1</p></def>
</def-item>
<def-item><term>SNAT2</term>
<def><p>sodium-dependent neutral amino acid transporter 2</p></def>
</def-item>
<def-item><term>TA</term>
<def><p>tibialis anterior</p></def>
</def-item>
<def-item><term>TCA</term>
<def><p>tricarboxylic acid</p></def>
</def-item>
<def-item><term>TEF</term>
<def><p>thyrotroph embryonic factor</p></def>
</def-item>
<def-item><term>TG</term>
<def><p>triglyceride</p></def>
</def-item>
<def-item><term>TGFβ</term>
<def><p>transforming growth factor beta</p></def>
</def-item>
<def-item><term>THRα</term>
<def><p>thyroid hormone receptor alpha</p></def>
</def-item>
<def-item><term>TR</term>
<def><p>thyroid hormone receptor</p></def>
</def-item>
<def-item><term>TSS</term>
<def><p>transcription start site</p></def>
</def-item>
<def-item><term>UPLC</term>
<def><p>ultra-performance liquid chromatography</p></def>
</def-item>
<def-item><term>WT</term>
<def><p>wild type</p></def>
</def-item>
<def-item><term>ZT</term>
<def><p>Zeitgeber time</p></def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="pbio.2005886.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reppert</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Weaver</surname> <given-names>DR</given-names></name>. <article-title>Coordination of circadian timing in mammals</article-title>. <source>Nature</source>. <year>2002</year>;<volume>418</volume>(<issue>6901</issue>):<fpage>935</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature00965" xlink:type="simple">10.1038/nature00965</ext-link></comment> <object-id pub-id-type="pmid">12198538</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eckel-Mahan</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sassone-Corsi</surname> <given-names>P</given-names></name>. <article-title>Metabolism and the circadian clock converge</article-title>. <source>Physiol Rev</source>. <year>2013</year>;<volume>93</volume>(<issue>1</issue>):<fpage>107</fpage>–<lpage>35</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physrev.00016.2012" xlink:type="simple">10.1152/physrev.00016.2012</ext-link></comment> <object-id pub-id-type="pmid">23303907</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schiaffino</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Blaauw</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Dyar</surname> <given-names>KA</given-names></name>. <article-title>The functional significance of the skeletal muscle clock: lessons from Bmal1 knockout models</article-title>. <source>Skelet Muscle</source>. <year>2016</year>;<volume>6</volume>:<fpage>33</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13395-016-0107-5" xlink:type="simple">10.1186/s13395-016-0107-5</ext-link></comment> <object-id pub-id-type="pmid">27752300</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DeFronzo</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Tripathy</surname> <given-names>D</given-names></name>. <article-title>Skeletal muscle insulin resistance is the primary defect in type 2 diabetes</article-title>. <source>Diabetes Care</source>. <year>2009</year>;<volume>32</volume> <issue>Suppl 2</issue>:<fpage>S157</fpage>–<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2337/dc09-S302" xlink:type="simple">10.2337/dc09-S302</ext-link></comment> <object-id pub-id-type="pmid">19875544</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goldberg</surname> <given-names>IJ</given-names></name>, <name name-style="western"><surname>Eckel</surname> <given-names>RH</given-names></name>, <name name-style="western"><surname>Abumrad</surname> <given-names>NA</given-names></name>. <article-title>Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways</article-title>. <source>J Lipid Res</source>. <year>2009</year>;<volume>50</volume> <issue>Suppl</issue>:<fpage>S86</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1194/jlr.R800085-JLR200" xlink:type="simple">10.1194/jlr.R800085-JLR200</ext-link></comment> <object-id pub-id-type="pmid">19033209</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Felig</surname> <given-names>P</given-names></name>. <article-title>Amino acid metabolism in man</article-title>. <source>Annu Rev Biochem</source>. <year>1975</year>;<volume>44</volume>:<fpage>933</fpage>–<lpage>55</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.bi.44.070175.004441" xlink:type="simple">10.1146/annurev.bi.44.070175.004441</ext-link></comment> <object-id pub-id-type="pmid">1094924</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dyar</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Ciciliot</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wright</surname> <given-names>LE</given-names></name>, <name name-style="western"><surname>Bienso</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Tagliazucchi</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Patel</surname> <given-names>VR</given-names></name>, <etal>et al</etal>. <article-title>Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock</article-title>. <source>Mol Metab</source>. <year>2014</year>;<volume>3</volume>(<issue>1</issue>):<fpage>29</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molmet.2013.10.005" xlink:type="simple">10.1016/j.molmet.2013.10.005</ext-link></comment> <object-id pub-id-type="pmid">24567902</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Chelliah</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Shan</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Taylor</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Yoo</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Partch</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Crystal structure of the heterodimeric CLOCK:BMAL1 transcriptional activator complex</article-title>. <source>Science</source>. <year>2012</year>;<volume>337</volume>(<issue>6091</issue>):<fpage>189</fpage>–<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1222804" xlink:type="simple">10.1126/science.1222804</ext-link></comment> <object-id pub-id-type="pmid">22653727</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kornmann</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Schaad</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Bujard</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Schibler</surname> <given-names>U</given-names></name>. <article-title>System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock</article-title>. <source>PLoS Biol</source>. <year>2007</year>;<volume>5</volume>(<issue>2</issue>):<fpage>e34</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.0050034" xlink:type="simple">10.1371/journal.pbio.0050034</ext-link></comment> <object-id pub-id-type="pmid">17298173</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bunger</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Wilsbacher</surname> <given-names>LD</given-names></name>, <name name-style="western"><surname>Moran</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Clendenin</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Radcliffe</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Hogenesch</surname> <given-names>JB</given-names></name>, <etal>et al</etal>. <article-title>Mop3 is an essential component of the master circadian pacemaker in mammals</article-title>. <source>Cell</source>. <year>2000</year>;<volume>103</volume>(<issue>7</issue>):<fpage>1009</fpage>–<lpage>17</lpage>. <object-id pub-id-type="pmid">11163178</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rey</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Cesbron</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Rougemont</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Reinke</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Brunner</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Naef</surname> <given-names>F</given-names></name>. <article-title>Genome-wide and phase-specific DNA-binding rhythms of BMAL1 control circadian output functions in mouse liver</article-title>. <source>PLoS Biol</source>. <year>2011</year>;<volume>9</volume>(<issue>2</issue>):<fpage>e1000595</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.1000595" xlink:type="simple">10.1371/journal.pbio.1000595</ext-link></comment> <object-id pub-id-type="pmid">21364973</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feng</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Bugge</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mullican</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Alenghat</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism</article-title>. <source>Science</source>. <year>2011</year>;<volume>331</volume>(<issue>6022</issue>):<fpage>1315</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1198125" xlink:type="simple">10.1126/science.1198125</ext-link></comment> <object-id pub-id-type="pmid">21393543</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Fang</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Emmett</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Damle</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Feng</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>GENE REGULATION. Discrete functions of nuclear receptor Rev-erbalpha couple metabolism to the clock</article-title>. <source>Science</source>. <year>2015</year>;<volume>348</volume>(<issue>6242</issue>):<fpage>1488</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.aab3021" xlink:type="simple">10.1126/science.aab3021</ext-link></comment> <object-id pub-id-type="pmid">26044300</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Koike</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Yoo</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>HC</given-names></name>, <name name-style="western"><surname>Kumar</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>TK</given-names></name>, <etal>et al</etal>. <article-title>Transcriptional architecture and chromatin landscape of the core circadian clock in mammals</article-title>. <source>Science</source>. <year>2012</year>;<volume>338</volume>(<issue>6105</issue>):<fpage>349</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1226339" xlink:type="simple">10.1126/science.1226339</ext-link></comment> <object-id pub-id-type="pmid">22936566</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cho</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Hatori</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Barish</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Lam</surname> <given-names>MT</given-names></name>, <etal>et al</etal>. <article-title>Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta</article-title>. <source>Nature</source>. <year>2012</year>;<volume>485</volume>(<issue>7396</issue>):<fpage>123</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature11048" xlink:type="simple">10.1038/nature11048</ext-link></comment> <object-id pub-id-type="pmid">22460952</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McLean</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Bristor</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Hiller</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Clarke</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Schaar</surname> <given-names>BT</given-names></name>, <name name-style="western"><surname>Lowe</surname> <given-names>CB</given-names></name>, <etal>et al</etal>. <article-title>GREAT improves functional interpretation of cis-regulatory regions</article-title>. <source>Nat Biotechnol</source>. <year>2010</year>;<volume>28</volume>(<issue>5</issue>):<fpage>495</fpage>–<lpage>501</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nbt.1630" xlink:type="simple">10.1038/nbt.1630</ext-link></comment> <object-id pub-id-type="pmid">20436461</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dyar</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Ciciliot</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tagliazucchi</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Pallafacchina</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Tothova</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Argentini</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>The calcineurin-NFAT pathway controls activity-dependent circadian gene expression in slow skeletal muscle</article-title>. <source>Mol Metab</source>. <year>2015</year>;<volume>4</volume>(<issue>11</issue>):<fpage>823</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molmet.2015.09.004" xlink:type="simple">10.1016/j.molmet.2015.09.004</ext-link></comment> <object-id pub-id-type="pmid">26629406</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Molkentin</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Olson</surname> <given-names>EN</given-names></name>. <article-title>Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1996</year>;<volume>93</volume>(<issue>18</issue>):<fpage>9366</fpage>–<lpage>73</lpage>. <object-id pub-id-type="pmid">8790335</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Downes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Bookout</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Straume</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Nuclear receptor expression links the circadian clock to metabolism</article-title>. <source>Cell</source>. <year>2006</year>;<volume>126</volume>(<issue>4</issue>):<fpage>801</fpage>–<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2006.06.050" xlink:type="simple">10.1016/j.cell.2006.06.050</ext-link></comment> <object-id pub-id-type="pmid">16923398</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>EY</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Kou</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Duan</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Meirelles</surname> <given-names>GV</given-names></name>, <etal>et al</etal>. <article-title>Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool</article-title>. <source>BMC Bioinformatics</source>. <year>2013</year>;<volume>14</volume>:<fpage>128</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2105-14-128" xlink:type="simple">10.1186/1471-2105-14-128</ext-link></comment> <object-id pub-id-type="pmid">23586463</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Acosta</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Vazquez Fonseca</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Desbats</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Cerqua</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Zordan</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Trevisson</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Coenzyme Q biosynthesis in health and disease</article-title>. <source>Biochim Biophys Acta</source>. <year>2016</year>;<volume>1857</volume>(<issue>8</issue>):<fpage>1079</fpage>–<lpage>85</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbabio.2016.03.036" xlink:type="simple">10.1016/j.bbabio.2016.03.036</ext-link></comment> <object-id pub-id-type="pmid">27060254</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yeramian</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Martin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Serrat</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Arpa</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Soler</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Bertran</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Arginine transport via cationic amino acid transporter 2 plays a critical regulatory role in classical or alternative activation of macrophages</article-title>. <source>J Immunol</source>. <year>2006</year>;<volume>176</volume>(<issue>10</issue>):<fpage>5918</fpage>–<lpage>24</lpage>. <object-id pub-id-type="pmid">16670299</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burke</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Downes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Carozzi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Giguere</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Muscat</surname> <given-names>GE</given-names></name>. <article-title>Transcriptional repression by the orphan steroid receptor RVR/Rev-erb beta is dependent on the signature motif and helix 5 in the E region: functional evidence for a biological role of RVR in myogenesis</article-title>. <source>Nucleic Acids Res</source>. <year>1996</year>;<volume>24</volume>(<issue>18</issue>):<fpage>3481</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">8836172</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crumbley</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Burris</surname> <given-names>TP</given-names></name>. <article-title>Direct regulation of CLOCK expression by REV-ERB</article-title>. <source>PLoS ONE</source>. <year>2011</year>;<volume>6</volume>(<issue>3</issue>):<fpage>e17290</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0017290" xlink:type="simple">10.1371/journal.pone.0017290</ext-link></comment> <object-id pub-id-type="pmid">21479263</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hong</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Fang</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Loro</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Damle</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion</article-title>. <source>Nat Med</source>. <year>2017</year>;<volume>23</volume>(<issue>2</issue>):<fpage>223</fpage>–<lpage>34</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm.4245" xlink:type="simple">10.1038/nm.4245</ext-link></comment> <object-id pub-id-type="pmid">27991918</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mouton</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Loos</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Moolman-Smook</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Kinnear</surname> <given-names>CJ</given-names></name>. <article-title>Ascribing novel functions to the sarcomeric protein, myosin binding protein H (MyBPH) in cardiac sarcomere contraction</article-title>. <source>Exp Cell Res</source>. <year>2015</year>;<volume>331</volume>(<issue>2</issue>):<fpage>338</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.yexcr.2014.11.006" xlink:type="simple">10.1016/j.yexcr.2014.11.006</ext-link></comment> <object-id pub-id-type="pmid">25449695</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bugge</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Feng</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Everett</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Briggs</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>Mullican</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Rev-erbalpha and Rev-erbbeta coordinately protect the circadian clock and normal metabolic function</article-title>. <source>Genes Dev</source>. <year>2012</year>;<volume>26</volume>(<issue>7</issue>):<fpage>657</fpage>–<lpage>67</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gad.186858.112" xlink:type="simple">10.1101/gad.186858.112</ext-link></comment> <object-id pub-id-type="pmid">22474260</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramakrishnan</surname> <given-names>SN</given-names></name>, <name name-style="western"><surname>Lau</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Burke</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Muscat</surname> <given-names>GE</given-names></name>. <article-title>Rev-erbbeta regulates the expression of genes involved in lipid absorption in skeletal muscle cells: evidence for cross-talk between orphan nuclear receptors and myokines</article-title>. <source>J Biol Chem</source>. <year>2005</year>;<volume>280</volume>(<issue>10</issue>):<fpage>8651</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M413949200" xlink:type="simple">10.1074/jbc.M413949200</ext-link></comment> <object-id pub-id-type="pmid">15623503</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Woldt</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Sebti</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Solt</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Duhem</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lancel</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Eeckhoute</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy</article-title>. <source>Nat Med</source>. <year>2013</year>;<volume>19</volume>(<issue>8</issue>):<fpage>1039</fpage>–<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm.3213" xlink:type="simple">10.1038/nm.3213</ext-link></comment> <object-id pub-id-type="pmid">23852339</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Downes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Carozzi</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Muscat</surname> <given-names>GE</given-names></name>. <article-title>Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family</article-title>. <source>Mol Endocrinol</source>. <year>1995</year>;<volume>9</volume>(<issue>12</issue>):<fpage>1666</fpage>–<lpage>78</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/mend.9.12.8614403" xlink:type="simple">10.1210/mend.9.12.8614403</ext-link></comment> <object-id pub-id-type="pmid">8614403</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marciano</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Corzo</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Goswami</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Lam</surname> <given-names>VQ</given-names></name>, <name name-style="western"><surname>Pascal</surname> <given-names>BD</given-names></name>, <etal>et al</etal>. <article-title>The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARgamma, RORs, and Rev-erbs</article-title>. <source>Cell Metab</source>. <year>2014</year>;<volume>19</volume>(<issue>2</issue>):<fpage>193</fpage>–<lpage>208</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cmet.2013.12.009" xlink:type="simple">10.1016/j.cmet.2013.12.009</ext-link></comment> <object-id pub-id-type="pmid">24440037</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Makowski</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Noland</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Koves</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Xing</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Ilkayeva</surname> <given-names>OR</given-names></name>, <name name-style="western"><surname>Muehlbauer</surname> <given-names>MJ</given-names></name>, <etal>et al</etal>. <article-title>Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation</article-title>. <source>FASEB J</source>. <year>2009</year>;<volume>23</volume>(<issue>2</issue>):<fpage>586</fpage>–<lpage>604</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1096/fj.08-119420" xlink:type="simple">10.1096/fj.08-119420</ext-link></comment> <object-id pub-id-type="pmid">18945875</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sugden</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Zariwala</surname> <given-names>MG</given-names></name>, <name name-style="western"><surname>Holness</surname> <given-names>MJ</given-names></name>. <article-title>PPARs and the orchestration of metabolic fuel selection</article-title>. <source>Pharmacol Res</source>. <year>2009</year>;<volume>60</volume>(<issue>3</issue>):<fpage>141</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.phrs.2009.03.014" xlink:type="simple">10.1016/j.phrs.2009.03.014</ext-link></comment> <object-id pub-id-type="pmid">19646653</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kassam</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Capone</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Rachubinski</surname> <given-names>RA</given-names></name>. <article-title>Orphan nuclear hormone receptor RevErbalpha modulates expression from the promoter of the hydratase-dehydrogenase gene by inhibiting peroxisome proliferator-activated receptor alpha-dependent transactivation</article-title>. <source>J Biol Chem</source>. <year>1999</year>;<volume>274</volume>(<issue>32</issue>):<fpage>22895</fpage>–<lpage>900</lpage>. <object-id pub-id-type="pmid">10428876</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Narkar</surname> <given-names>VA</given-names></name>, <name name-style="western"><surname>Downes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Embler</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>YX</given-names></name>, <name name-style="western"><surname>Banayo</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>AMPK and PPARdelta agonists are exercise mimetics</article-title>. <source>Cell</source>. <year>2008</year>;<volume>134</volume>(<issue>3</issue>):<fpage>405</fpage>–<lpage>15</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2008.06.051" xlink:type="simple">10.1016/j.cell.2008.06.051</ext-link></comment> <object-id pub-id-type="pmid">18674809</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bindesboll</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Berg</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Arntsen</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Nebb</surname> <given-names>HI</given-names></name>, <name name-style="western"><surname>Dalen</surname> <given-names>KT</given-names></name>. <article-title>Fatty acids regulate perilipin5 in muscle by activating PPARdelta</article-title>. <source>J Lipid Res</source>. <year>2013</year>;<volume>54</volume>(<issue>7</issue>):<fpage>1949</fpage>–<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1194/jlr.M038992" xlink:type="simple">10.1194/jlr.M038992</ext-link></comment> <object-id pub-id-type="pmid">23606724</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schoonjans</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Staels</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Auwerx</surname> <given-names>J</given-names></name>. <article-title>Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression</article-title>. <source>J Lipid Res</source>. <year>1996</year>;<volume>37</volume>(<issue>5</issue>):<fpage>907</fpage>–<lpage>25</lpage>. <object-id pub-id-type="pmid">8725145</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Phuc Le</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Friedman</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Schug</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Brestelli</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Parker</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Bochkis</surname> <given-names>IM</given-names></name>, <etal>et al</etal>. <article-title>Glucocorticoid receptor-dependent gene regulatory networks</article-title>. <source>PLoS Genet</source>. <year>2005</year>;<volume>1</volume>(<issue>2</issue>):<fpage>e16</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.0010016" xlink:type="simple">10.1371/journal.pgen.0010016</ext-link></comment> <object-id pub-id-type="pmid">16110340</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kiens</surname> <given-names>B</given-names></name>. <article-title>Skeletal muscle lipid metabolism in exercise and insulin resistance</article-title>. <source>Physiol Rev</source>. <year>2006</year>;<volume>86</volume>(<issue>1</issue>):<fpage>205</fpage>–<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physrev.00023.2004" xlink:type="simple">10.1152/physrev.00023.2004</ext-link></comment> <object-id pub-id-type="pmid">16371598</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rennie</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Tipton</surname> <given-names>KD</given-names></name>. <article-title>Protein and amino acid metabolism during and after exercise and the effects of nutrition</article-title>. <source>Annu Rev Nutr</source>. <year>2000</year>;<volume>20</volume>:<fpage>457</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.nutr.20.1.457" xlink:type="simple">10.1146/annurev.nutr.20.1.457</ext-link></comment> <object-id pub-id-type="pmid">10940342</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shimizu</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Maruyama</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yoshikawa</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Matsumiya</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ito</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>A muscle-liver-fat signalling axis is essential for central control of adaptive adipose remodelling</article-title>. <source>Nat Commun</source>. <year>2015</year>;<volume>6</volume>:<fpage>6693</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms7693" xlink:type="simple">10.1038/ncomms7693</ext-link></comment> <object-id pub-id-type="pmid">25827749</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schiaffino</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Dyar</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Ciciliot</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Blaauw</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Sandri</surname> <given-names>M</given-names></name>. <article-title>Mechanisms regulating skeletal muscle growth and atrophy</article-title>. <source>FEBS J</source>. <year>2013</year>;<volume>280</volume>(<issue>17</issue>):<fpage>4294</fpage>–<lpage>314</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/febs.12253" xlink:type="simple">10.1111/febs.12253</ext-link></comment> <object-id pub-id-type="pmid">23517348</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mayeuf-Louchart</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Thorel</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Delhaye</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Beauchamp</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Duhem</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Danckaert</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Rev-erb-alpha regulates atrophy-related genes to control skeletal muscle mass</article-title>. <source>Sci Rep</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>14383</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41598-017-14596-2" xlink:type="simple">10.1038/s41598-017-14596-2</ext-link></comment> <object-id pub-id-type="pmid">29085009</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abbondante</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Eckel-Mahan</surname> <given-names>KL</given-names></name>, <name name-style="western"><surname>Ceglia</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>Baldi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sassone-Corsi</surname> <given-names>P</given-names></name>. <article-title>Comparative Circadian Metabolomics Reveal Differential Effects of Nutritional Challenge in the Serum and Liver</article-title>. <source>J Biol Chem</source>. <year>2016</year>;<volume>291</volume>(<issue>6</issue>):<fpage>2812</fpage>–<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M115.681130" xlink:type="simple">10.1074/jbc.M115.681130</ext-link></comment> <object-id pub-id-type="pmid">26644470</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jones</surname> <given-names>HN</given-names></name>, <name name-style="western"><surname>Ashworth</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Page</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>McArdle</surname> <given-names>HJ</given-names></name>. <article-title>Cortisol stimulates system A amino acid transport and SNAT2 expression in a human placental cell line (BeWo)</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2006</year>;<volume>291</volume>(<issue>3</issue>):<fpage>E596</fpage>–<lpage>603</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpendo.00359.2005" xlink:type="simple">10.1152/ajpendo.00359.2005</ext-link></comment> <object-id pub-id-type="pmid">16621896</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Franchi-Gazzola</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Dall’Asta</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Sala</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Visigalli</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bevilacqua</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Gaccioli</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>The role of the neutral amino acid transporter SNAT2 in cell volume regulation</article-title>. <source>Acta Physiol (Oxf)</source>. <year>2006</year>;<volume>187</volume>(<issue>1–2</issue>):<fpage>273</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1748-1716.2006.01552.x" xlink:type="simple">10.1111/j.1748-1716.2006.01552.x</ext-link></comment> <object-id pub-id-type="pmid">16734764</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xia</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wishart</surname> <given-names>DS</given-names></name>. <article-title>Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis</article-title>. <source>Curr Protoc Bioinformatics</source>. <year>2016</year>;<volume>55</volume>:<issue>14</issue> <fpage>0 1</fpage>–<lpage>0 91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cpbi.11" xlink:type="simple">10.1002/cpbi.11</ext-link></comment> <object-id pub-id-type="pmid">27603023</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harfmann</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Schroder</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Kachman</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Hodge</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Esser</surname> <given-names>KA</given-names></name>. <article-title>Muscle-specific loss of Bmal1 leads to disrupted tissue glucose metabolism and systemic glucose homeostasis</article-title>. <source>Skelet Muscle</source>. <year>2016</year>;<volume>6</volume>:<fpage>12</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13395-016-0082-x" xlink:type="simple">10.1186/s13395-016-0082-x</ext-link></comment> <object-id pub-id-type="pmid">27486508</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hodge</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Wen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Riley</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>England</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Harfmann</surname> <given-names>BD</given-names></name>, <etal>et al</etal>. <article-title>The endogenous molecular clock orchestrates the temporal separation of substrate metabolism in skeletal muscle</article-title>. <source>Skelet Muscle</source>. <year>2015</year>;<volume>5</volume>:<fpage>17</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13395-015-0039-5" xlink:type="simple">10.1186/s13395-015-0039-5</ext-link></comment> <object-id pub-id-type="pmid">26000164</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johnson</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Stannard</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>MW</given-names></name>. <article-title>Muscle triglyceride and glycogen in endurance exercise: implications for performance</article-title>. <source>Sports Med</source>. <year>2004</year>;<volume>34</volume>(<issue>3</issue>):<fpage>151</fpage>–<lpage>64</lpage>. <object-id pub-id-type="pmid">14987125</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krssak</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>KF</given-names></name>, <name name-style="western"><surname>Bergeron</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Price</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Laurent</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Rothman</surname> <given-names>DL</given-names></name>, <etal>et al</etal>. <article-title>Intramuscular glycogen and intramyocellular lipid utilization during prolonged exercise and recovery in man: a 13C and 1H nuclear magnetic resonance spectroscopy study</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2000</year>;<volume>85</volume>(<issue>2</issue>):<fpage>748</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jcem.85.2.6354" xlink:type="simple">10.1210/jcem.85.2.6354</ext-link></comment> <object-id pub-id-type="pmid">10690886</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larson-Meyer</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Newcomer</surname> <given-names>BR</given-names></name>, <name name-style="western"><surname>Hunter</surname> <given-names>GR</given-names></name>. <article-title>Influence of endurance running and recovery diet on intramyocellular lipid content in women: a 1H NMR study</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2002</year>;<volume>282</volume>(<issue>1</issue>):<fpage>E95</fpage>–<lpage>E106</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpendo.2002.282.1.E95" xlink:type="simple">10.1152/ajpendo.2002.282.1.E95</ext-link></comment> <object-id pub-id-type="pmid">11739089</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stannard</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>NA</given-names></name>. <article-title>Insulin resistance and elevated triglyceride in muscle: more important for survival than "thrifty" genes?</article-title> <source>J Physiol</source>. <year>2004</year>;<volume>554</volume>(<issue>Pt 3</issue>):<fpage>595</fpage>–<lpage>607</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1113/jphysiol.2003.053926" xlink:type="simple">10.1113/jphysiol.2003.053926</ext-link></comment> <object-id pub-id-type="pmid">14608009</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takahashi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Goto</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yamazaki</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kamakari</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hirata</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Suzuki</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Metabolomics reveal 1-palmitoyl lysophosphatidylcholine production by peroxisome proliferator-activated receptor alpha</article-title>. <source>J Lipid Res</source>. <year>2015</year>;<volume>56</volume>(<issue>2</issue>):<fpage>254</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1194/jlr.M052464" xlink:type="simple">10.1194/jlr.M052464</ext-link></comment> <object-id pub-id-type="pmid">25510248</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Varga</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Czimmerer</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Nagy</surname> <given-names>L</given-names></name>. <article-title>PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation</article-title>. <source>Biochim Biophys Acta</source>. <year>2011</year>;<volume>1812</volume>(<issue>8</issue>):<fpage>1007</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbadis.2011.02.014" xlink:type="simple">10.1016/j.bbadis.2011.02.014</ext-link></comment> <object-id pub-id-type="pmid">21382489</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sahlin</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Palmskog</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Hultman</surname> <given-names>E</given-names></name>. <article-title>Adenine nucleotide and IMP contents of the quadriceps muscle in man after exercise</article-title>. <source>Pflugers Arch</source>. <year>1978</year>;<volume>374</volume>(<issue>2</issue>):<fpage>193</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">566428</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jouffe</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gobet</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Martin</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Metairon</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Morin-Rivron</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Masoodi</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Perturbed rhythmic activation of signaling pathways in mice deficient for Sterol Carrier Protein 2-dependent diurnal lipid transport and metabolism</article-title>. <source>Sci Rep</source>. <year>2016</year>;<volume>6</volume>:<fpage>24631</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep24631" xlink:type="simple">10.1038/srep24631</ext-link></comment> <object-id pub-id-type="pmid">27097688</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Snell</surname> <given-names>K</given-names></name>. <article-title>Muscle alanine synthesis and hepatic gluconeogenesis</article-title>. <source>Biochem Soc Trans</source>. <year>1980</year>;<volume>8</volume>(<issue>2</issue>):<fpage>205</fpage>–<lpage>13</lpage>. <object-id pub-id-type="pmid">6989679</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gibala</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Young</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Taegtmeyer</surname> <given-names>H</given-names></name>. <article-title>Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle</article-title>. <source>Acta Physiol Scand</source>. <year>2000</year>;<volume>168</volume>(<issue>4</issue>):<fpage>657</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1046/j.1365-201x.2000.00717.x" xlink:type="simple">10.1046/j.1365-201x.2000.00717.x</ext-link></comment> <object-id pub-id-type="pmid">10759602</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ruderman</surname> <given-names>NB</given-names></name>. <article-title>Muscle amino acid metabolism and gluconeogenesis</article-title>. <source>Annu Rev Med</source>. <year>1975</year>;<volume>26</volume>:<fpage>245</fpage>–<lpage>58</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.me.26.020175.001333" xlink:type="simple">10.1146/annurev.me.26.020175.001333</ext-link></comment> <object-id pub-id-type="pmid">1096762</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pozefsky</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Tancredi</surname> <given-names>RG</given-names></name>, <name name-style="western"><surname>Moxley</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Dupre</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tobin</surname> <given-names>JD</given-names></name>. <article-title>Effects of brief starvation on muscle amino acid metabolism in nonobese man</article-title>. <source>J Clin Invest</source>. <year>1976</year>;<volume>57</volume>(<issue>2</issue>):<fpage>444</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI108295" xlink:type="simple">10.1172/JCI108295</ext-link></comment> <object-id pub-id-type="pmid">1254728</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Goldberg</surname> <given-names>AL</given-names></name>. <article-title>Effects of food deprivation on protein synthesis and degradation in rat skeletal muscles</article-title>. <source>Am J Physiol</source>. <year>1976</year>;<volume>231</volume>(<issue>2</issue>):<fpage>441</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajplegacy.1976.231.2.441" xlink:type="simple">10.1152/ajplegacy.1976.231.2.441</ext-link></comment> <object-id pub-id-type="pmid">961895</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Felig</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Pozefsky</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Marliss</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Cahill</surname> <given-names>GF</given-names><suffix>Jr</suffix></name>. <article-title>Alanine: key role in gluconeogenesis</article-title>. <source>Science</source>. <year>1970</year>;<volume>167</volume>(<issue>3920</issue>):<fpage>1003</fpage>–<lpage>4</lpage>. <object-id pub-id-type="pmid">5411169</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Odessey</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Khairallah</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Goldberg</surname> <given-names>AL</given-names></name>. <article-title>Origin and possible significance of alanine production by skeletal muscle</article-title>. <source>J Biol Chem</source>. <year>1974</year>;<volume>249</volume>(<issue>23</issue>):<fpage>7623</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">4436328</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garber</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Karl</surname> <given-names>IE</given-names></name>, <name name-style="western"><surname>Kipnis</surname> <given-names>DM</given-names></name>. <article-title>Alanine and glutamine synthesis and release from skeletal muscle. II. The precursor role of amino acids in alanine and glutamine synthesis</article-title>. <source>J Biol Chem</source>. <year>1976</year>;<volume>251</volume>(<issue>3</issue>):<fpage>836</fpage>–<lpage>43</lpage>. <object-id pub-id-type="pmid">1249059</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Muoio</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Neufer</surname> <given-names>PD</given-names></name>. <article-title>Lipid-induced mitochondrial stress and insulin action in muscle</article-title>. <source>Cell Metab</source>. <year>2012</year>;<volume>15</volume>(<issue>5</issue>):<fpage>595</fpage>–<lpage>605</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cmet.2012.04.010" xlink:type="simple">10.1016/j.cmet.2012.04.010</ext-link></comment> <object-id pub-id-type="pmid">22560212</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Newgard</surname> <given-names>CB</given-names></name>. <article-title>Interplay between lipids and branched-chain amino acids in development of insulin resistance</article-title>. <source>Cell Metab</source>. <year>2012</year>;<volume>15</volume>(<issue>5</issue>):<fpage>606</fpage>–<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cmet.2012.01.024" xlink:type="simple">10.1016/j.cmet.2012.01.024</ext-link></comment> <object-id pub-id-type="pmid">22560213</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Divakaruni</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Brand</surname> <given-names>MD</given-names></name>. <article-title>The regulation and physiology of mitochondrial proton leak</article-title>. <source>Physiology (Bethesda)</source>. <year>2011</year>;<volume>26</volume>(<issue>3</issue>):<fpage>192</fpage>–<lpage>205</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physiol.00046.2010" xlink:type="simple">10.1152/physiol.00046.2010</ext-link></comment> <object-id pub-id-type="pmid">21670165</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fisher-Wellman</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Neufer</surname> <given-names>PD</given-names></name>. <article-title>Linking mitochondrial bioenergetics to insulin resistance via redox biology</article-title>. <source>Trends Endocrinol Metab</source>. <year>2012</year>;<volume>23</volume>(<issue>3</issue>):<fpage>142</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tem.2011.12.008" xlink:type="simple">10.1016/j.tem.2011.12.008</ext-link></comment> <object-id pub-id-type="pmid">22305519</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref070"><label>70</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gomes-Marcondes</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Tisdale</surname> <given-names>MJ</given-names></name>. <article-title>Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress</article-title>. <source>Cancer Lett</source>. <year>2002</year>;<volume>180</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>74</lpage>. <object-id pub-id-type="pmid">11911972</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref071"><label>71</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Echtay</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Roussel</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>St-Pierre</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Jekabsons</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Cadenas</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Stuart</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Superoxide activates mitochondrial uncoupling proteins</article-title>. <source>Nature</source>. <year>2002</year>;<volume>415</volume>(<issue>6867</issue>):<fpage>96</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/415096a" xlink:type="simple">10.1038/415096a</ext-link></comment> <object-id pub-id-type="pmid">11780125</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref072"><label>72</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Befroy</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>KF</given-names></name>, <name name-style="western"><surname>Dufour</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mason</surname> <given-names>GF</given-names></name>, <name name-style="western"><surname>Rothman</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Shulman</surname> <given-names>GI</given-names></name>. <article-title>Increased substrate oxidation and mitochondrial uncoupling in skeletal muscle of endurance-trained individuals</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2008</year>;<volume>105</volume>(<issue>43</issue>):<fpage>16701</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0808889105" xlink:type="simple">10.1073/pnas.0808889105</ext-link></comment> <object-id pub-id-type="pmid">18936488</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tonkonogi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Krook</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Walsh</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Sahlin</surname> <given-names>K</given-names></name>. <article-title>Endurance training increases stimulation of uncoupling of skeletal muscle mitochondria in humans by non-esterified fatty acids: an uncoupling-protein-mediated effect?</article-title> <source>Biochem J</source>. <year>2000</year>;<volume>351</volume> <issue>Pt 3</issue>:<fpage>805</fpage>–<lpage>10</lpage>. <object-id pub-id-type="pmid">11042137</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref074"><label>74</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iossa</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mollica</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Lionetti</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Crescenzo</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Botta</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Liverini</surname> <given-names>G</given-names></name>. <article-title>Skeletal muscle oxidative capacity in rats fed high-fat diet</article-title>. <source>Int J Obes Relat Metab Disord</source>. <year>2002</year>;<volume>26</volume>(<issue>1</issue>):<fpage>65</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.ijo.0801844" xlink:type="simple">10.1038/sj.ijo.0801844</ext-link></comment> <object-id pub-id-type="pmid">11791148</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref075"><label>75</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Booth</surname> <given-names>FW</given-names></name>, <name name-style="western"><surname>Laye</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Spangenburg</surname> <given-names>EE</given-names></name>. <article-title>Gold standards for scientists who are conducting animal-based exercise studies</article-title>. <source>J Appl Physiol (1985)</source>. <year>2010</year>;<volume>108</volume>(<issue>1</issue>):<fpage>219</fpage>–<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.00125.2009" xlink:type="simple">10.1152/japplphysiol.00125.2009</ext-link></comment> <object-id pub-id-type="pmid">19574508</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref076"><label>76</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Muoio</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>MacLean</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Lang</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Houmard</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Way</surname> <given-names>JM</given-names></name>, <etal>et al</etal>. <article-title>Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta</article-title>. <source>J Biol Chem</source>. <year>2002</year>;<volume>277</volume>(<issue>29</issue>):<fpage>26089</fpage>–<lpage>97</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M203997200" xlink:type="simple">10.1074/jbc.M203997200</ext-link></comment> <object-id pub-id-type="pmid">12118038</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref077"><label>77</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pederson</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Cope</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Schroeder</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Irimia</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Thurberg</surname> <given-names>BL</given-names></name>, <etal>et al</etal>. <article-title>Exercise capacity of mice genetically lacking muscle glycogen synthase: in mice, muscle glycogen is not essential for exercise</article-title>. <source>J Biol Chem</source>. <year>2005</year>;<volume>280</volume>(<issue>17</issue>):<fpage>17260</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M410448200" xlink:type="simple">10.1074/jbc.M410448200</ext-link></comment> <object-id pub-id-type="pmid">15711014</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref078"><label>78</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goodman</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Mabrey</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Frey</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Miu</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Schmidt</surname> <given-names>EK</given-names></name>, <name name-style="western"><surname>Pierre</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive in vivo technique</article-title>. <source>FASEB J</source>. <year>2011</year>;<volume>25</volume>(<issue>3</issue>):<fpage>1028</fpage>–<lpage>39</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1096/fj.10-168799" xlink:type="simple">10.1096/fj.10-168799</ext-link></comment> <object-id pub-id-type="pmid">21148113</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref079"><label>79</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blaauw</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Canato</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Agatea</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Toniolo</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Mammucari</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Masiero</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation</article-title>. <source>FASEB J</source>. <year>2009</year>;<volume>23</volume>(<issue>11</issue>):<fpage>3896</fpage>–<lpage>905</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1096/fj.09-131870" xlink:type="simple">10.1096/fj.09-131870</ext-link></comment> <object-id pub-id-type="pmid">19661286</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref080"><label>80</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anderson</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Gilge</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Steiber</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Previs</surname> <given-names>SF</given-names></name>. <article-title>Diet-induced obesity alters protein synthesis: tissue-specific effects in fasted versus fed mice</article-title>. <source>Metabolism</source>. <year>2008</year>;<volume>57</volume>(<issue>3</issue>):<fpage>347</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.metabol.2007.10.009" xlink:type="simple">10.1016/j.metabol.2007.10.009</ext-link></comment> <object-id pub-id-type="pmid">18249206</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref081"><label>81</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Svanberg</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Zachrisson</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ohlsson</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Iresjo</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Lundholm</surname> <given-names>KG</given-names></name>. <article-title>Role of insulin and IGF-I in activation of muscle protein synthesis after oral feeding</article-title>. <source>Am J Physiol</source>. <year>1996</year>;<volume>270</volume>(<issue>4 Pt 1</issue>):<fpage>E614</fpage>–<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpendo.1996.270.4.E614" xlink:type="simple">10.1152/ajpendo.1996.270.4.E614</ext-link></comment> <object-id pub-id-type="pmid">8928767</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref082"><label>82</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cannon</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Nedergaard</surname> <given-names>J</given-names></name>. <article-title>Nonshivering thermogenesis and its adequate measurement in metabolic studies</article-title>. <source>J Exp Biol</source>. <year>2011</year>;<volume>214</volume>(<issue>Pt 2</issue>):<fpage>242</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/jeb.050989" xlink:type="simple">10.1242/jeb.050989</ext-link></comment> <object-id pub-id-type="pmid">21177944</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref083"><label>83</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weyer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Snitker</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Rising</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bogardus</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ravussin</surname> <given-names>E</given-names></name>. <article-title>Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects</article-title>. <source>Int J Obes Relat Metab Disord</source>. <year>1999</year>;<volume>23</volume>(<issue>7</issue>):<fpage>715</fpage>–<lpage>22</lpage>. <object-id pub-id-type="pmid">10454105</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref084"><label>84</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tschop</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Speakman</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Arch</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Auwerx</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bruning</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>A guide to analysis of mouse energy metabolism</article-title>. <source>Nat Methods</source>. <year>2011</year>;<volume>9</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nmeth.1806" xlink:type="simple">10.1038/nmeth.1806</ext-link></comment> <object-id pub-id-type="pmid">22205519</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref085"><label>85</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Speakman</surname> <given-names>JR</given-names></name>. <article-title>Measuring energy metabolism in the mouse—theoretical, practical, and analytical considerations</article-title>. <source>Front Physiol</source>. <year>2013</year>;<volume>4</volume>:<fpage>34</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2013.00034" xlink:type="simple">10.3389/fphys.2013.00034</ext-link></comment> <object-id pub-id-type="pmid">23504620</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref086"><label>86</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Prasad</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Garg</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Agarwal</surname> <given-names>AK</given-names></name>. <article-title>Enzymatic activities of the human AGPAT isoform 3 and isoform 5: localization of AGPAT5 to mitochondria</article-title>. <source>J Lipid Res</source>. <year>2011</year>;<volume>52</volume>(<issue>3</issue>):<fpage>451</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1194/jlr.M007575" xlink:type="simple">10.1194/jlr.M007575</ext-link></comment> <object-id pub-id-type="pmid">21173190</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref087"><label>87</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>FY</given-names></name>, <name name-style="western"><surname>Hatch</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Choy</surname> <given-names>PC</given-names></name>. <article-title>Cloning and characterization of murine 1-acyl-sn-glycerol 3-phosphate acyltransferases and their regulation by PPARalpha in murine heart</article-title>. <source>Biochem J</source>. <year>2005</year>;<volume>385</volume>(<issue>Pt 2</issue>):<fpage>469</fpage>–<lpage>77</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1042/BJ20041348" xlink:type="simple">10.1042/BJ20041348</ext-link></comment> <object-id pub-id-type="pmid">15367102</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref088"><label>88</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kumari</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Schoiswohl</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Chitraju</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Paar</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cornaciu</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Rangrez</surname> <given-names>AY</given-names></name>, <etal>et al</etal>. <article-title>Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase</article-title>. <source>Cell Metab</source>. <year>2012</year>;<volume>15</volume>(<issue>5</issue>):<fpage>691</fpage>–<lpage>702</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cmet.2012.04.008" xlink:type="simple">10.1016/j.cmet.2012.04.008</ext-link></comment> <object-id pub-id-type="pmid">22560221</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref089"><label>89</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yen</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Stone</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Koliwad</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Harris</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Farese</surname> <given-names>RV</given-names> <suffix>Jr</suffix></name>. <article-title>Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis</article-title>. <source>J Lipid Res</source>. <year>2008</year>;<volume>49</volume>(<issue>11</issue>):<fpage>2283</fpage>–<lpage>301</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1194/jlr.R800018-JLR200" xlink:type="simple">10.1194/jlr.R800018-JLR200</ext-link></comment> <object-id pub-id-type="pmid">18757836</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref090"><label>90</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McCarthy</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Andrews</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>McDearmon</surname> <given-names>EL</given-names></name>, <name name-style="western"><surname>Campbell</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Barber</surname> <given-names>BK</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>BH</given-names></name>, <etal>et al</etal>. <article-title>Identification of the circadian transcriptome in adult mouse skeletal muscle</article-title>. <source>Physiol Genomics</source>. <year>2007</year>;<volume>31</volume>(<issue>1</issue>):<fpage>86</fpage>–<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physiolgenomics.00066.2007" xlink:type="simple">10.1152/physiolgenomics.00066.2007</ext-link></comment> <object-id pub-id-type="pmid">17550994</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref091"><label>91</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Levin</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Monetti</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Watt</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Sajan</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Stevens</surname> <given-names>RD</given-names></name>, <name name-style="western"><surname>Bain</surname> <given-names>JR</given-names></name>, <etal>et al</etal>. <article-title>Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2007</year>;<volume>293</volume>(<issue>6</issue>):<fpage>E1772</fpage>–<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpendo.00158.2007" xlink:type="simple">10.1152/ajpendo.00158.2007</ext-link></comment> <object-id pub-id-type="pmid">17940217</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref092"><label>92</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Welsh</surname> <given-names>DK</given-names></name>, <name name-style="western"><surname>Yoo</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Kay</surname> <given-names>SA</given-names></name>. <article-title>Bioluminescence imaging of individual fibroblasts reveals persistent, independently phased circadian rhythms of clock gene expression</article-title>. <source>Curr Biol</source>. <year>2004</year>;<volume>14</volume>(<issue>24</issue>):<fpage>2289</fpage>–<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cub.2004.11.057" xlink:type="simple">10.1016/j.cub.2004.11.057</ext-link></comment> <object-id pub-id-type="pmid">15620658</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref093"><label>93</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lazar</surname> <given-names>MA</given-names></name>. <article-title>The orphan nuclear receptor Rev-erbalpha recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene</article-title>. <source>Mol Endocrinol</source>. <year>2005</year>;<volume>19</volume>(<issue>6</issue>):<fpage>1452</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/me.2005-0057" xlink:type="simple">10.1210/me.2005-0057</ext-link></comment> <object-id pub-id-type="pmid">15761026</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref094"><label>94</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Waddell</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Baehr</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>van den Brandt</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Johnsen</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Reichardt</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Furlow</surname> <given-names>JD</given-names></name>, <etal>et al</etal>. <article-title>The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2008</year>;<volume>295</volume>(<issue>4</issue>):<fpage>E785</fpage>–<lpage>97</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpendo.00646.2007" xlink:type="simple">10.1152/ajpendo.00646.2007</ext-link></comment> <object-id pub-id-type="pmid">18612045</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref095"><label>95</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sandri</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sandri</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gilbert</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Skurk</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Calabria</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Picard</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy</article-title>. <source>Cell</source>. <year>2004</year>;<volume>117</volume>(<issue>3</issue>):<fpage>399</fpage>–<lpage>412</lpage>. <object-id pub-id-type="pmid">15109499</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref096"><label>96</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cahill</surname> <given-names>GF</given-names> <suffix>Jr</suffix></name>. <article-title>Fuel metabolism in starvation</article-title>. <source>Annu Rev Nutr</source>. <year>2006</year>;<volume>26</volume>:<fpage>1</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.nutr.26.061505.111258" xlink:type="simple">10.1146/annurev.nutr.26.061505.111258</ext-link></comment> <object-id pub-id-type="pmid">16848698</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref097"><label>97</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kalsbeek</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Yi</surname> <given-names>CX</given-names></name>, <name name-style="western"><surname>La Fleur</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Fliers</surname> <given-names>E</given-names></name>. <article-title>The hypothalamic clock and its control of glucose homeostasis</article-title>. <source>Trends Endocrinol Metab</source>. <year>2010</year>;<volume>21</volume>(<issue>7</issue>):<fpage>402</fpage>–<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tem.2010.02.005" xlink:type="simple">10.1016/j.tem.2010.02.005</ext-link></comment> <object-id pub-id-type="pmid">20303779</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref098"><label>98</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Perelis</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ramsey</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Bass</surname> <given-names>J</given-names></name>. <article-title>The molecular clock as a metabolic rheostat</article-title>. <source>Diabetes Obes Metab</source>. <year>2015</year>;<volume>17</volume> <issue>Suppl 1</issue>:<fpage>99</fpage>–<lpage>105</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/dom.12521" xlink:type="simple">10.1111/dom.12521</ext-link></comment> <object-id pub-id-type="pmid">26332974</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref099"><label>99</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Welch</surname> <given-names>RD</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Sengupta</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Carpenter</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Stephens</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Arnett</surname> <given-names>SA</given-names></name>, <etal>et al</etal>. <article-title>Rev-Erb co-regulates muscle regeneration via tethered interaction with the NF-Y cistrome</article-title>. <source>Mol Metab</source>. <year>2017</year>;<volume>6</volume>(<issue>7</issue>):<fpage>703</fpage>–<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molmet.2017.05.001" xlink:type="simple">10.1016/j.molmet.2017.05.001</ext-link></comment> <object-id pub-id-type="pmid">28702326</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref100"><label>100</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Green</surname> <given-names>S</given-names></name>. <article-title>Nuclear hormone receptors. Promiscuous liaisons</article-title>. <source>Nature</source>. <year>1993</year>;<volume>361</volume>(<issue>6413</issue>):<fpage>590</fpage>–<lpage>1</lpage>. <object-id pub-id-type="pmid">8382343</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref101"><label>101</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gronemeyer</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Moras</surname> <given-names>D</given-names></name>. <article-title>Nuclear receptors. How to finger DNA</article-title>. <source>Nature</source>. <year>1995</year>;<volume>375</volume>(<issue>6528</issue>):<fpage>190</fpage>–<lpage>1</lpage>. <object-id pub-id-type="pmid">7746310</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref102"><label>102</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bosma</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sparks</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Hooiveld</surname> <given-names>GJ</given-names></name>, <name name-style="western"><surname>Jorgensen</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Houten</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Schrauwen</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Overexpression of PLIN5 in skeletal muscle promotes oxidative gene expression and intramyocellular lipid content without compromising insulin sensitivity</article-title>. <source>Biochim Biophys Acta</source>. <year>2013</year>;<volume>1831</volume>(<issue>4</issue>):<fpage>844</fpage>–<lpage>52</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbalip.2013.01.007" xlink:type="simple">10.1016/j.bbalip.2013.01.007</ext-link></comment> <object-id pub-id-type="pmid">23353597</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref103"><label>103</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gachon</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Olela</surname> <given-names>FF</given-names></name>, <name name-style="western"><surname>Schaad</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Descombes</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Schibler</surname> <given-names>U</given-names></name>. <article-title>The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification</article-title>. <source>Cell Metab</source>. <year>2006</year>;<volume>4</volume>(<issue>1</issue>):<fpage>25</fpage>–<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cmet.2006.04.015" xlink:type="simple">10.1016/j.cmet.2006.04.015</ext-link></comment> <object-id pub-id-type="pmid">16814730</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref104"><label>104</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gachon</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Leuenberger</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Claudel</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Gos</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Jouffe</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fleury Olela</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Proline- and acidic amino acid-rich basic leucine zipper proteins modulate peroxisome proliferator-activated receptor alpha (PPARalpha) activity</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>108</volume>(<issue>12</issue>):<fpage>4794</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1002862108" xlink:type="simple">10.1073/pnas.1002862108</ext-link></comment> <object-id pub-id-type="pmid">21383142</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref105"><label>105</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Keniry</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Dearth</surname> <given-names>RK</given-names></name>, <name name-style="western"><surname>Persans</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Parsons</surname> <given-names>R</given-names></name>. <article-title>New Frontiers for the NFIL3 bZIP Transcription Factor in Cancer, Metabolism and Beyond</article-title>. <source>Discoveries (Craiova)</source>. <year>2014</year>;<volume>2</volume>(<issue>2</issue>):<fpage>e15</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15190/d.2014.7" xlink:type="simple">10.15190/d.2014.7</ext-link></comment> <object-id pub-id-type="pmid">26539561</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref106"><label>106</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakao</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Shimba</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Oishi</surname> <given-names>K</given-names></name>. <article-title>Muscle Bmal1 is Dispensable for the Progress of Neurogenic Muscle Atrophy in Mice</article-title>. <source>Journal of Circadian Rhythms</source>. <year>2016</year>; <volume>14</volume>(<issue>1</issue>):p.<fpage>6</fpage>. <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.5334/jcr.141" xlink:type="simple">http://doi.org/10.5334/jcr.141</ext-link>.</mixed-citation></ref>
<ref id="pbio.2005886.ref107"><label>107</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Quy</surname> <given-names>PN</given-names></name>, <name name-style="western"><surname>Kuma</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pierre</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mizushima</surname> <given-names>N</given-names></name>. <article-title>Proteasome-dependent activation of mammalian target of rapamycin complex 1 (mTORC1) is essential for autophagy suppression and muscle remodeling following denervation</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>2</issue>):<fpage>1125</fpage>–<lpage>34</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M112.399949" xlink:type="simple">10.1074/jbc.M112.399949</ext-link></comment> <object-id pub-id-type="pmid">23209294</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref108"><label>108</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bell</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Al-Khalaf</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Megeney</surname> <given-names>LA</given-names></name>. <article-title>The beneficial role of proteolysis in skeletal muscle growth and stress adaptation</article-title>. <source>Skelet Muscle</source>. <year>2016</year>;<volume>6</volume>:<fpage>16</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13395-016-0086-6" xlink:type="simple">10.1186/s13395-016-0086-6</ext-link></comment> <object-id pub-id-type="pmid">27054028</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref109"><label>109</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Evans</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nasim</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Butler</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kauser</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Varoqui</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Acidosis-sensing glutamine pump SNAT2 determines amino acid levels and mammalian target of rapamycin signalling to protein synthesis in L6 muscle cells</article-title>. <source>J Am Soc Nephrol</source>. <year>2007</year>;<volume>18</volume>(<issue>5</issue>):<fpage>1426</fpage>–<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1681/ASN.2006091014" xlink:type="simple">10.1681/ASN.2006091014</ext-link></comment> <object-id pub-id-type="pmid">17429052</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref110"><label>110</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hundal</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Taylor</surname> <given-names>PM</given-names></name>. <article-title>Amino acid transceptors: gate keepers of nutrient exchange and regulators of nutrient signaling</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2009</year>;<volume>296</volume>(<issue>4</issue>):<fpage>E603</fpage>–<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpendo.91002.2008" xlink:type="simple">10.1152/ajpendo.91002.2008</ext-link></comment> <object-id pub-id-type="pmid">19158318</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref111"><label>111</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zurlo</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Larson</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Bogardus</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ravussin</surname> <given-names>E</given-names></name>. <article-title>Skeletal muscle metabolism is a major determinant of resting energy expenditure</article-title>. <source>J Clin Invest</source>. <year>1990</year>;<volume>86</volume>(<issue>5</issue>):<fpage>1423</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI114857" xlink:type="simple">10.1172/JCI114857</ext-link></comment> <object-id pub-id-type="pmid">2243122</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref112"><label>112</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Waterlow</surname> <given-names>JC</given-names></name>. <article-title>Whole-body protein turnover in humans—past, present, and future</article-title>. <source>Annu Rev Nutr</source>. <year>1995</year>;<volume>15</volume>:<fpage>57</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.nu.15.070195.000421" xlink:type="simple">10.1146/annurev.nu.15.070195.000421</ext-link></comment> <object-id pub-id-type="pmid">8527232</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref113"><label>113</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lipton</surname> <given-names>JO</given-names></name>, <name name-style="western"><surname>Yuan</surname> <given-names>ED</given-names></name>, <name name-style="western"><surname>Boyle</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Ebrahimi-Fakhari</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kwiatkowski</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Nathan</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>The Circadian Protein BMAL1 Regulates Translation in Response to S6K1-Mediated Phosphorylation</article-title>. <source>Cell</source>. <year>2015</year>;<volume>161</volume>(<issue>5</issue>):<fpage>1138</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2015.04.002" xlink:type="simple">10.1016/j.cell.2015.04.002</ext-link></comment> <object-id pub-id-type="pmid">25981667</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref114"><label>114</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Henshaw</surname> <given-names>EC</given-names></name>, <name name-style="western"><surname>Hirsch</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Morton</surname> <given-names>BE</given-names></name>, <name name-style="western"><surname>Hiatt</surname> <given-names>HH</given-names></name>. <article-title>Control of protein synthesis in mammalian tissues through changes in ribosome activity</article-title>. <source>J Biol Chem</source>. <year>1971</year>;<volume>246</volume>(<issue>2</issue>):<fpage>436</fpage>–<lpage>46</lpage>. <object-id pub-id-type="pmid">5542013</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref115"><label>115</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garelick</surname> <given-names>MG</given-names></name>, <name name-style="western"><surname>Mackay</surname> <given-names>VL</given-names></name>, <name name-style="western"><surname>Yanagida</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Academia</surname> <given-names>EC</given-names></name>, <name name-style="western"><surname>Schreiber</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Ladiges</surname> <given-names>WC</given-names></name>, <etal>et al</etal>. <article-title>Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo</article-title>. <source>Cell Cycle</source>. <year>2013</year>;<volume>12</volume>(<issue>15</issue>):<fpage>2493</fpage>–<lpage>504</lpage>. <object-id pub-id-type="pmid">23839034</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref116"><label>116</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mieulet</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Roceri</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Espeillac</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Sotiropoulos</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ohanna</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Oorschot</surname> <given-names>V</given-names></name>, <etal>et al</etal>. <article-title>S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover</article-title>. <source>Am J Physiol Cell Physiol</source>. <year>2007</year>;<volume>293</volume>(<issue>2</issue>):<fpage>C712</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpcell.00499.2006" xlink:type="simple">10.1152/ajpcell.00499.2006</ext-link></comment> <object-id pub-id-type="pmid">17494629</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref117"><label>117</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kimball</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Jefferson</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Nguyen</surname> <given-names>HV</given-names></name>, <name name-style="western"><surname>Suryawan</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bush</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Davis</surname> <given-names>TA</given-names></name>. <article-title>Feeding stimulates protein synthesis in muscle and liver of neonatal pigs through an mTOR-dependent process</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2000</year>;<volume>279</volume>(<issue>5</issue>):<fpage>E1080</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpendo.2000.279.5.E1080" xlink:type="simple">10.1152/ajpendo.2000.279.5.E1080</ext-link></comment> <object-id pub-id-type="pmid">11052963</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref118"><label>118</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Suryawan</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Nguyen</surname> <given-names>HV</given-names></name>, <name name-style="western"><surname>Almonaci</surname> <given-names>RD</given-names></name>, <name name-style="western"><surname>Davis</surname> <given-names>TA</given-names></name>. <article-title>Differential regulation of protein synthesis in skeletal muscle and liver of neonatal pigs by leucine through an mTORC1-dependent pathway</article-title>. <source>J Anim Sci Biotechnol</source>. <year>2012</year>;<volume>3</volume>(<issue>3</issue>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/2049-1891-3-3" xlink:type="simple">10.1186/2049-1891-3-3</ext-link></comment> <object-id pub-id-type="pmid">22675606</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref119"><label>119</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anthony</surname> <given-names>TG</given-names></name>, <name name-style="western"><surname>Anthony</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Yoshizawa</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Kimball</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Jefferson</surname> <given-names>LS</given-names></name>. <article-title>Oral administration of leucine stimulates ribosomal protein mRNA translation but not global rates of protein synthesis in the liver of rats</article-title>. <source>J Nutr</source>. <year>2001</year>;<volume>131</volume>(<issue>4</issue>):<fpage>1171</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/jn/131.4.1171" xlink:type="simple">10.1093/jn/131.4.1171</ext-link></comment> <object-id pub-id-type="pmid">11285321</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref120"><label>120</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anthony</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Yoshizawa</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Anthony</surname> <given-names>TG</given-names></name>, <name name-style="western"><surname>Vary</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Jefferson</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Kimball</surname> <given-names>SR</given-names></name>. <article-title>Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway</article-title>. <source>J Nutr</source>. <year>2000</year>;<volume>130</volume>(<issue>10</issue>):<fpage>2413</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/jn/130.10.2413" xlink:type="simple">10.1093/jn/130.10.2413</ext-link></comment> <object-id pub-id-type="pmid">11015466</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref121"><label>121</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anthony</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Anthony</surname> <given-names>TG</given-names></name>, <name name-style="western"><surname>Kimball</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Vary</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Jefferson</surname> <given-names>LS</given-names></name>. <article-title>Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation</article-title>. <source>J Nutr</source>. <year>2000</year>;<volume>130</volume>(<issue>2</issue>):<fpage>139</fpage>–<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/jn/130.2.139" xlink:type="simple">10.1093/jn/130.2.139</ext-link></comment> <object-id pub-id-type="pmid">10720160</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref122"><label>122</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marabita</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Baraldo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Solagna</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ceelen</surname> <given-names>JJM</given-names></name>, <name name-style="western"><surname>Sartori</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Nolte</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>S6K1 Is Required for Increasing Skeletal Muscle Force during Hypertrophy</article-title>. <source>Cell Rep</source>. <year>2016</year>;<volume>17</volume>(<issue>2</issue>):<fpage>501</fpage>–<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2016.09.020" xlink:type="simple">10.1016/j.celrep.2016.09.020</ext-link></comment> <object-id pub-id-type="pmid">27705797</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref123"><label>123</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pastore</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hood</surname> <given-names>DA</given-names></name>. <article-title>Endurance training ameliorates the metabolic and performance characteristics of circadian Clock mutant mice</article-title>. <source>J Appl Physiol (1985)</source>. <year>2013</year>;<volume>114</volume>(<issue>8</issue>):<fpage>1076</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.01505.2012" xlink:type="simple">10.1152/japplphysiol.01505.2012</ext-link></comment> <object-id pub-id-type="pmid">23429867</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref124"><label>124</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kojetin</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kamenecka</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Burris</surname> <given-names>TP</given-names></name>. <article-title>Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB</article-title>. <source>ACS Chem Biol</source>. <year>2011</year>;<volume>6</volume>(<issue>2</issue>):<fpage>131</fpage>–<lpage>4</lpage>. <object-id pub-id-type="pmid">21043485</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref125"><label>125</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kojetin</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Burris</surname> <given-names>TP</given-names></name>. <article-title>REV-ERB and ROR nuclear receptors as drug targets</article-title>. <source>Nat Rev Drug Discov</source>. <year>2014</year>;<volume>13</volume>(<issue>3</issue>):<fpage>197</fpage>–<lpage>216</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrd4100" xlink:type="simple">10.1038/nrd4100</ext-link></comment> <object-id pub-id-type="pmid">24577401</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref126"><label>126</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Laher</surname> <given-names>I</given-names></name>. <article-title>Exercise Pills: At the Starting Line</article-title>. <source>Trends Pharmacol Sci</source>. <year>2015</year>;<volume>36</volume>(<issue>12</issue>):<fpage>906</fpage>–<lpage>17</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tips.2015.08.014" xlink:type="simple">10.1016/j.tips.2015.08.014</ext-link></comment> <object-id pub-id-type="pmid">26439443</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref127"><label>127</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Welch</surname> <given-names>RD</given-names></name>, <name name-style="western"><surname>Billon</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Valfort</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Burris</surname> <given-names>TP</given-names></name>, <name name-style="western"><surname>Flaveny</surname> <given-names>CA</given-names></name>. <article-title>Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle</article-title>. <source>Sci Rep</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>17142</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41598-017-17496-7" xlink:type="simple">10.1038/s41598-017-17496-7</ext-link></comment> <object-id pub-id-type="pmid">29215066</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref128"><label>128</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ehlen</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Brager</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Baggs</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Pinckney</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Gray</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>DeBruyne</surname> <given-names>JP</given-names></name>, <etal>et al</etal>. <article-title>Bmal1 function in skeletal muscle regulates sleep</article-title>. <source>Elife</source>. <year>2017</year>;<volume>6</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.26557" xlink:type="simple">10.7554/eLife.26557</ext-link></comment> <object-id pub-id-type="pmid">28726633</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref129"><label>129</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McDearmon</surname> <given-names>EL</given-names></name>, <name name-style="western"><surname>Patel</surname> <given-names>KN</given-names></name>, <name name-style="western"><surname>Ko</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Walisser</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Schook</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Chong</surname> <given-names>JL</given-names></name>, <etal>et al</etal>. <article-title>Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice</article-title>. <source>Science</source>. <year>2006</year>;<volume>314</volume>(<issue>5803</issue>):<fpage>1304</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1132430" xlink:type="simple">10.1126/science.1132430</ext-link></comment> <object-id pub-id-type="pmid">17124323</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref130"><label>130</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hansen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Timmers</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Moonen-Kornips</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Duez</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Staels</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hesselink</surname> <given-names>MK</given-names></name>, <etal>et al</etal>. <article-title>Synchronized human skeletal myotubes of lean, obese and type 2 diabetic patients maintain circadian oscillation of clock genes</article-title>. <source>Sci Rep</source>. <year>2016</year>;<volume>6</volume>:<fpage>35047</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep35047" xlink:type="simple">10.1038/srep35047</ext-link></comment> <object-id pub-id-type="pmid">27756900</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref131"><label>131</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Loizides-Mangold</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Perrin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Vandereycken</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Betts</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Walhin</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Templeman</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Lipidomics reveals diurnal lipid oscillations in human skeletal muscle persisting in cellular myotubes cultured in vitro</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2017</year>;<volume>114</volume>(<issue>41</issue>):<fpage>E8565</fpage>–<lpage>E74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1705821114" xlink:type="simple">10.1073/pnas.1705821114</ext-link></comment> <object-id pub-id-type="pmid">28973848</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref132"><label>132</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Perrin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Loizides-Mangold</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Chanon</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gobet</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Hulo</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Isenegger</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Transcriptomic analyses reveal rhythmic and CLOCK-driven pathways in human skeletal muscle</article-title>. <source>Elife</source>. <year>2018</year>;<volume>7</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.34114" xlink:type="simple">10.7554/eLife.34114</ext-link></comment> <object-id pub-id-type="pmid">29658882</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref133"><label>133</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Perrin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Loizides-Mangold</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Skarupelova</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Pulimeno</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Chanon</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Robert</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Human skeletal myotubes display a cell-autonomous circadian clock implicated in basal myokine secretion</article-title>. <source>Mol Metab</source>. <year>2015</year>;<volume>4</volume>(<issue>11</issue>):<fpage>834</fpage>–<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molmet.2015.07.009" xlink:type="simple">10.1016/j.molmet.2015.07.009</ext-link></comment> <object-id pub-id-type="pmid">26629407</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref134"><label>134</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Moorsel</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Hansen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Havekes</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Scheer</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Jorgensen</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Hoeks</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Demonstration of a day-night rhythm in human skeletal muscle oxidative capacity</article-title>. <source>Mol Metab</source>. <year>2016</year>;<volume>5</volume>(<issue>8</issue>):<fpage>635</fpage>–<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molmet.2016.06.012" xlink:type="simple">10.1016/j.molmet.2016.06.012</ext-link></comment> <object-id pub-id-type="pmid">27656401</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref135"><label>135</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Waters</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Redfern</surname> <given-names>SI</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mao</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Annex</surname> <given-names>BH</given-names></name>, <etal>et al</etal>. <article-title>Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice</article-title>. <source>Am J Pathol</source>. <year>2007</year>;<volume>170</volume>(<issue>2</issue>):<fpage>599</fpage>–<lpage>608</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2353/ajpath.2007.060505" xlink:type="simple">10.2353/ajpath.2007.060505</ext-link></comment> <object-id pub-id-type="pmid">17255328</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref136"><label>136</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Antonione</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Caliandro</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Zorat</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Guarnieri</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Heer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Biolo</surname> <given-names>G</given-names></name>. <article-title>Whey protein ingestion enhances postprandial anabolism during short-term bed rest in young men</article-title>. <source>J Nutr</source>. <year>2008</year>;<volume>138</volume>(<issue>11</issue>):<fpage>2212</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3945/jn.108.086462" xlink:type="simple">10.3945/jn.108.086462</ext-link></comment> <object-id pub-id-type="pmid">18936221</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref137"><label>137</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Uhlenhaut</surname> <given-names>NH</given-names></name>, <name name-style="western"><surname>Barish</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Downes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Karunasiri</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Liddle</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes</article-title>. <source>Mol Cell</source>. <year>2013</year>;<volume>49</volume>(<issue>1</issue>):<fpage>158</fpage>–<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2012.10.013" xlink:type="simple">10.1016/j.molcel.2012.10.013</ext-link></comment> <object-id pub-id-type="pmid">23159735</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref138"><label>138</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Durbin</surname> <given-names>R</given-names></name>. <article-title>Fast and accurate long-read alignment with Burrows-Wheeler transform</article-title>. <source>Bioinformatics</source>. <year>2010</year>;<volume>26</volume>(<issue>5</issue>):<fpage>589</fpage>–<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btp698" xlink:type="simple">10.1093/bioinformatics/btp698</ext-link></comment> <object-id pub-id-type="pmid">20080505</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref139"><label>139</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Handsaker</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Wysoker</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Fennell</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ruan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Homer</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinformatics</source>. <year>2009</year>;<volume>25</volume>(<issue>16</issue>):<fpage>2078</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btp352" xlink:type="simple">10.1093/bioinformatics/btp352</ext-link></comment> <object-id pub-id-type="pmid">19505943</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref140"><label>140</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barnett</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Garrison</surname> <given-names>EK</given-names></name>, <name name-style="western"><surname>Quinlan</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Stromberg</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Marth</surname> <given-names>GT</given-names></name>. <article-title>BamTools: a C++ API and toolkit for analyzing and managing BAM files</article-title>. <source>Bioinformatics</source>. <year>2011</year>;<volume>27</volume>(<issue>12</issue>):<fpage>1691</fpage>–<lpage>2</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btr174" xlink:type="simple">10.1093/bioinformatics/btr174</ext-link></comment> <object-id pub-id-type="pmid">21493652</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref141"><label>141</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Meyer</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Eeckhoute</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Bernstein</surname> <given-names>BE</given-names></name>, <etal>et al</etal>. <article-title>Model-based analysis of ChIP-Seq (MACS)</article-title>. <source>Genome Biol</source>. <year>2008</year>;<volume>9</volume>(<issue>9</issue>):<fpage>R137</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/gb-2008-9-9-r137" xlink:type="simple">10.1186/gb-2008-9-9-r137</ext-link></comment> <object-id pub-id-type="pmid">18798982</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref142"><label>142</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Freese</surname> <given-names>NH</given-names></name>, <name name-style="western"><surname>Norris</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Loraine</surname> <given-names>AE</given-names></name>. <article-title>Integrated genome browser: visual analytics platform for genomics</article-title>. <source>Bioinformatics</source>. <year>2016</year>;<volume>32</volume>(<issue>14</issue>):<fpage>2089</fpage>–<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btw069" xlink:type="simple">10.1093/bioinformatics/btw069</ext-link></comment> <object-id pub-id-type="pmid">27153568</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref143"><label>143</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramirez</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Dundar</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Diehl</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gruning</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Manke</surname> <given-names>T</given-names></name>. <article-title>deepTools: a flexible platform for exploring deep-sequencing data</article-title>. <source>Nucleic Acids Res</source>. <year>2014</year>;<volume>42</volume>(<issue>Web Server issue</issue>):<fpage>W187</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gku365" xlink:type="simple">10.1093/nar/gku365</ext-link></comment> <object-id pub-id-type="pmid">24799436</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref144"><label>144</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Heinz</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Benner</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Spann</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Bertolino</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Laslo</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title>. <source>Mol Cell</source>. <year>2010</year>;<volume>38</volume>(<issue>4</issue>):<fpage>576</fpage>–<lpage>89</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2010.05.004" xlink:type="simple">10.1016/j.molcel.2010.05.004</ext-link></comment> <object-id pub-id-type="pmid">20513432</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref145"><label>145</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mudge</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Harrow</surname> <given-names>J</given-names></name>. <article-title>Creating reference gene annotation for the mouse C57BL6/J genome assembly</article-title>. <source>Mamm Genome</source>. <year>2015</year>;<volume>26</volume>(<issue>9–10</issue>):<fpage>366</fpage>–<lpage>78</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00335-015-9583-x" xlink:type="simple">10.1007/s00335-015-9583-x</ext-link></comment> <object-id pub-id-type="pmid">26187010</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref146"><label>146</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frith</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Fu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Hansen</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Weng</surname> <given-names>Z</given-names></name>. <article-title>Detection of functional DNA motifs via statistical over-representation</article-title>. <source>Nucleic Acids Res</source>. <year>2004</year>;<volume>32</volume>(<issue>4</issue>):<fpage>1372</fpage>–<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkh299" xlink:type="simple">10.1093/nar/gkh299</ext-link></comment> <object-id pub-id-type="pmid">14988425</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref147"><label>147</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eckel-Mahan</surname> <given-names>KL</given-names></name>, <name name-style="western"><surname>Patel</surname> <given-names>VR</given-names></name>, <name name-style="western"><surname>Mohney</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Vignola</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Baldi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sassone-Corsi</surname> <given-names>P</given-names></name>. <article-title>Coordination of the transcriptome and metabolome by the circadian clock</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2012</year>;<volume>109</volume>(<issue>14</issue>):<fpage>5541</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1118726109" xlink:type="simple">10.1073/pnas.1118726109</ext-link></comment> <object-id pub-id-type="pmid">22431615</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref148"><label>148</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shin</surname> <given-names>SY</given-names></name>, <name name-style="western"><surname>Fauman</surname> <given-names>EB</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Krumsiek</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Santos</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>An atlas of genetic influences on human blood metabolites</article-title>. <source>Nat Genet</source>. <year>2014</year>;<volume>46</volume>(<issue>6</issue>):<fpage>543</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.2982" xlink:type="simple">10.1038/ng.2982</ext-link></comment> <object-id pub-id-type="pmid">24816252</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref149"><label>149</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Folch</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lees</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sloane Stanley</surname> <given-names>GH</given-names></name>. <article-title>A simple method for the isolation and purification of total lipides from animal tissues</article-title>. <source>J Biol Chem</source>. <year>1957</year>;<volume>226</volume>(<issue>1</issue>):<fpage>497</fpage>–<lpage>509</lpage>. <object-id pub-id-type="pmid">13428781</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref150"><label>150</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knittelfelder</surname> <given-names>OL</given-names></name>, <name name-style="western"><surname>Weberhofer</surname> <given-names>BP</given-names></name>, <name name-style="western"><surname>Eichmann</surname> <given-names>TO</given-names></name>, <name name-style="western"><surname>Kohlwein</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Rechberger</surname> <given-names>GN</given-names></name>. <article-title>A versatile ultra-high performance LC-MS method for lipid profiling</article-title>. <source>J Chromatogr B Analyt Technol Biomed Life Sci</source>. <year>2014</year>;<volume>951–952</volume>:<fpage>119</fpage>–<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jchromb.2014.01.011" xlink:type="simple">10.1016/j.jchromb.2014.01.011</ext-link></comment> <object-id pub-id-type="pmid">24548922</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref151"><label>151</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hartler</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Trotzmuller</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chitraju</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Spener</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Kofeler</surname> <given-names>HC</given-names></name>, <name name-style="western"><surname>Thallinger</surname> <given-names>GG</given-names></name>. <article-title>Lipid Data Analyzer: unattended identification and quantitation of lipids in LC-MS data</article-title>. <source>Bioinformatics</source>. <year>2011</year>;<volume>27</volume>(<issue>4</issue>):<fpage>572</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btq699" xlink:type="simple">10.1093/bioinformatics/btq699</ext-link></comment> <object-id pub-id-type="pmid">21169379</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref152"><label>152</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spinazzi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Casarin</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pertegato</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Salviati</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Angelini</surname> <given-names>C</given-names></name>. <article-title>Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells</article-title>. <source>Nat Protoc</source>. <year>2012</year>;<volume>7</volume>(<issue>6</issue>):<fpage>1235</fpage>–<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nprot.2012.058" xlink:type="simple">10.1038/nprot.2012.058</ext-link></comment> <object-id pub-id-type="pmid">22653162</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref153"><label>153</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Romanello</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Guadagnin</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Gomes</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Roder</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Sandri</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Mitochondrial fission and remodelling contributes to muscle atrophy</article-title>. <source>EMBO J</source>. <year>2010</year>;<volume>29</volume>(<issue>10</issue>):<fpage>1774</fpage>–<lpage>85</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/emboj.2010.60" xlink:type="simple">10.1038/emboj.2010.60</ext-link></comment> <object-id pub-id-type="pmid">20400940</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref154"><label>154</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kiyohara</surname> <given-names>YB</given-names></name>, <name name-style="western"><surname>Tagao</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tamanini</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Morita</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sugisawa</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yasuda</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>The BMAL1 C terminus regulates the circadian transcription feedback loop</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2006</year>;<volume>103</volume>(<issue>26</issue>):<fpage>10074</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0601416103" xlink:type="simple">10.1073/pnas.0601416103</ext-link></comment> <object-id pub-id-type="pmid">16777965</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref155"><label>155</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kondratov</surname> <given-names>RV</given-names></name>, <name name-style="western"><surname>Chernov</surname> <given-names>MV</given-names></name>, <name name-style="western"><surname>Kondratova</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Gorbacheva</surname> <given-names>VY</given-names></name>, <name name-style="western"><surname>Gudkov</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Antoch</surname> <given-names>MP</given-names></name>. <article-title>BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system</article-title>. <source>Genes Dev</source>. <year>2003</year>;<volume>17</volume>(<issue>15</issue>):<fpage>1921</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gad.1099503" xlink:type="simple">10.1101/gad.1099503</ext-link></comment> <object-id pub-id-type="pmid">12897057</object-id>.</mixed-citation></ref>
<ref id="pbio.2005886.ref156"><label>156</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akimoto</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sorg</surname> <given-names>BS</given-names></name>, <name name-style="western"><surname>Yan</surname> <given-names>Z</given-names></name>. <article-title>Real-time imaging of peroxisome proliferator-activated receptor-gamma coactivator-1alpha promoter activity in skeletal muscles of living mice</article-title>. <source>Am J Physiol Cell Physiol</source>. <year>2004</year>;<volume>287</volume>(<issue>3</issue>):<fpage>C790</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpcell.00425.2003" xlink:type="simple">10.1152/ajpcell.00425.2003</ext-link></comment> <object-id pub-id-type="pmid">15151904</object-id>.</mixed-citation></ref>
</ref-list>
</back>
</article>